id	sid	tid	token	lemma	pos
aji-159	1	1	_	_	PUNCT
aji-159	2	1	_	_	PUNCT
aji-159	3	1	_	_	PUNCT
aji-159	4	1	_	_	PUNCT
aji-159	5	1	_	_	PUNCT
aji-159	6	1	_	_	PUNCT
aji-159	7	1	_	_	PUNCT
aji-159	8	1	_	_	PUNCT
aji-159	9	1	_	_	PUNCT
aji-159	10	1	_	_	PUNCT
aji-159	11	1	_	_	PUNCT
aji-159	12	1	_	_	PUNCT
aji-159	13	1	_	_	PUNCT
aji-159	14	1	_	_	PUNCT
aji-159	15	1	_	_	PUNCT
aji-159	16	1	_	_	PUNCT
aji-159	17	1	_	_	PUNCT
aji-159	18	1	_	_	PUNCT
aji-159	19	1	_	_	PUNCT
aji-159	20	1	_	_	PUNCT
aji-159	21	1	_	_	PUNCT
aji-159	22	1	_	_	PUNCT
aji-159	23	1	_	_	PUNCT
aji-159	24	1	_	_	PUNCT
aji-159	25	1	_	_	PUNCT
aji-159	26	1	_	_	PUNCT
aji-159	27	1	_	_	PUNCT
aji-159	28	1	_	_	PUNCT
aji-159	29	1	_	_	PUNCT
aji-159	30	1	_	_	PUNCT
aji-159	31	1	_	_	PUNCT
aji-159	32	1	_	_	PUNCT
aji-159	33	1	_	_	PUNCT
aji-159	34	1	_	_	PUNCT
aji-159	35	1	_	_	PUNCT
aji-159	36	1	_	_	PUNCT
aji-159	37	1	_	_	PUNCT
aji-159	38	1	_	_	PUNCT
aji-159	39	1	_	_	PUNCT
aji-159	40	1	_	_	PUNCT
aji-159	41	1	_	_	PUNCT
aji-159	42	1	_	_	PUNCT
aji-159	43	1	_	_	PUNCT
aji-159	44	1	_	_	PUNCT
aji-159	45	1	_	_	PUNCT
aji-159	46	1	_	_	PUNCT
aji-159	47	1	_	_	PUNCT
aji-159	48	1	_	_	PUNCT
aji-159	49	1	_	_	PUNCT
aji-159	50	1	_	_	PUNCT
aji-159	51	1	_	_	PUNCT
aji-159	52	1	_	_	PUNCT
aji-159	53	1	_	_	PUNCT
aji-159	54	1	_	_	PUNCT
aji-159	55	1	_	_	PUNCT
aji-159	56	1	_	_	PUNCT
aji-159	57	1	_	_	PUNCT
aji-159	58	1	_	_	PUNCT
aji-159	59	1	_	_	PUNCT
aji-159	60	1	_	_	PUNCT
aji-159	61	1	_	_	PUNCT
aji-159	62	1	_	_	PUNCT
aji-159	63	1	_	_	PUNCT
aji-159	64	1	_	_	PUNCT
aji-159	65	1	_	_	PUNCT
aji-159	66	1	_	_	PUNCT
aji-159	67	1	_	_	PUNCT
aji-159	68	1	_	_	PUNCT
aji-159	69	1	_	_	PUNCT
aji-159	70	1	_	_	PUNCT
aji-159	71	1	_	_	PUNCT
aji-159	72	1	_	_	PUNCT
aji-159	73	1	_	_	PUNCT
aji-159	74	1	_	_	PUNCT
aji-159	75	1	_	_	PUNCT
aji-159	76	1	_	_	PUNCT
aji-159	77	1	_	_	PUNCT
aji-159	78	1	_	_	PUNCT
aji-159	79	1	_	_	PUNCT
aji-159	80	1	_	_	PUNCT
aji-159	81	1	_	_	PUNCT
aji-159	82	1	_	_	PUNCT
aji-159	83	1	_	_	PUNCT
aji-159	84	1	_	_	PUNCT
aji-159	85	1	_	_	PUNCT
aji-159	86	1	_	_	PUNCT
aji-159	87	1	_	_	PUNCT
aji-159	88	1	_	_	PUNCT
aji-159	89	1	_	_	PUNCT
aji-159	90	1	_	_	PUNCT
aji-159	91	1	_	_	PUNCT
aji-159	92	1	_	_	PUNCT
aji-159	93	1	_	_	PUNCT
aji-159	94	1	_	_	PUNCT
aji-159	95	1	_	_	PUNCT
aji-159	96	1	_	_	PUNCT
aji-159	97	1	_	_	PUNCT
aji-159	98	1	_	_	PUNCT
aji-159	99	1	_	_	PUNCT
aji-159	100	1	_	_	PUNCT
aji-159	101	1	_	_	PUNCT
aji-159	102	1	*	*	PUNCT
aji-159	102	2	corresponding	correspond	VERB
aji-159	102	3	author	author	NOUN
aji-159	102	4	:	:	PUNCT
aji-159	102	5	e	e	NOUN
aji-159	102	6	-	-	NOUN
aji-159	102	7	mail	mail	NOUN
aji-159	102	8	:	:	PUNCT
aji-159	102	9	ahmedkhalaf214@gmail.com	ahmedkhalaf214@gmail.com	NUM
aji-159	102	10	;	;	PUNCT
aji-159	102	11	cite	cite	VERB
aji-159	102	12	as	as	ADP
aji-159	102	13	:	:	PUNCT
aji-159	102	14	khalaf	khalaf	PROPN
aji-159	102	15	,	,	PUNCT
aji-159	102	16	ahmed	ahmed	PROPN
aji-159	102	17	a.	a.	PROPN
aji-159	102	18	m.	m.	PROPN
aji-159	102	19	2025	2025	NUM
aji-159	102	20	.	.	PUNCT
aji-159	103	1	“	"	PUNCT
aji-159	103	2	human	human	ADJ
aji-159	103	3	immunodeficiency	immunodeficiency	NOUN
aji-159	103	4	virus	virus	NOUN
aji-159	103	5	epidemic	epidemic	NOUN
aji-159	103	6	among	among	ADP
aji-159	103	7	people	people	NOUN
aji-159	103	8	who	who	PRON
aji-159	103	9	inject	inject	VERB
aji-159	103	10	drugs	drug	NOUN
aji-159	103	11	and	and	CCONJ
aji-159	103	12	female	female	ADJ
aji-159	103	13	sex	sex	NOUN
aji-159	103	14	workers	worker	NOUN
aji-159	103	15	in	in	ADP
aji-159	103	16	north	north	PROPN
aji-159	103	17	africa	africa	PROPN
aji-159	103	18	:	:	PUNCT
aji-159	103	19	a	a	DET
aji-159	103	20	systematic	systematic	ADJ
aji-159	103	21	review	review	NOUN
aji-159	103	22	”	"	PUNCT
aji-159	103	23	.	.	PUNCT
aji-159	104	1	asian	asian	ADJ
aji-159	104	2	journal	journal	NOUN
aji-159	104	3	of	of	ADP
aji-159	104	4	immunology	immunology	NOUN
aji-159	104	5	8	8	NUM
aji-159	104	6	(	(	PUNCT
aji-159	104	7	1):50	1):50	NUM
aji-159	104	8	-	-	SYM
aji-159	104	9	59	59	NUM
aji-159	104	10	.	.	PUNCT
aji-159	105	1	https://doi.org/10.9734/aji/2025/v8i1159	https://doi.org/10.9734/aji/2025/v8i1159	PROPN
aji-159	105	2	.	.	PUNCT
aji-159	106	1	asian	asian	ADJ
aji-159	106	2	journal	journal	PROPN
aji-159	106	3	of	of	ADP
aji-159	106	4	immunology	immunology	NOUN
aji-159	106	5	volume	volume	NOUN
aji-159	106	6	8	8	NUM
aji-159	106	7	,	,	PUNCT
aji-159	106	8	issue	issue	NOUN
aji-159	106	9	1	1	NUM
aji-159	106	10	,	,	PUNCT
aji-159	106	11	page	page	NOUN
aji-159	106	12	50	50	NUM
aji-159	106	13	-	-	SYM
aji-159	106	14	59	59	NUM
aji-159	106	15	,	,	PUNCT
aji-159	106	16	2025	2025	NUM
aji-159	106	17	;	;	PUNCT
aji-159	106	18	article	article	NOUN
aji-159	106	19	no.aji.125999	no.aji.125999	NOUN
aji-159	106	20	human	human	ADJ
aji-159	106	21	immunodeficiency	immunodeficiency	NOUN
aji-159	106	22	virus	virus	NOUN
aji-159	106	23	epidemic	epidemic	NOUN
aji-159	106	24	among	among	ADP
aji-159	106	25	people	people	NOUN
aji-159	106	26	who	who	PRON
aji-159	106	27	inject	inject	VERB
aji-159	106	28	drugs	drug	NOUN
aji-159	106	29	and	and	CCONJ
aji-159	106	30	female	female	ADJ
aji-159	106	31	sex	sex	NOUN
aji-159	106	32	workers	worker	NOUN
aji-159	106	33	in	in	ADP
aji-159	106	34	north	north	PROPN
aji-159	106	35	africa	africa	PROPN
aji-159	106	36	:	:	PUNCT
aji-159	106	37	a	a	DET
aji-159	106	38	systematic	systematic	ADJ
aji-159	106	39	review	review	NOUN
aji-159	106	40	ahmed	ahmed	PROPN
aji-159	106	41	a.	a.	PROPN
aji-159	106	42	m.	m.	PROPN
aji-159	107	1	khalaf	khalaf	PROPN
aji-159	108	1	a	a	PROPN
aji-159	108	2	*	*	PUNCT
aji-159	108	3	a	a	DET
aji-159	108	4	ministry	ministry	PROPN
aji-159	108	5	of	of	ADP
aji-159	108	6	health	health	PROPN
aji-159	108	7	,	,	PUNCT
aji-159	108	8	tripoli	tripoli	PROPN
aji-159	108	9	,	,	PUNCT
aji-159	108	10	libya	libya	PROPN
aji-159	108	11	.	.	PUNCT
aji-159	109	1	author	author	PROPN
aji-159	109	2	’s	’s	PART
aji-159	109	3	contribution	contribution	NOUN
aji-159	109	4	the	the	DET
aji-159	109	5	sole	sole	ADJ
aji-159	109	6	author	author	NOUN
aji-159	109	7	designed	design	VERB
aji-159	109	8	,	,	PUNCT
aji-159	109	9	analysed	analyse	VERB
aji-159	109	10	,	,	PUNCT
aji-159	109	11	interpreted	interpret	VERB
aji-159	109	12	and	and	CCONJ
aji-159	109	13	prepared	prepare	VERB
aji-159	109	14	the	the	DET
aji-159	109	15	manuscript	manuscript	NOUN
aji-159	109	16	.	.	PUNCT
aji-159	110	1	article	article	NOUN
aji-159	110	2	information	information	PROPN
aji-159	110	3	doi	doi	PROPN
aji-159	110	4	:	:	PUNCT
aji-159	110	5	https://doi.org/10.9734/aji/2025/v8i1159	https://doi.org/10.9734/aji/2025/v8i1159	PROPN
aji-159	110	6	open	open	ADJ
aji-159	110	7	peer	peer	NOUN
aji-159	110	8	review	review	NOUN
aji-159	110	9	history	history	NOUN
aji-159	110	10	:	:	PUNCT
aji-159	110	11	this	this	DET
aji-159	110	12	journal	journal	NOUN
aji-159	110	13	follows	follow	VERB
aji-159	110	14	the	the	DET
aji-159	110	15	advanced	advance	VERB
aji-159	110	16	open	open	ADJ
aji-159	110	17	peer	peer	NOUN
aji-159	110	18	review	review	NOUN
aji-159	110	19	policy	policy	NOUN
aji-159	110	20	.	.	PUNCT
aji-159	111	1	identity	identity	NOUN
aji-159	111	2	of	of	ADP
aji-159	111	3	the	the	DET
aji-159	111	4	reviewers	reviewer	NOUN
aji-159	111	5	,	,	PUNCT
aji-159	111	6	editor(s	editor(s	NOUN
aji-159	111	7	)	)	PUNCT
aji-159	111	8	and	and	CCONJ
aji-159	111	9	additional	additional	ADJ
aji-159	111	10	reviewers	reviewer	NOUN
aji-159	111	11	,	,	PUNCT
aji-159	111	12	peer	peer	NOUN
aji-159	111	13	review	review	NOUN
aji-159	111	14	comments	comment	NOUN
aji-159	111	15	,	,	PUNCT
aji-159	111	16	different	different	ADJ
aji-159	111	17	versions	version	NOUN
aji-159	111	18	of	of	ADP
aji-159	111	19	the	the	DET
aji-159	111	20	manuscript	manuscript	NOUN
aji-159	111	21	,	,	PUNCT
aji-159	111	22	comments	comment	NOUN
aji-159	111	23	of	of	ADP
aji-159	111	24	the	the	DET
aji-159	111	25	editors	editor	NOUN
aji-159	111	26	,	,	PUNCT
aji-159	111	27	etc	etc	X
aji-159	111	28	are	be	AUX
aji-159	111	29	available	available	ADJ
aji-159	111	30	here	here	ADV
aji-159	111	31	:	:	PUNCT
aji-159	111	32	https://pr.sdiarticle5.com/review-history/125999	https://pr.sdiarticle5.com/review-history/125999	PRON
aji-159	111	33	received	receive	VERB
aji-159	111	34	:	:	PUNCT
aji-159	111	35	19/10/2024	19/10/2024	NUM
aji-159	111	36	published	publish	VERB
aji-159	111	37	:	:	PUNCT
aji-159	111	38	18/04/2025	18/04/2025	NUM
aji-159	111	39	abstract	abstract	ADJ
aji-159	111	40	background	background	NOUN
aji-159	111	41	:	:	PUNCT
aji-159	111	42	human	human	ADJ
aji-159	111	43	immunodeficiency	immunodeficiency	NOUN
aji-159	111	44	virus	virus	NOUN
aji-159	111	45	(	(	PUNCT
aji-159	111	46	hiv	hiv	PROPN
aji-159	111	47	)	)	PUNCT
aji-159	111	48	and	and	CCONJ
aji-159	111	49	acquired	acquire	VERB
aji-159	111	50	immunodeficiency	immunodeficiency	NOUN
aji-159	111	51	syndrome	syndrome	NOUN
aji-159	111	52	(	(	PUNCT
aji-159	111	53	aids	aids	PROPN
aji-159	111	54	)	)	PUNCT
aji-159	111	55	remain	remain	VERB
aji-159	111	56	major	major	ADJ
aji-159	111	57	health	health	NOUN
aji-159	111	58	problems	problem	NOUN
aji-159	111	59	worldwide	worldwide	ADV
aji-159	111	60	,	,	PUNCT
aji-159	111	61	with	with	ADP
aji-159	111	62	high	high	ADJ
aji-159	111	63	mortality	mortality	NOUN
aji-159	111	64	and	and	CCONJ
aji-159	111	65	morbidity	morbidity	NOUN
aji-159	111	66	rates	rate	NOUN
aji-159	111	67	,	,	PUNCT
aji-159	111	68	particularly	particularly	ADV
aji-159	111	69	in	in	ADP
aji-159	111	70	developing	develop	VERB
aji-159	111	71	countries	country	NOUN
aji-159	111	72	.	.	PUNCT
aji-159	112	1	the	the	DET
aji-159	112	2	united	united	PROPN
aji-159	112	3	nations	nations	PROPN
aji-159	112	4	programme	programme	PROPN
aji-159	112	5	on	on	ADP
aji-159	112	6	hiv	hiv	PROPN
aji-159	112	7	/	/	SYM
aji-159	112	8	aids	aids	PROPN
aji-159	112	9	(	(	PUNCT
aji-159	112	10	unaids	unaid	NOUN
aji-159	112	11	)	)	PUNCT
aji-159	112	12	reported	report	VERB
aji-159	112	13	that	that	SCONJ
aji-159	112	14	there	there	PRON
aji-159	112	15	were	be	VERB
aji-159	112	16	38.4	38.4	NUM
aji-159	112	17	million	million	NUM
aji-159	112	18	individuals	individual	NOUN
aji-159	112	19	globally	globally	ADV
aji-159	112	20	who	who	PRON
aji-159	112	21	had	have	VERB
aji-159	112	22	hiv	hiv	PROPN
aji-159	112	23	.	.	PUNCT
aji-159	113	1	around	around	ADP
aji-159	113	2	1.5	1.5	NUM
aji-159	113	3	million	million	NUM
aji-159	113	4	new	new	ADJ
aji-159	113	5	hiv	hiv	PROPN
aji-159	113	6	infections	infection	NOUN
aji-159	113	7	were	be	AUX
aji-159	113	8	recorded	record	VERB
aji-159	113	9	in	in	ADP
aji-159	113	10	2021	2021	NUM
aji-159	113	11	,	,	PUNCT
aji-159	113	12	while	while	SCONJ
aji-159	113	13	approximately	approximately	ADV
aji-159	113	14	650,000	650,000	NUM
aji-159	113	15	individuals	individual	NOUN
aji-159	113	16	worldwide	worldwide	ADV
aji-159	113	17	lost	lose	VERB
aji-159	113	18	their	their	PRON
aji-159	113	19	lives	life	NOUN
aji-159	113	20	due	due	ADJ
aji-159	113	21	to	to	ADP
aji-159	113	22	aidsrelated	aidsrelate	VERB
aji-159	113	23	illnesses	illness	NOUN
aji-159	113	24	.	.	PUNCT
aji-159	114	1	the	the	DET
aji-159	114	2	prevalence	prevalence	NOUN
aji-159	114	3	of	of	ADP
aji-159	114	4	hiv	hiv	PROPN
aji-159	114	5	in	in	ADP
aji-159	114	6	people	people	NOUN
aji-159	114	7	who	who	PRON
aji-159	114	8	inject	inject	VERB
aji-159	114	9	drugs	drug	NOUN
aji-159	114	10	(	(	PUNCT
aji-159	114	11	pwid	pwid	NOUN
aji-159	114	12	)	)	PUNCT
aji-159	114	13	and	and	CCONJ
aji-159	114	14	female	female	ADJ
aji-159	114	15	sex	sex	NOUN
aji-159	114	16	workers	worker	NOUN
aji-159	114	17	(	(	PUNCT
aji-159	114	18	fsws	fsws	ADJ
aji-159	114	19	)	)	PUNCT
aji-159	114	20	has	have	AUX
aji-159	114	21	not	not	PART
aji-159	114	22	been	be	AUX
aji-159	114	23	widely	widely	ADV
aji-159	114	24	investigated	investigate	VERB
aji-159	114	25	.	.	PUNCT
aji-159	115	1	information	information	NOUN
aji-159	115	2	on	on	ADP
aji-159	115	3	the	the	DET
aji-159	115	4	epidemiology	epidemiology	NOUN
aji-159	115	5	of	of	ADP
aji-159	115	6	hiv	hiv	PROPN
aji-159	115	7	infection	infection	NOUN
aji-159	115	8	among	among	ADP
aji-159	115	9	pwid	pwid	NOUN
aji-159	115	10	and	and	CCONJ
aji-159	115	11	fsws	fsws	ADJ
aji-159	115	12	in	in	ADP
aji-159	115	13	north	north	PROPN
aji-159	115	14	africa	africa	PROPN
aji-159	115	15	is	be	AUX
aji-159	115	16	limited	limited	ADJ
aji-159	115	17	.	.	PUNCT
aji-159	116	1	the	the	DET
aji-159	116	2	aim	aim	NOUN
aji-159	116	3	of	of	ADP
aji-159	116	4	the	the	DET
aji-159	116	5	present	present	ADJ
aji-159	116	6	study	study	NOUN
aji-159	116	7	was	be	AUX
aji-159	116	8	to	to	PART
aji-159	116	9	review	review	VERB
aji-159	116	10	the	the	DET
aji-159	116	11	status	status	NOUN
aji-159	116	12	of	of	ADP
aji-159	116	13	the	the	DET
aji-159	116	14	hiv	hiv	PROPN
aji-159	116	15	epidemic	epidemic	NOUN
aji-159	116	16	among	among	ADP
aji-159	116	17	pwid	pwid	NOUN
aji-159	116	18	and	and	CCONJ
aji-159	116	19	fsws	fsws	ADJ
aji-159	116	20	in	in	ADP
aji-159	116	21	north	north	ADJ
aji-159	116	22	african	african	ADJ
aji-159	116	23	countries	country	NOUN
aji-159	116	24	by	by	ADP
aji-159	116	25	explaining	explain	VERB
aji-159	116	26	hiv	hiv	PROPN
aji-159	116	27	prevalence	prevalence	NOUN
aji-159	116	28	.	.	PUNCT
aji-159	117	1	methods	method	NOUN
aji-159	117	2	:	:	PUNCT
aji-159	117	3	a	a	DET
aji-159	117	4	comprehensive	comprehensive	ADJ
aji-159	117	5	literature	literature	NOUN
aji-159	117	6	search	search	NOUN
aji-159	117	7	was	be	AUX
aji-159	117	8	performed	perform	VERB
aji-159	117	9	on	on	ADP
aji-159	117	10	studies	study	NOUN
aji-159	117	11	related	relate	VERB
aji-159	117	12	to	to	ADP
aji-159	117	13	the	the	DET
aji-159	117	14	prevalence	prevalence	NOUN
aji-159	117	15	of	of	ADP
aji-159	117	16	hiv	hiv	PROPN
aji-159	117	17	infection	infection	NOUN
aji-159	117	18	in	in	ADP
aji-159	117	19	pwid	pwid	NOUN
aji-159	117	20	and	and	CCONJ
aji-159	117	21	fsws	fsws	ADJ
aji-159	117	22	published	publish	VERB
aji-159	117	23	between	between	ADP
aji-159	117	24	1990	1990	NUM
aji-159	117	25	and	and	CCONJ
aji-159	117	26	2024	2024	NUM
aji-159	117	27	using	use	VERB
aji-159	117	28	search	search	NOUN
aji-159	117	29	engines	engine	NOUN
aji-159	117	30	such	such	ADJ
aji-159	117	31	as	as	ADP
aji-159	117	32	pubmed	pubmed	PROPN
aji-159	117	33	,	,	PUNCT
aji-159	117	34	science	science	NOUN
aji-159	117	35	-	-	PUNCT
aji-159	117	36	direct	direct	ADJ
aji-159	117	37	,	,	PUNCT
aji-159	117	38	google	google	PROPN
aji-159	117	39	scholar	scholar	NOUN
aji-159	117	40	.	.	PUNCT
aji-159	118	1	reports	report	NOUN
aji-159	118	2	that	that	PRON
aji-159	118	3	are	be	AUX
aji-159	118	4	entirely	entirely	ADV
aji-159	118	5	on	on	ADP
aji-159	118	6	north	north	PROPN
aji-159	118	7	africa	africa	PROPN
aji-159	118	8	were	be	AUX
aji-159	118	9	considered	consider	VERB
aji-159	118	10	,	,	PUNCT
aji-159	118	11	systematic	systematic	ADJ
aji-159	118	12	review	review	NOUN
aji-159	118	13	article	article	NOUN
aji-159	118	14	https://doi.org/10.9734/aji/2025/v8i1159	https://doi.org/10.9734/aji/2025/v8i1159	PROPN
aji-159	118	15	https://pr.sdiarticle5.com/review-history/125999	https://pr.sdiarticle5.com/review-history/125999	PROPN
aji-159	118	16	khalaf	khalaf	PROPN
aji-159	118	17	;	;	PUNCT
aji-159	118	18	asian	asian	PROPN
aji-159	118	19	j.	j.	PROPN
aji-159	118	20	immunol	immunol	PROPN
aji-159	118	21	.	.	PROPN
aji-159	119	1	,	,	PUNCT
aji-159	119	2	vol	vol	NOUN
aji-159	119	3	.	.	PROPN
aji-159	119	4	8	8	NUM
aji-159	119	5	,	,	PUNCT
aji-159	119	6	no	no	INTJ
aji-159	119	7	.	.	NOUN
aji-159	119	8	1	1	NUM
aji-159	119	9	,	,	PUNCT
aji-159	119	10	pp	pp	ADJ
aji-159	119	11	.	.	PUNCT
aji-159	120	1	50	50	NUM
aji-159	120	2	-	-	SYM
aji-159	120	3	59	59	NUM
aji-159	120	4	,	,	PUNCT
aji-159	120	5	2025	2025	NUM
aji-159	120	6	;	;	PUNCT
aji-159	120	7	article	article	NOUN
aji-159	120	8	no.aji.125999	no.aji.125999	NOUN
aji-159	120	9	51	51	NUM
aji-159	120	10	including	include	VERB
aji-159	120	11	studies	study	NOUN
aji-159	120	12	reporting	report	VERB
aji-159	120	13	hiv	hiv	PROPN
aji-159	120	14	infection	infection	NOUN
aji-159	120	15	in	in	ADP
aji-159	120	16	high	high	ADJ
aji-159	120	17	-	-	PUNCT
aji-159	120	18	risk	risk	NOUN
aji-159	120	19	groups	group	NOUN
aji-159	120	20	,	,	PUNCT
aji-159	120	21	particularly	particularly	ADV
aji-159	120	22	pwid	pwid	NOUN
aji-159	120	23	and	and	CCONJ
aji-159	120	24	fsws	fsws	ADJ
aji-159	120	25	,	,	PUNCT
aji-159	120	26	with	with	ADP
aji-159	120	27	the	the	DET
aji-159	120	28	data	datum	NOUN
aji-159	120	29	organized	organize	VERB
aji-159	120	30	into	into	ADP
aji-159	120	31	a	a	DET
aji-159	120	32	customized	customize	VERB
aji-159	120	33	database	database	NOUN
aji-159	120	34	.	.	PUNCT
aji-159	121	1	results	result	NOUN
aji-159	121	2	:	:	PUNCT
aji-159	121	3	a	a	DET
aji-159	121	4	total	total	NOUN
aji-159	121	5	of	of	ADP
aji-159	121	6	3605	3605	NUM
aji-159	121	7	records	record	NOUN
aji-159	121	8	were	be	AUX
aji-159	121	9	retrieved	retrieve	VERB
aji-159	121	10	in	in	ADP
aji-159	121	11	the	the	DET
aji-159	121	12	initial	initial	ADJ
aji-159	121	13	search	search	NOUN
aji-159	121	14	,	,	PUNCT
aji-159	121	15	10	10	NUM
aji-159	121	16	relevant	relevant	ADJ
aji-159	121	17	records	record	NOUN
aji-159	121	18	hiv	hiv	PROPN
aji-159	121	19	among	among	ADP
aji-159	121	20	pwid	pwid	NOUN
aji-159	121	21	and	and	CCONJ
aji-159	121	22	fsws	fsws	ADJ
aji-159	121	23	were	be	AUX
aji-159	121	24	recognized	recognize	VERB
aji-159	121	25	and	and	CCONJ
aji-159	121	26	included	include	VERB
aji-159	121	27	in	in	ADP
aji-159	121	28	the	the	DET
aji-159	121	29	study	study	NOUN
aji-159	121	30	.	.	PUNCT
aji-159	122	1	the	the	DET
aji-159	122	2	overall	overall	ADJ
aji-159	122	3	prevalence	prevalence	NOUN
aji-159	122	4	of	of	ADP
aji-159	122	5	hiv	hiv	PROPN
aji-159	122	6	in	in	ADP
aji-159	122	7	pwid	pwid	NOUN
aji-159	122	8	ranged	range	VERB
aji-159	122	9	from	from	ADP
aji-159	122	10	0.15	0.15	NUM
aji-159	122	11	%	%	NOUN
aji-159	122	12	to	to	ADP
aji-159	122	13	87.1	87.1	NUM
aji-159	122	14	%	%	NOUN
aji-159	122	15	and	and	CCONJ
aji-159	122	16	0	0	NUM
aji-159	122	17	%	%	NOUN
aji-159	122	18	to	to	PART
aji-159	122	19	15.7	15.7	NUM
aji-159	122	20	%	%	NOUN
aji-159	122	21	in	in	ADP
aji-159	122	22	fsws	fsws	ADJ
aji-159	122	23	.	.	PUNCT
aji-159	123	1	injection	injection	NOUN
aji-159	123	2	drug	drug	NOUN
aji-159	123	3	abuse	abuse	NOUN
aji-159	123	4	and	and	CCONJ
aji-159	123	5	women	woman	NOUN
aji-159	123	6	engaged	engage	VERB
aji-159	123	7	in	in	ADP
aji-159	123	8	sex	sex	NOUN
aji-159	123	9	work	work	NOUN
aji-159	123	10	were	be	AUX
aji-159	123	11	commonly	commonly	ADV
aji-159	123	12	associated	associate	VERB
aji-159	123	13	with	with	ADP
aji-159	123	14	hiv	hiv	PROPN
aji-159	123	15	infection	infection	NOUN
aji-159	123	16	.	.	PUNCT
aji-159	124	1	conclusion	conclusion	NOUN
aji-159	124	2	:	:	PUNCT
aji-159	124	3	the	the	DET
aji-159	124	4	findings	finding	NOUN
aji-159	124	5	of	of	ADP
aji-159	124	6	this	this	DET
aji-159	124	7	study	study	NOUN
aji-159	124	8	showed	show	VERB
aji-159	124	9	that	that	SCONJ
aji-159	124	10	the	the	DET
aji-159	124	11	prevalence	prevalence	NOUN
aji-159	124	12	of	of	ADP
aji-159	124	13	hiv	hiv	PROPN
aji-159	124	14	among	among	ADP
aji-159	124	15	pwid	pwid	NOUN
aji-159	124	16	and	and	CCONJ
aji-159	124	17	fsws	fsws	ADJ
aji-159	124	18	in	in	ADP
aji-159	124	19	north	north	PROPN
aji-159	124	20	africa	africa	PROPN
aji-159	124	21	is	be	AUX
aji-159	124	22	high	high	ADJ
aji-159	124	23	.	.	PUNCT
aji-159	125	1	pwid	pwid	NOUN
aji-159	125	2	and	and	CCONJ
aji-159	125	3	fsws	fsws	ADJ
aji-159	125	4	has	have	AUX
aji-159	125	5	been	be	AUX
aji-159	125	6	identified	identify	VERB
aji-159	125	7	as	as	ADP
aji-159	125	8	the	the	DET
aji-159	125	9	dominant	dominant	ADJ
aji-159	125	10	method	method	NOUN
aji-159	125	11	of	of	ADP
aji-159	125	12	transmission	transmission	NOUN
aji-159	125	13	in	in	ADP
aji-159	125	14	various	various	ADJ
aji-159	125	15	north	north	ADJ
aji-159	125	16	african	african	ADJ
aji-159	125	17	countries	country	NOUN
aji-159	125	18	like	like	ADP
aji-159	125	19	libya	libya	PROPN
aji-159	125	20	,	,	PUNCT
aji-159	125	21	egypt	egypt	PROPN
aji-159	125	22	,	,	PUNCT
aji-159	125	23	morocco	morocco	PROPN
aji-159	125	24	and	and	CCONJ
aji-159	125	25	tunisia	tunisia	NOUN
aji-159	125	26	.	.	PUNCT
aji-159	126	1	the	the	DET
aji-159	126	2	execution	execution	NOUN
aji-159	126	3	of	of	ADP
aji-159	126	4	initiatives	initiative	NOUN
aji-159	126	5	designed	design	VERB
aji-159	126	6	to	to	PART
aji-159	126	7	improve	improve	VERB
aji-159	126	8	sanitation	sanitation	NOUN
aji-159	126	9	infrastructure	infrastructure	NOUN
aji-159	126	10	,	,	PUNCT
aji-159	126	11	elevate	elevate	VERB
aji-159	126	12	educational	educational	ADJ
aji-159	126	13	standards	standard	NOUN
aji-159	126	14	,	,	PUNCT
aji-159	126	15	and	and	CCONJ
aji-159	126	16	enhance	enhance	VERB
aji-159	126	17	socioeconomic	socioeconomic	ADJ
aji-159	126	18	situations	situation	NOUN
aji-159	126	19	is	be	AUX
aji-159	126	20	crucial	crucial	ADJ
aji-159	126	21	for	for	ADP
aji-159	126	22	decreasing	decrease	VERB
aji-159	126	23	the	the	DET
aji-159	126	24	prevalence	prevalence	NOUN
aji-159	126	25	of	of	ADP
aji-159	126	26	hiv	hiv	PROPN
aji-159	126	27	infections	infection	NOUN
aji-159	126	28	among	among	ADP
aji-159	126	29	pwid	pwid	NOUN
aji-159	126	30	and	and	CCONJ
aji-159	126	31	fsws	fsws	ADJ
aji-159	126	32	.	.	PUNCT
aji-159	127	1	keywords	keyword	NOUN
aji-159	127	2	:	:	PUNCT
aji-159	127	3	human	human	ADJ
aji-159	127	4	immunodeficiency	immunodeficiency	NOUN
aji-159	127	5	virus	virus	NOUN
aji-159	127	6	;	;	PUNCT
aji-159	127	7	people	people	NOUN
aji-159	127	8	who	who	PRON
aji-159	127	9	inject	inject	VERB
aji-159	127	10	drugs	drug	NOUN
aji-159	127	11	;	;	PUNCT
aji-159	127	12	female	female	ADJ
aji-159	127	13	sex	sex	NOUN
aji-159	127	14	workers	worker	NOUN
aji-159	127	15	;	;	PUNCT
aji-159	127	16	north	north	PROPN
aji-159	127	17	africa	africa	PROPN
aji-159	127	18	.	.	PUNCT
aji-159	128	1	1	1	X
aji-159	128	2	.	.	X
aji-159	128	3	introduction	introduction	NOUN
aji-159	128	4	human	human	ADJ
aji-159	128	5	immunodeficiency	immunodeficiency	NOUN
aji-159	128	6	virus	virus	NOUN
aji-159	128	7	(	(	PUNCT
aji-159	128	8	hiv	hiv	PROPN
aji-159	128	9	)	)	PUNCT
aji-159	128	10	is	be	AUX
aji-159	128	11	a	a	DET
aji-159	128	12	member	member	NOUN
aji-159	128	13	of	of	ADP
aji-159	128	14	the	the	DET
aji-159	128	15	lentivirus	lentivirus	NOUN
aji-159	128	16	genus	genus	NOUN
aji-159	128	17	belonging	belong	VERB
aji-159	128	18	to	to	ADP
aji-159	128	19	the	the	DET
aji-159	128	20	retroviridae	retroviridae	NOUN
aji-159	128	21	family	family	NOUN
aji-159	128	22	.	.	PUNCT
aji-159	129	1	in	in	ADP
aji-159	129	2	1981	1981	NUM
aji-159	129	3	,	,	PUNCT
aji-159	129	4	it	it	PRON
aji-159	129	5	was	be	AUX
aji-159	129	6	identified	identify	VERB
aji-159	129	7	as	as	ADP
aji-159	129	8	the	the	DET
aji-159	129	9	initial	initial	ADJ
aji-159	129	10	cause	cause	NOUN
aji-159	129	11	of	of	ADP
aji-159	129	12	the	the	DET
aji-159	129	13	illness	illness	NOUN
aji-159	129	14	now	now	ADV
aji-159	129	15	referred	refer	VERB
aji-159	129	16	to	to	ADP
aji-159	129	17	as	as	ADP
aji-159	129	18	acquired	acquire	VERB
aji-159	129	19	immunodeficiency	immunodeficiency	NOUN
aji-159	129	20	syndromes	syndrome	NOUN
aji-159	129	21	(	(	PUNCT
aji-159	129	22	aids	aids	PROPN
aji-159	129	23	)	)	PUNCT
aji-159	129	24	(	(	PUNCT
aji-159	129	25	gruters	gruter	NOUN
aji-159	129	26	et	et	NOUN
aji-159	129	27	al	al	PROPN
aji-159	129	28	.	.	PROPN
aji-159	129	29	,	,	PUNCT
aji-159	129	30	1987	1987	NUM
aji-159	129	31	;	;	PUNCT
aji-159	129	32	fauci	fauci	ADJ
aji-159	129	33	,	,	PUNCT
aji-159	129	34	1999	1999	NUM
aji-159	129	35	)	)	PUNCT
aji-159	129	36	.	.	PUNCT
aji-159	130	1	hiv	hiv	PROPN
aji-159	130	2	is	be	AUX
aji-159	130	3	spread	spread	VERB
aji-159	130	4	mainly	mainly	ADV
aji-159	130	5	from	from	ADP
aji-159	130	6	the	the	DET
aji-159	130	7	body	body	NOUN
aji-159	130	8	fluids	fluid	NOUN
aji-159	130	9	of	of	ADP
aji-159	130	10	an	an	DET
aji-159	130	11	infected	infected	ADJ
aji-159	130	12	person	person	NOUN
aji-159	130	13	,	,	PUNCT
aji-159	130	14	including	include	VERB
aji-159	130	15	blood	blood	NOUN
aji-159	130	16	,	,	PUNCT
aji-159	130	17	breast	breast	NOUN
aji-159	130	18	milk	milk	NOUN
aji-159	130	19	,	,	PUNCT
aji-159	130	20	semen	semen	NOUN
aji-159	130	21	and	and	CCONJ
aji-159	130	22	vaginal	vaginal	ADJ
aji-159	130	23	fluids	fluid	NOUN
aji-159	130	24	(	(	PUNCT
aji-159	130	25	world	world	NOUN
aji-159	130	26	health	health	NOUN
aji-159	130	27	organization	organization	NOUN
aji-159	130	28	[	[	X
aji-159	130	29	who	who	PRON
aji-159	130	30	]	]	X
aji-159	130	31	,	,	PUNCT
aji-159	130	32	2024a	2024a	NUM
aji-159	130	33	)	)	PUNCT
aji-159	130	34	.	.	PUNCT
aji-159	131	1	hiv	hiv	PROPN
aji-159	131	2	infection	infection	NOUN
aji-159	131	3	is	be	AUX
aji-159	131	4	characterized	characterize	VERB
aji-159	131	5	by	by	ADP
aji-159	131	6	mild	mild	ADJ
aji-159	131	7	immune	immune	ADJ
aji-159	131	8	system	system	NOUN
aji-159	131	9	alterations	alteration	NOUN
aji-159	131	10	that	that	PRON
aji-159	131	11	occur	occur	VERB
aji-159	131	12	before	before	SCONJ
aji-159	131	13	any	any	DET
aji-159	131	14	symptoms	symptom	NOUN
aji-159	131	15	or	or	CCONJ
aji-159	131	16	negative	negative	ADJ
aji-159	131	17	emotions	emotion	NOUN
aji-159	131	18	appear	appear	VERB
aji-159	131	19	.	.	PUNCT
aji-159	132	1	before	before	ADP
aji-159	132	2	seroconversion	seroconversion	NOUN
aji-159	132	3	,	,	PUNCT
aji-159	132	4	which	which	PRON
aji-159	132	5	occurs	occur	VERB
aji-159	132	6	when	when	SCONJ
aji-159	132	7	an	an	DET
aji-159	132	8	individual	individual	NOUN
aji-159	132	9	has	have	AUX
aji-159	132	10	just	just	ADV
aji-159	132	11	been	be	AUX
aji-159	132	12	exposed	expose	VERB
aji-159	132	13	to	to	ADP
aji-159	132	14	hiv	hiv	PROPN
aji-159	132	15	,	,	PUNCT
aji-159	132	16	this	this	DET
aji-159	132	17	stage	stage	NOUN
aji-159	132	18	lasts	last	VERB
aji-159	132	19	for	for	ADP
aji-159	132	20	up	up	ADP
aji-159	132	21	to	to	PART
aji-159	132	22	three	three	NUM
aji-159	132	23	months	month	NOUN
aji-159	132	24	after	after	ADP
aji-159	132	25	infection	infection	NOUN
aji-159	132	26	.	.	PUNCT
aji-159	133	1	although	although	SCONJ
aji-159	133	2	the	the	DET
aji-159	133	3	course	course	NOUN
aji-159	133	4	of	of	ADP
aji-159	133	5	an	an	DET
aji-159	133	6	infection	infection	NOUN
aji-159	133	7	and	and	CCONJ
aji-159	133	8	the	the	DET
aji-159	133	9	amount	amount	NOUN
aji-159	133	10	of	of	ADP
aji-159	133	11	time	time	NOUN
aji-159	133	12	it	it	PRON
aji-159	133	13	takes	take	VERB
aji-159	133	14	for	for	ADP
aji-159	133	15	clinical	clinical	ADJ
aji-159	133	16	signs	sign	NOUN
aji-159	133	17	to	to	PART
aji-159	133	18	appear	appear	VERB
aji-159	133	19	might	might	AUX
aji-159	133	20	vary	vary	VERB
aji-159	133	21	widely	widely	ADV
aji-159	133	22	from	from	ADP
aji-159	133	23	person	person	NOUN
aji-159	133	24	to	to	ADP
aji-159	133	25	person	person	NOUN
aji-159	133	26	,	,	PUNCT
aji-159	133	27	the	the	DET
aji-159	133	28	disease	disease	NOUN
aji-159	133	29	typically	typically	ADV
aji-159	133	30	advances	advance	VERB
aji-159	133	31	rather	rather	ADV
aji-159	133	32	slowly	slowly	ADV
aji-159	133	33	.	.	PUNCT
aji-159	134	1	the	the	DET
aji-159	134	2	onset	onset	NOUN
aji-159	134	3	of	of	ADP
aji-159	134	4	progressive	progressive	ADJ
aji-159	134	5	hiv	hiv	PROPN
aji-159	134	6	illnesses	illness	NOUN
aji-159	134	7	and	and	CCONJ
aji-159	134	8	immunosuppressive	immunosuppressive	ADJ
aji-159	134	9	symptoms	symptom	NOUN
aji-159	134	10	takes	take	VERB
aji-159	134	11	several	several	ADJ
aji-159	134	12	years	year	NOUN
aji-159	134	13	after	after	ADP
aji-159	134	14	the	the	DET
aji-159	134	15	first	first	ADJ
aji-159	134	16	infection	infection	NOUN
aji-159	134	17	(	(	PUNCT
aji-159	134	18	naif	naif	NOUN
aji-159	134	19	,	,	PUNCT
aji-159	134	20	2013	2013	NUM
aji-159	134	21	)	)	PUNCT
aji-159	134	22	.	.	PUNCT
aji-159	135	1	hiv	hiv	PROPN
aji-159	135	2	targets	target	VERB
aji-159	135	3	cells	cell	NOUN
aji-159	135	4	of	of	ADP
aji-159	135	5	the	the	DET
aji-159	135	6	human	human	ADJ
aji-159	135	7	immune	immune	ADJ
aji-159	135	8	system	system	NOUN
aji-159	135	9	,	,	PUNCT
aji-159	135	10	such	such	ADJ
aji-159	135	11	as	as	ADP
aji-159	135	12	cd4	cd4	PROPN
aji-159	135	13	+	+	PROPN
aji-159	135	14	t	t	NOUN
aji-159	135	15	cells	cell	NOUN
aji-159	135	16	,	,	PUNCT
aji-159	135	17	macrophages	macrophage	NOUN
aji-159	135	18	,	,	PUNCT
aji-159	135	19	and	and	CCONJ
aji-159	135	20	dendritic	dendritic	ADJ
aji-159	135	21	cells	cell	NOUN
aji-159	135	22	.	.	PUNCT
aji-159	136	1	cd4	cd4	PROPN
aji-159	136	2	+	+	PROPN
aji-159	136	3	cells	cell	NOUN
aji-159	136	4	play	play	VERB
aji-159	136	5	an	an	DET
aji-159	136	6	important	important	ADJ
aji-159	136	7	role	role	NOUN
aji-159	136	8	in	in	ADP
aji-159	136	9	maintaining	maintain	VERB
aji-159	136	10	the	the	DET
aji-159	136	11	immune	immune	ADJ
aji-159	136	12	system	system	NOUN
aji-159	136	13	.	.	PUNCT
aji-159	137	1	following	follow	VERB
aji-159	137	2	infection	infection	NOUN
aji-159	137	3	,	,	PUNCT
aji-159	137	4	hiv	hiv	PROPN
aji-159	137	5	utilizes	utilize	VERB
aji-159	137	6	cd4	cd4	PROPN
aji-159	137	7	+	+	PROPN
aji-159	137	8	cells	cell	NOUN
aji-159	137	9	as	as	ADP
aji-159	137	10	a	a	DET
aji-159	137	11	host	host	NOUN
aji-159	137	12	to	to	PART
aji-159	137	13	replicate	replicate	VERB
aji-159	137	14	and	and	CCONJ
aji-159	137	15	infect	infect	VERB
aji-159	137	16	additional	additional	ADJ
aji-159	137	17	cells	cell	NOUN
aji-159	137	18	.	.	PUNCT
aji-159	138	1	this	this	DET
aji-159	138	2	results	result	VERB
aji-159	138	3	in	in	ADP
aji-159	138	4	the	the	DET
aji-159	138	5	decrease	decrease	NOUN
aji-159	138	6	of	of	ADP
aji-159	138	7	cd4	cd4	PROPN
aji-159	138	8	+	+	PROPN
aji-159	138	9	cells	cell	NOUN
aji-159	138	10	in	in	ADP
aji-159	138	11	the	the	DET
aji-159	138	12	body	body	NOUN
aji-159	138	13	,	,	PUNCT
aji-159	138	14	causing	cause	VERB
aji-159	138	15	a	a	DET
aji-159	138	16	complete	complete	ADJ
aji-159	138	17	breakdown	breakdown	NOUN
aji-159	138	18	of	of	ADP
aji-159	138	19	the	the	DET
aji-159	138	20	immune	immune	ADJ
aji-159	138	21	system	system	NOUN
aji-159	138	22	.	.	PUNCT
aji-159	139	1	the	the	DET
aji-159	139	2	progression	progression	NOUN
aji-159	139	3	from	from	ADP
aji-159	139	4	hiv	hiv	PROPN
aji-159	139	5	to	to	ADP
aji-159	139	6	aids	aids	PROPN
aji-159	139	7	is	be	AUX
aji-159	139	8	monitored	monitor	VERB
aji-159	139	9	by	by	ADP
aji-159	139	10	the	the	DET
aji-159	139	11	sharp	sharp	ADJ
aji-159	139	12	decrease	decrease	NOUN
aji-159	139	13	in	in	ADP
aji-159	139	14	cd4	cd4	PROPN
aji-159	139	15	+	+	PROPN
aji-159	139	16	cells	cell	NOUN
aji-159	139	17	(	(	PUNCT
aji-159	139	18	yousaf	yousaf	PROPN
aji-159	139	19	et	et	PROPN
aji-159	139	20	al	al	PROPN
aji-159	139	21	.	.	PROPN
aji-159	139	22	,	,	PUNCT
aji-159	139	23	2011	2011	NUM
aji-159	139	24	)	)	PUNCT
aji-159	139	25	.	.	PUNCT
aji-159	140	1	chronic	chronic	ADJ
aji-159	140	2	hiv	hiv	PROPN
aji-159	140	3	infection	infection	NOUN
aji-159	140	4	is	be	AUX
aji-159	140	5	causing	cause	VERB
aji-159	140	6	a	a	DET
aji-159	140	7	deficiency	deficiency	NOUN
aji-159	140	8	in	in	ADP
aji-159	140	9	cellular	cellular	ADJ
aji-159	140	10	immunity	immunity	NOUN
aji-159	140	11	.	.	PUNCT
aji-159	141	1	the	the	DET
aji-159	141	2	unexpected	unexpected	ADJ
aji-159	141	3	emergence	emergence	NOUN
aji-159	141	4	of	of	ADP
aji-159	141	5	opportunistic	opportunistic	ADJ
aji-159	141	6	infections	infection	NOUN
aji-159	141	7	characterizes	characterize	VERB
aji-159	141	8	this	this	DET
aji-159	141	9	final	final	ADJ
aji-159	141	10	stage	stage	NOUN
aji-159	141	11	of	of	ADP
aji-159	141	12	hiv	hiv	PROPN
aji-159	141	13	infection	infection	NOUN
aji-159	141	14	.	.	PUNCT
aji-159	142	1	the	the	DET
aji-159	142	2	main	main	ADJ
aji-159	142	3	contributors	contributor	NOUN
aji-159	142	4	to	to	ADP
aji-159	142	5	hiv	hiv	PROPN
aji-159	142	6	-	-	PUNCT
aji-159	142	7	related	relate	VERB
aji-159	142	8	morbidity	morbidity	NOUN
aji-159	142	9	an	an	DET
aji-159	142	10	death	death	NOUN
aji-159	142	11	are	be	AUX
aji-159	142	12	these	these	DET
aji-159	142	13	last	last	ADJ
aji-159	142	14	ones	one	NOUN
aji-159	142	15	.	.	PUNCT
aji-159	143	1	the	the	DET
aji-159	143	2	use	use	NOUN
aji-159	143	3	of	of	ADP
aji-159	143	4	cotrimoxazole	cotrimoxazole	NOUN
aji-159	143	5	and	and	CCONJ
aji-159	143	6	antiretroviruses	antiretroviruse	NOUN
aji-159	143	7	can	can	AUX
aji-159	143	8	significantly	significantly	ADV
aji-159	143	9	lower	lower	VERB
aji-159	143	10	the	the	DET
aji-159	143	11	frequency	frequency	NOUN
aji-159	143	12	of	of	ADP
aji-159	143	13	opportunistic	opportunistic	ADJ
aji-159	143	14	infections	infection	NOUN
aji-159	143	15	and	and	CCONJ
aji-159	143	16	increase	increase	VERB
aji-159	143	17	the	the	DET
aji-159	143	18	life	life	NOUN
aji-159	143	19	expectancy	expectancy	NOUN
aji-159	143	20	of	of	ADP
aji-159	143	21	hiv	hiv	PROPN
aji-159	143	22	patients	patient	NOUN
aji-159	143	23	.	.	PUNCT
aji-159	144	1	the	the	DET
aji-159	144	2	initiation	initiation	NOUN
aji-159	144	3	of	of	ADP
aji-159	144	4	antiretroviral	antiretroviral	ADJ
aji-159	144	5	therapy	therapy	NOUN
aji-159	144	6	for	for	ADP
aji-159	144	7	an	an	DET
aji-159	144	8	individual	individual	NOUN
aji-159	144	9	with	with	ADP
aji-159	144	10	hiv	hiv	PROPN
aji-159	144	11	is	be	AUX
aji-159	144	12	determined	determine	VERB
aji-159	144	13	by	by	ADP
aji-159	144	14	their	their	PRON
aji-159	144	15	level	level	NOUN
aji-159	144	16	of	of	ADP
aji-159	144	17	immune	immune	ADJ
aji-159	144	18	system	system	NOUN
aji-159	144	19	weakness	weakness	NOUN
aji-159	144	20	(	(	PUNCT
aji-159	144	21	comlan	comlan	PROPN
aji-159	144	22	et	et	PROPN
aji-159	144	23	al	al	PROPN
aji-159	144	24	.	.	PROPN
aji-159	144	25	,	,	PUNCT
aji-159	144	26	2017	2017	NUM
aji-159	144	27	)	)	PUNCT
aji-159	144	28	.	.	PUNCT
aji-159	145	1	the	the	DET
aji-159	145	2	sensitive	sensitive	ADJ
aji-159	145	3	enzyme	enzyme	NOUN
aji-159	145	4	immunoassays	immunoassay	NOUN
aji-159	145	5	available	available	ADJ
aji-159	145	6	today	today	NOUN
aji-159	145	7	can	can	AUX
aji-159	145	8	identify	identify	VERB
aji-159	145	9	antibodies	antibody	NOUN
aji-159	145	10	as	as	ADV
aji-159	145	11	soon	soon	ADV
aji-159	145	12	as	as	ADP
aji-159	145	13	one	one	NUM
aji-159	145	14	to	to	PART
aji-159	145	15	two	two	NUM
aji-159	145	16	weeks	week	NOUN
aji-159	145	17	following	follow	VERB
aji-159	145	18	infection	infection	NOUN
aji-159	145	19	.	.	PUNCT
aji-159	146	1	other	other	ADJ
aji-159	146	2	tests	test	NOUN
aji-159	146	3	are	be	AUX
aji-159	146	4	necessary	necessary	ADJ
aji-159	146	5	to	to	PART
aji-159	146	6	support	support	VERB
aji-159	146	7	antibody	antibody	NOUN
aji-159	146	8	investigation	investigation	NOUN
aji-159	146	9	(	(	PUNCT
aji-159	146	10	p24	p24	NOUN
aji-159	146	11	antigen	antigen	PROPN
aji-159	146	12	,	,	PUNCT
aji-159	146	13	pcr	pcr	PROPN
aji-159	146	14	)	)	PUNCT
aji-159	146	15	,	,	PUNCT
aji-159	146	16	corroborate	corroborate	VERB
aji-159	146	17	positive	positive	ADJ
aji-159	146	18	antibody	antibody	NOUN
aji-159	146	19	screens	screen	NOUN
aji-159	146	20	(	(	PUNCT
aji-159	146	21	western	western	ADJ
aji-159	146	22	blot	blot	NOUN
aji-159	146	23	,	,	PUNCT
aji-159	146	24	pcr	pcr	NOUN
aji-159	146	25	)	)	PUNCT
aji-159	146	26	,	,	PUNCT
aji-159	146	27	and	and	CCONJ
aji-159	146	28	give	give	VERB
aji-159	146	29	clinicians	clinician	NOUN
aji-159	146	30	treating	treat	VERB
aji-159	146	31	hivpositive	hivpositive	ADJ
aji-159	146	32	patients	patient	NOUN
aji-159	146	33	additional	additional	ADJ
aji-159	146	34	information	information	NOUN
aji-159	146	35	(	(	PUNCT
aji-159	146	36	qualitative	qualitative	ADJ
aji-159	146	37	and	and	CCONJ
aji-159	146	38	quantitative	quantitative	ADJ
aji-159	146	39	pcr	pcr	NOUN
aji-159	146	40	,	,	PUNCT
aji-159	146	41	genotyping	genotyping	NOUN
aji-159	146	42	)	)	PUNCT
aji-159	146	43	(	(	PUNCT
aji-159	146	44	fearon	fearon	PROPN
aji-159	146	45	,	,	PUNCT
aji-159	146	46	2005	2005	NUM
aji-159	146	47	)	)	PUNCT
aji-159	146	48	.	.	PUNCT
aji-159	147	1	two	two	NUM
aji-159	147	2	types	type	NOUN
aji-159	147	3	of	of	ADP
aji-159	147	4	hiv	hiv	PROPN
aji-159	147	5	have	have	AUX
aji-159	147	6	been	be	AUX
aji-159	147	7	described	describe	VERB
aji-159	147	8	which	which	PRON
aji-159	147	9	are	be	AUX
aji-159	147	10	hiv-1	hiv-1	PUNCT
aji-159	147	11	and	and	CCONJ
aji-159	147	12	hiv-2	hiv-2	ADV
aji-159	147	13	.	.	PUNCT
aji-159	148	1	globally	globally	ADV
aji-159	148	2	,	,	PUNCT
aji-159	148	3	hiv-1	hiv-1	PUNCT
aji-159	148	4	infection	infection	NOUN
aji-159	148	5	is	be	AUX
aji-159	148	6	the	the	DET
aji-159	148	7	leading	lead	VERB
aji-159	148	8	cause	cause	NOUN
aji-159	148	9	of	of	ADP
aji-159	148	10	the	the	DET
aji-159	148	11	aids	aid	NOUN
aji-159	148	12	pandemic	pandemic	ADJ
aji-159	148	13	,	,	PUNCT
aji-159	148	14	while	while	SCONJ
aji-159	148	15	the	the	DET
aji-159	148	16	emergence	emergence	NOUN
aji-159	148	17	of	of	ADP
aji-159	148	18	hiv-2	hiv-2	NUM
aji-159	148	19	is	be	AUX
aji-159	148	20	concentrated	concentrate	VERB
aji-159	148	21	in	in	ADP
aji-159	148	22	west	west	ADJ
aji-159	148	23	african	african	ADJ
aji-159	148	24	countries	country	NOUN
aji-159	148	25	(	(	PUNCT
aji-159	148	26	campbell	campbell	PROPN
aji-159	148	27	&	&	CCONJ
aji-159	148	28	gandhi	gandhi	PROPN
aji-159	148	29	,	,	PUNCT
aji-159	148	30	2011	2011	NUM
aji-159	148	31	)	)	PUNCT
aji-159	148	32	.	.	PUNCT
aji-159	149	1	at	at	ADP
aji-159	149	2	present	present	ADJ
aji-159	149	3	,	,	PUNCT
aji-159	149	4	hiv	hiv	PROPN
aji-159	149	5	infection	infection	NOUN
aji-159	149	6	continues	continue	VERB
aji-159	149	7	to	to	PART
aji-159	149	8	be	be	AUX
aji-159	149	9	one	one	NUM
aji-159	149	10	of	of	ADP
aji-159	149	11	the	the	DET
aji-159	149	12	most	most	ADV
aji-159	149	13	serious	serious	ADJ
aji-159	149	14	global	global	ADJ
aji-159	149	15	health	health	NOUN
aji-159	149	16	issues	issue	NOUN
aji-159	149	17	facing	face	VERB
aji-159	149	18	humans	human	NOUN
aji-159	149	19	.	.	PUNCT
aji-159	150	1	according	accord	VERB
aji-159	150	2	to	to	ADP
aji-159	150	3	statistics	statistic	NOUN
aji-159	150	4	from	from	ADP
aji-159	150	5	the	the	DET
aji-159	150	6	united	united	PROPN
aji-159	150	7	nations	nations	PROPN
aji-159	150	8	(	(	PUNCT
aji-159	150	9	un	un	PROPN
aji-159	150	10	)	)	PUNCT
aji-159	150	11	,	,	PUNCT
aji-159	150	12	the	the	DET
aji-159	150	13	global	global	ADJ
aji-159	150	14	number	number	NOUN
aji-159	150	15	of	of	ADP
aji-159	150	16	individuals	individual	NOUN
aji-159	150	17	living	live	VERB
aji-159	150	18	with	with	ADP
aji-159	150	19	hiv	hiv	PROPN
aji-159	150	20	in	in	ADP
aji-159	150	21	2021	2021	NUM
aji-159	150	22	tallied	tally	VERB
aji-159	150	23	at	at	ADP
aji-159	150	24	approximately	approximately	ADV
aji-159	150	25	38.4	38.4	NUM
aji-159	150	26	million	million	NUM
aji-159	150	27	.	.	PUNCT
aji-159	151	1	furthermore	furthermore	ADV
aji-159	151	2	,	,	PUNCT
aji-159	151	3	an	an	DET
aji-159	151	4	estimated	estimate	VERB
aji-159	151	5	1.5	1.5	NUM
aji-159	151	6	million	million	NUM
aji-159	151	7	new	new	ADJ
aji-159	151	8	cases	case	NOUN
aji-159	151	9	of	of	ADP
aji-159	151	10	hiv	hiv	PROPN
aji-159	151	11	infections	infection	NOUN
aji-159	151	12	emerged	emerge	VERB
aji-159	151	13	.	.	PUNCT
aji-159	152	1	additionally	additionally	ADV
aji-159	152	2	,	,	PUNCT
aji-159	152	3	in	in	ADP
aji-159	152	4	2021	2021	NUM
aji-159	152	5	,	,	PUNCT
aji-159	152	6	around	around	ADP
aji-159	152	7	650,000	650,000	NUM
aji-159	152	8	deaths	death	NOUN
aji-159	152	9	were	be	AUX
aji-159	152	10	attributed	attribute	VERB
aji-159	152	11	to	to	ADP
aji-159	152	12	aids	aid	NOUN
aji-159	152	13	related	relate	VERB
aji-159	152	14	illnesses	illness	NOUN
aji-159	152	15	.	.	PUNCT
aji-159	153	1	the	the	DET
aji-159	153	2	un	un	PROPN
aji-159	153	3	program	program	PROPN
aji-159	153	4	on	on	ADP
aji-159	153	5	hiv	hiv	PROPN
aji-159	153	6	/	/	SYM
aji-159	153	7	aids	aids	PROPN
aji-159	153	8	estimated	estimate	VERB
aji-159	153	9	that	that	SCONJ
aji-159	153	10	at	at	ADP
aji-159	153	11	the	the	DET
aji-159	153	12	end	end	NOUN
aji-159	153	13	of	of	ADP
aji-159	153	14	2021	2021	NUM
aji-159	153	15	there	there	PRON
aji-159	153	16	were	be	VERB
aji-159	153	17	20.6	20.6	NUM
aji-159	153	18	million	million	NUM
aji-159	153	19	persons	person	NOUN
aji-159	153	20	living	live	VERB
aji-159	153	21	with	with	ADP
aji-159	153	22	hiv	hiv	PROPN
aji-159	153	23	infection	infection	NOUN
aji-159	153	24	in	in	ADP
aji-159	153	25	sub	sub	PROPN
aji-159	153	26	saharan	saharan	PROPN
aji-159	153	27	africa	africa	PROPN
aji-159	153	28	,	,	PUNCT
aji-159	153	29	which	which	PRON
aji-159	153	30	is	be	AUX
aji-159	153	31	the	the	DET
aji-159	153	32	highest	high	ADJ
aji-159	153	33	globally	globally	ADV
aji-159	153	34	.	.	PUNCT
aji-159	154	1	moreover	moreover	ADV
aji-159	154	2	,	,	PUNCT
aji-159	154	3	the	the	DET
aji-159	154	4	lowest	low	ADJ
aji-159	154	5	infection	infection	NOUN
aji-159	154	6	was	be	AUX
aji-159	154	7	in	in	ADP
aji-159	154	8	north	north	PROPN
aji-159	154	9	africa	africa	PROPN
aji-159	154	10	and	and	CCONJ
aji-159	154	11	the	the	DET
aji-159	154	12	middle	middle	PROPN
aji-159	154	13	east	east	PROPN
aji-159	154	14	;	;	PUNCT
aji-159	154	15	roughly	roughly	ADV
aji-159	154	16	180,000	180,000	NUM
aji-159	154	17	individuals	individual	NOUN
aji-159	154	18	were	be	AUX
aji-159	154	19	estimated	estimate	VERB
aji-159	154	20	to	to	PART
aji-159	154	21	be	be	AUX
aji-159	154	22	living	live	VERB
aji-159	154	23	with	with	ADP
aji-159	154	24	hiv	hiv	PROPN
aji-159	154	25	.	.	PUNCT
aji-159	155	1	infection	infection	NOUN
aji-159	155	2	with	with	ADP
aji-159	155	3	hiv	hiv	PROPN
aji-159	155	4	remains	remain	VERB
aji-159	155	5	a	a	DET
aji-159	155	6	major	major	ADJ
aji-159	155	7	cause	cause	NOUN
aji-159	155	8	of	of	ADP
aji-159	155	9	illness	illness	NOUN
aji-159	155	10	and	and	CCONJ
aji-159	155	11	death	death	NOUN
aji-159	155	12	in	in	ADP
aji-159	155	13	developing	develop	VERB
aji-159	155	14	nations	nation	NOUN
aji-159	155	15	,	,	PUNCT
aji-159	155	16	including	include	VERB
aji-159	155	17	north	north	ADJ
aji-159	155	18	african	african	ADJ
aji-159	155	19	countries	country	NOUN
aji-159	155	20	(	(	PUNCT
aji-159	155	21	unaids	unaid	NOUN
aji-159	155	22	,	,	PUNCT
aji-159	155	23	2022	2022	NUM
aji-159	155	24	)	)	PUNCT
aji-159	155	25	.	.	PUNCT
aji-159	156	1	people	people	NOUN
aji-159	156	2	who	who	PRON
aji-159	156	3	inject	inject	VERB
aji-159	156	4	drugs	drug	NOUN
aji-159	156	5	(	(	PUNCT
aji-159	156	6	pwid	pwid	NOUN
aji-159	156	7	)	)	PUNCT
aji-159	156	8	are	be	AUX
aji-159	156	9	at	at	ADP
aji-159	156	10	increased	increase	VERB
aji-159	156	11	risk	risk	NOUN
aji-159	156	12	of	of	ADP
aji-159	156	13	hiv	hiv	PROPN
aji-159	156	14	;	;	PUNCT
aji-159	156	15	worldwide	worldwide	ADV
aji-159	156	16	,	,	PUNCT
aji-159	156	17	about	about	ADV
aji-159	156	18	11	11	NUM
aji-159	156	19	million	million	NUM
aji-159	156	20	people	people	NOUN
aji-159	156	21	inject	inject	PROPN
aji-159	156	22	khalaf	khalaf	PROPN
aji-159	156	23	;	;	PUNCT
aji-159	156	24	asian	asian	PROPN
aji-159	156	25	j.	j.	PROPN
aji-159	156	26	immunol	immunol	PROPN
aji-159	156	27	.	.	PROPN
aji-159	156	28	,	,	PUNCT
aji-159	156	29	vol	vol	NOUN
aji-159	156	30	.	.	PROPN
aji-159	156	31	8	8	NUM
aji-159	156	32	,	,	PUNCT
aji-159	156	33	no	no	INTJ
aji-159	156	34	.	.	NOUN
aji-159	156	35	1	1	NUM
aji-159	156	36	,	,	PUNCT
aji-159	156	37	pp	pp	ADJ
aji-159	156	38	.	.	PUNCT
aji-159	157	1	50	50	NUM
aji-159	157	2	-	-	SYM
aji-159	157	3	59	59	NUM
aji-159	157	4	,	,	PUNCT
aji-159	157	5	2025	2025	NUM
aji-159	157	6	;	;	PUNCT
aji-159	157	7	article	article	NOUN
aji-159	157	8	no.aji.125999	no.aji.125999	NOUN
aji-159	157	9	52	52	NUM
aji-159	157	10	drugs	drug	NOUN
aji-159	157	11	,	,	PUNCT
aji-159	157	12	and	and	CCONJ
aji-159	157	13	around	around	ADV
aji-159	157	14	1	1	NUM
aji-159	157	15	in	in	ADP
aji-159	157	16	8	8	NUM
aji-159	157	17	(	(	PUNCT
aji-159	157	18	or	or	CCONJ
aji-159	157	19	1.4	1.4	NUM
aji-159	157	20	million	million	NUM
aji-159	157	21	)	)	PUNCT
aji-159	157	22	of	of	ADP
aji-159	157	23	these	these	DET
aji-159	157	24	people	people	NOUN
aji-159	157	25	are	be	AUX
aji-159	157	26	living	live	VERB
aji-159	157	27	with	with	ADP
aji-159	157	28	hiv	hiv	PROPN
aji-159	157	29	.	.	PUNCT
aji-159	158	1	in	in	ADP
aji-159	158	2	addition	addition	NOUN
aji-159	158	3	,	,	PUNCT
aji-159	158	4	10	10	NUM
aji-159	158	5	%	%	NOUN
aji-159	158	6	of	of	ADP
aji-159	158	7	new	new	ADJ
aji-159	158	8	hiv	hiv	PROPN
aji-159	158	9	infections	infection	NOUN
aji-159	158	10	worldwide	worldwide	ADV
aji-159	158	11	are	be	AUX
aji-159	158	12	due	due	ADJ
aji-159	158	13	to	to	ADP
aji-159	158	14	the	the	DET
aji-159	158	15	use	use	NOUN
aji-159	158	16	of	of	ADP
aji-159	158	17	injection	injection	NOUN
aji-159	158	18	drugs	drug	NOUN
aji-159	158	19	(	(	PUNCT
aji-159	158	20	who	who	PRON
aji-159	158	21	,	,	PUNCT
aji-159	158	22	2024b	2024b	NUM
aji-159	158	23	)	)	PUNCT
aji-159	158	24	.	.	PUNCT
aji-159	159	1	globally	globally	ADV
aji-159	159	2	,	,	PUNCT
aji-159	159	3	sex	sex	NOUN
aji-159	159	4	workers	worker	NOUN
aji-159	159	5	are	be	AUX
aji-159	159	6	facing	face	VERB
aji-159	159	7	a	a	DET
aji-159	159	8	greater	great	ADJ
aji-159	159	9	impact	impact	NOUN
aji-159	159	10	from	from	ADP
aji-159	159	11	the	the	DET
aji-159	159	12	hiv	hiv	PROPN
aji-159	159	13	pandemic	pandemic	NOUN
aji-159	159	14	(	(	PUNCT
aji-159	159	15	who	who	PRON
aji-159	159	16	,	,	PUNCT
aji-159	159	17	2012	2012	NUM
aji-159	159	18	)	)	PUNCT
aji-159	159	19	.	.	PUNCT
aji-159	160	1	treatment	treatment	NOUN
aji-159	160	2	abandonment	abandonment	NOUN
aji-159	160	3	among	among	ADP
aji-159	160	4	patients	patient	NOUN
aji-159	160	5	with	with	ADP
aji-159	160	6	hiv	hiv	PROPN
aji-159	160	7	infection	infection	NOUN
aji-159	160	8	is	be	AUX
aji-159	160	9	a	a	DET
aji-159	160	10	public	public	ADJ
aji-159	160	11	health	health	NOUN
aji-159	160	12	issue	issue	NOUN
aji-159	160	13	worldwide	worldwide	ADV
aji-159	160	14	.	.	PUNCT
aji-159	161	1	at	at	ADP
aji-159	161	2	the	the	DET
aji-159	161	3	end	end	NOUN
aji-159	161	4	of	of	ADP
aji-159	161	5	december	december	PROPN
aji-159	161	6	2021	2021	NUM
aji-159	161	7	,	,	PUNCT
aji-159	161	8	75	75	NUM
aji-159	161	9	%	%	NOUN
aji-159	161	10	of	of	ADP
aji-159	161	11	all	all	DET
aji-159	161	12	people	people	NOUN
aji-159	161	13	living	live	VERB
aji-159	161	14	with	with	ADP
aji-159	161	15	hiv	hiv	PROPN
aji-159	161	16	were	be	AUX
aji-159	161	17	accessing	access	VERB
aji-159	161	18	treatment	treatment	NOUN
aji-159	161	19	(	(	PUNCT
aji-159	161	20	unaids	unaid	NOUN
aji-159	161	21	,	,	PUNCT
aji-159	161	22	2022	2022	NUM
aji-159	161	23	)	)	PUNCT
aji-159	161	24	.	.	PUNCT
aji-159	162	1	adherence	adherence	NOUN
aji-159	162	2	to	to	ADP
aji-159	162	3	antiretroviral	antiretroviral	ADJ
aji-159	162	4	therapy	therapy	NOUN
aji-159	162	5	(	(	PUNCT
aji-159	162	6	art	art	NOUN
aji-159	162	7	)	)	PUNCT
aji-159	162	8	and	and	CCONJ
aji-159	162	9	loss	loss	NOUN
aji-159	162	10	of	of	ADP
aji-159	162	11	follow	follow	NOUN
aji-159	162	12	-	-	PUNCT
aji-159	162	13	up	up	ADP
aji-159	162	14	impact	impact	NOUN
aji-159	162	15	the	the	DET
aji-159	162	16	prognosis	prognosis	NOUN
aji-159	162	17	of	of	ADP
aji-159	162	18	individuals	individual	NOUN
aji-159	162	19	living	live	VERB
aji-159	162	20	with	with	ADP
aji-159	162	21	hiv	hiv	PROPN
aji-159	162	22	/	/	SYM
aji-159	162	23	aids	aids	PROPN
aji-159	162	24	in	in	ADP
aji-159	162	25	various	various	ADJ
aji-159	162	26	regions	region	NOUN
aji-159	162	27	globally	globally	ADV
aji-159	162	28	(	(	PUNCT
aji-159	162	29	lima	lima	NOUN
aji-159	162	30	et	et	PROPN
aji-159	162	31	al	al	PROPN
aji-159	162	32	.	.	PROPN
aji-159	162	33	,	,	PUNCT
aji-159	162	34	2018	2018	NUM
aji-159	162	35	)	)	PUNCT
aji-159	162	36	.	.	PUNCT
aji-159	163	1	however	however	ADV
aji-159	163	2	,	,	PUNCT
aji-159	163	3	by	by	ADP
aji-159	163	4	the	the	DET
aji-159	163	5	end	end	NOUN
aji-159	163	6	of	of	ADP
aji-159	163	7	2013	2013	NUM
aji-159	163	8	,	,	PUNCT
aji-159	163	9	the	the	DET
aji-159	163	10	art	art	NOUN
aji-159	163	11	coverage	coverage	NOUN
aji-159	163	12	level	level	NOUN
aji-159	163	13	in	in	ADP
aji-159	163	14	the	the	DET
aji-159	163	15	north	north	NOUN
aji-159	163	16	africa	africa	PROPN
aji-159	163	17	and	and	CCONJ
aji-159	163	18	middle	middle	PROPN
aji-159	163	19	east	east	PROPN
aji-159	163	20	region	region	NOUN
aji-159	163	21	remained	remain	VERB
aji-159	163	22	the	the	DET
aji-159	163	23	lowest	low	ADJ
aji-159	163	24	in	in	ADP
aji-159	163	25	the	the	DET
aji-159	163	26	world	world	NOUN
aji-159	163	27	at	at	ADP
aji-159	163	28	11	11	NUM
aji-159	163	29	%	%	NOUN
aji-159	163	30	.	.	PUNCT
aji-159	164	1	hiv	hiv	PROPN
aji-159	164	2	-	-	PUNCT
aji-159	164	3	positive	positive	ADJ
aji-159	164	4	individuals	individual	NOUN
aji-159	164	5	who	who	PRON
aji-159	164	6	inject	inject	VERB
aji-159	164	7	drugs	drug	NOUN
aji-159	164	8	and	and	CCONJ
aji-159	164	9	sex	sex	NOUN
aji-159	164	10	workers	worker	NOUN
aji-159	164	11	who	who	PRON
aji-159	164	12	have	have	AUX
aji-159	164	13	discontinued	discontinue	VERB
aji-159	164	14	treatment	treatment	NOUN
aji-159	164	15	and	and	CCONJ
aji-159	164	16	follow	follow	VERB
aji-159	164	17	-	-	PUNCT
aji-159	164	18	up	up	NOUN
aji-159	164	19	contribute	contribute	NOUN
aji-159	164	20	to	to	ADP
aji-159	164	21	increased	increase	VERB
aji-159	164	22	morbidity	morbidity	NOUN
aji-159	164	23	,	,	PUNCT
aji-159	164	24	mortality	mortality	NOUN
aji-159	164	25	risks	risk	NOUN
aji-159	164	26	,	,	PUNCT
aji-159	164	27	and	and	CCONJ
aji-159	164	28	hiv	hiv	PROPN
aji-159	164	29	transmission	transmission	NOUN
aji-159	164	30	,	,	PUNCT
aji-159	164	31	especially	especially	ADV
aji-159	164	32	in	in	ADP
aji-159	164	33	north	north	ADJ
aji-159	164	34	african	african	ADJ
aji-159	164	35	countries	country	NOUN
aji-159	164	36	(	(	PUNCT
aji-159	164	37	gökengin	gökengin	VERB
aji-159	164	38	et	et	PROPN
aji-159	164	39	al	al	PROPN
aji-159	164	40	.	.	PROPN
aji-159	164	41	,	,	PUNCT
aji-159	164	42	2016	2016	NUM
aji-159	164	43	)	)	PUNCT
aji-159	164	44	.	.	PUNCT
aji-159	165	1	although	although	SCONJ
aji-159	165	2	hiv	hiv	PROPN
aji-159	165	3	/	/	SYM
aji-159	165	4	aids	aids	PROPN
aji-159	165	5	is	be	AUX
aji-159	165	6	a	a	DET
aji-159	165	7	silent	silent	ADJ
aji-159	165	8	and	and	CCONJ
aji-159	165	9	fatal	fatal	ADJ
aji-159	165	10	disease	disease	NOUN
aji-159	165	11	,	,	PUNCT
aji-159	165	12	little	little	ADJ
aji-159	165	13	is	be	AUX
aji-159	165	14	known	know	VERB
aji-159	165	15	about	about	ADP
aji-159	165	16	its	its	PRON
aji-159	165	17	infection	infection	NOUN
aji-159	165	18	among	among	ADP
aji-159	165	19	pwid	pwid	NOUN
aji-159	165	20	and	and	CCONJ
aji-159	165	21	fsw	fsw	PROPN
aji-159	165	22	in	in	ADP
aji-159	165	23	north	north	ADJ
aji-159	165	24	african	african	ADJ
aji-159	165	25	countries	country	NOUN
aji-159	165	26	.	.	PUNCT
aji-159	166	1	however	however	ADV
aji-159	166	2	,	,	PUNCT
aji-159	166	3	having	have	VERB
aji-159	166	4	updated	update	VERB
aji-159	166	5	literature	literature	NOUN
aji-159	166	6	on	on	ADP
aji-159	166	7	hiv	hiv	PROPN
aji-159	166	8	prevalence	prevalence	NOUN
aji-159	166	9	is	be	AUX
aji-159	166	10	crucial	crucial	ADJ
aji-159	166	11	for	for	ADP
aji-159	166	12	tracking	track	VERB
aji-159	166	13	the	the	DET
aji-159	166	14	spread	spread	NOUN
aji-159	166	15	of	of	ADP
aji-159	166	16	infection	infection	NOUN
aji-159	166	17	and	and	CCONJ
aji-159	166	18	describing	describe	VERB
aji-159	166	19	the	the	DET
aji-159	166	20	burden	burden	NOUN
aji-159	166	21	on	on	ADP
aji-159	166	22	global	global	ADJ
aji-159	166	23	public	public	ADJ
aji-159	166	24	health	health	NOUN
aji-159	166	25	.	.	PUNCT
aji-159	167	1	hence	hence	ADV
aji-159	167	2	,	,	PUNCT
aji-159	167	3	the	the	DET
aji-159	167	4	aim	aim	NOUN
aji-159	167	5	of	of	ADP
aji-159	167	6	this	this	DET
aji-159	167	7	study	study	NOUN
aji-159	167	8	was	be	AUX
aji-159	167	9	to	to	PART
aji-159	167	10	assess	assess	VERB
aji-159	167	11	the	the	DET
aji-159	167	12	status	status	NOUN
aji-159	167	13	of	of	ADP
aji-159	167	14	the	the	DET
aji-159	167	15	hiv	hiv	PROPN
aji-159	167	16	prevalence	prevalence	NOUN
aji-159	167	17	among	among	ADP
aji-159	167	18	pwid	pwid	NOUN
aji-159	167	19	and	and	CCONJ
aji-159	167	20	fsws	fsws	ADJ
aji-159	167	21	in	in	ADP
aji-159	167	22	north	north	PROPN
aji-159	167	23	africa	africa	PROPN
aji-159	167	24	to	to	PART
aji-159	167	25	help	help	VERB
aji-159	167	26	understand	understand	VERB
aji-159	167	27	the	the	DET
aji-159	167	28	hiv	hiv	PROPN
aji-159	167	29	epidemiology	epidemiology	NOUN
aji-159	167	30	in	in	ADP
aji-159	167	31	this	this	DET
aji-159	167	32	part	part	NOUN
aji-159	167	33	of	of	ADP
aji-159	167	34	the	the	DET
aji-159	167	35	african	african	ADJ
aji-159	167	36	continent	continent	NOUN
aji-159	167	37	.	.	PUNCT
aji-159	168	1	2	2	X
aji-159	168	2	.	.	X
aji-159	168	3	methodology	methodology	NOUN
aji-159	168	4	present	present	ADJ
aji-159	168	5	systematic	systematic	ADJ
aji-159	168	6	review	review	NOUN
aji-159	168	7	summarizes	summarize	VERB
aji-159	168	8	main	main	ADJ
aji-159	168	9	results	result	NOUN
aji-159	168	10	of	of	ADP
aji-159	168	11	the	the	DET
aji-159	168	12	hiv	hiv	PROPN
aji-159	168	13	epidemiology	epidemiology	NOUN
aji-159	168	14	among	among	ADP
aji-159	168	15	pwid	pwid	NOUN
aji-159	168	16	and	and	CCONJ
aji-159	168	17	fsws	fsws	ADJ
aji-159	168	18	in	in	ADP
aji-159	168	19	north	north	PROPN
aji-159	168	20	africa	africa	PROPN
aji-159	168	21	.	.	PUNCT
aji-159	169	1	a	a	DET
aji-159	169	2	comprehensive	comprehensive	ADJ
aji-159	169	3	literature	literature	NOUN
aji-159	169	4	search	search	NOUN
aji-159	169	5	was	be	AUX
aji-159	169	6	performed	perform	VERB
aji-159	169	7	using	use	VERB
aji-159	169	8	pub	pub	NOUN
aji-159	169	9	med	me	VERB
aji-159	169	10	,	,	PUNCT
aji-159	169	11	science	science	NOUN
aji-159	169	12	-	-	PUNCT
aji-159	169	13	direct	direct	ADJ
aji-159	169	14	and	and	CCONJ
aji-159	169	15	google	google	PROPN
aji-159	169	16	scholar	scholar	NOUN
aji-159	169	17	,	,	PUNCT
aji-159	169	18	databases	database	NOUN
aji-159	169	19	for	for	ADP
aji-159	169	20	articles	article	NOUN
aji-159	169	21	published	publish	VERB
aji-159	169	22	in	in	ADP
aji-159	169	23	english	english	PROPN
aji-159	169	24	from	from	ADP
aji-159	169	25	1990	1990	NUM
aji-159	169	26	until	until	ADP
aji-159	169	27	2024	2024	NUM
aji-159	169	28	.	.	PUNCT
aji-159	170	1	the	the	DET
aji-159	170	2	data	datum	NOUN
aji-159	170	3	included	include	VERB
aji-159	170	4	in	in	ADP
aji-159	170	5	the	the	DET
aji-159	170	6	present	present	ADJ
aji-159	170	7	review	review	NOUN
aji-159	170	8	were	be	AUX
aji-159	170	9	primarily	primarily	ADV
aji-159	170	10	conducted	conduct	VERB
aji-159	170	11	in	in	ADP
aji-159	170	12	the	the	DET
aji-159	170	13	countries	country	NOUN
aji-159	170	14	of	of	ADP
aji-159	170	15	north	north	PROPN
aji-159	170	16	africa	africa	PROPN
aji-159	170	17	.	.	PUNCT
aji-159	171	1	these	these	DET
aji-159	171	2	data	datum	NOUN
aji-159	171	3	sources	source	NOUN
aji-159	171	4	were	be	AUX
aji-159	171	5	recognized	recognize	VERB
aji-159	171	6	through	through	ADP
aji-159	171	7	a	a	DET
aji-159	171	8	comprehensive	comprehensive	ADJ
aji-159	171	9	search	search	NOUN
aji-159	171	10	of	of	ADP
aji-159	171	11	pertinent	pertinent	ADJ
aji-159	171	12	studies	study	NOUN
aji-159	171	13	and	and	CCONJ
aji-159	171	14	databases	database	NOUN
aji-159	171	15	.	.	PUNCT
aji-159	172	1	the	the	DET
aji-159	172	2	keywords	keyword	NOUN
aji-159	172	3	used	use	VERB
aji-159	172	4	to	to	PART
aji-159	172	5	question	question	VERB
aji-159	172	6	the	the	DET
aji-159	172	7	databases	database	NOUN
aji-159	172	8	included	include	VERB
aji-159	172	9	hiv	hiv	PROPN
aji-159	172	10	in	in	ADP
aji-159	172	11	combination	combination	NOUN
aji-159	172	12	with	with	ADP
aji-159	172	13	prevalence	prevalence	NOUN
aji-159	172	14	,	,	PUNCT
aji-159	172	15	“	"	PUNCT
aji-159	172	16	pwid	pwid	NOUN
aji-159	172	17	”	"	PUNCT
aji-159	172	18	,	,	PUNCT
aji-159	172	19	“	"	PUNCT
aji-159	172	20	fsws	fsws	ADJ
aji-159	172	21	”	"	PUNCT
aji-159	172	22	,	,	PUNCT
aji-159	172	23	as	as	ADV
aji-159	172	24	well	well	ADV
aji-159	172	25	as	as	ADP
aji-159	172	26	north	north	PROPN
aji-159	172	27	africa	africa	PROPN
aji-159	172	28	and	and	CCONJ
aji-159	172	29	country	country	NOUN
aji-159	172	30	names	name	NOUN
aji-159	172	31	.	.	PUNCT
aji-159	173	1	all	all	DET
aji-159	173	2	articles	article	NOUN
aji-159	173	3	were	be	AUX
aji-159	173	4	evaluated	evaluate	VERB
aji-159	173	5	for	for	ADP
aji-159	173	6	pertinence	pertinence	NOUN
aji-159	173	7	before	before	ADP
aji-159	173	8	inclusion	inclusion	NOUN
aji-159	173	9	.	.	PUNCT
aji-159	174	1	the	the	DET
aji-159	174	2	review	review	NOUN
aji-159	174	3	involved	involve	VERB
aji-159	174	4	all	all	DET
aji-159	174	5	countries	country	NOUN
aji-159	174	6	contained	contain	VERB
aji-159	174	7	in	in	ADP
aji-159	174	8	the	the	DET
aji-159	174	9	north	north	PROPN
aji-159	174	10	africa	africa	PROPN
aji-159	174	11	descriptions	description	NOUN
aji-159	174	12	of	of	ADP
aji-159	174	13	the	the	DET
aji-159	174	14	world	world	NOUN
aji-159	174	15	bank	bank	PROPN
aji-159	174	16	and	and	CCONJ
aji-159	174	17	who	who	PRON
aji-159	174	18	emro	emro	VERB
aji-159	174	19	.	.	PUNCT
aji-159	175	1	these	these	PRON
aji-159	175	2	include	include	VERB
aji-159	175	3	algeria	algeria	PROPN
aji-159	175	4	,	,	PUNCT
aji-159	175	5	libya	libya	PROPN
aji-159	175	6	,	,	PUNCT
aji-159	175	7	egypt	egypt	PROPN
aji-159	175	8	,	,	PUNCT
aji-159	175	9	morocco	morocco	PROPN
aji-159	175	10	,	,	PUNCT
aji-159	175	11	and	and	CCONJ
aji-159	175	12	tunisia	tunisia	NOUN
aji-159	175	13	.	.	PUNCT
aji-159	176	1	in	in	ADP
aji-159	176	2	this	this	DET
aji-159	176	3	article	article	NOUN
aji-159	176	4	,	,	PUNCT
aji-159	176	5	the	the	DET
aji-159	176	6	north	north	PROPN
aji-159	176	7	africa	africa	PROPN
aji-159	176	8	high	high	ADJ
aji-159	176	9	-	-	PUNCT
aji-159	176	10	risk	risk	NOUN
aji-159	176	11	groups	group	NOUN
aji-159	176	12	were	be	AUX
aji-159	176	13	including	include	VERB
aji-159	176	14	people	people	NOUN
aji-159	176	15	who	who	PRON
aji-159	176	16	inject	inject	VERB
aji-159	176	17	drugs	drug	NOUN
aji-159	176	18	(	(	PUNCT
aji-159	176	19	pwid	pwid	NOUN
aji-159	176	20	)	)	PUNCT
aji-159	176	21	as	as	ADV
aji-159	176	22	well	well	ADV
aji-159	176	23	as	as	ADP
aji-159	176	24	female	female	ADJ
aji-159	176	25	sex	sex	NOUN
aji-159	176	26	workers	worker	NOUN
aji-159	176	27	(	(	PUNCT
aji-159	176	28	fsws	fsws	ADJ
aji-159	176	29	)	)	PUNCT
aji-159	176	30	.	.	PUNCT
aji-159	177	1	eligibility	eligibility	NOUN
aji-159	177	2	and	and	CCONJ
aji-159	177	3	evaluation	evaluation	NOUN
aji-159	177	4	of	of	ADP
aji-159	177	5	the	the	DET
aji-159	177	6	studies	study	NOUN
aji-159	177	7	:	:	PUNCT
aji-159	177	8	each	each	DET
aji-159	177	9	study	study	NOUN
aji-159	177	10	was	be	AUX
aji-159	177	11	examined	examine	VERB
aji-159	177	12	and	and	CCONJ
aji-159	177	13	thoroughly	thoroughly	ADV
aji-159	177	14	assessed	assess	VERB
aji-159	177	15	for	for	ADP
aji-159	177	16	its	its	PRON
aji-159	177	17	inclusion	inclusion	NOUN
aji-159	177	18	in	in	ADP
aji-159	177	19	the	the	DET
aji-159	177	20	studies	study	NOUN
aji-159	177	21	:	:	PUNCT
aji-159	177	22	all	all	DET
aji-159	177	23	the	the	DET
aji-159	177	24	studies	study	NOUN
aji-159	177	25	were	be	AUX
aji-159	177	26	examined	examine	VERB
aji-159	177	27	and	and	CCONJ
aji-159	177	28	thoroughly	thoroughly	ADV
aji-159	177	29	evaluated	evaluate	VERB
aji-159	177	30	for	for	ADP
aji-159	177	31	inclusion	inclusion	NOUN
aji-159	177	32	in	in	ADP
aji-159	177	33	the	the	DET
aji-159	177	34	study	study	NOUN
aji-159	177	35	.	.	PUNCT
aji-159	178	1	all	all	DET
aji-159	178	2	descriptive	descriptive	ADJ
aji-159	178	3	/	/	SYM
aji-159	178	4	cross	cross	ADJ
aji-159	178	5	-	-	ADJ
aji-159	178	6	sectional	sectional	ADJ
aji-159	178	7	,	,	PUNCT
aji-159	178	8	case	case	NOUN
aji-159	178	9	control	control	NOUN
aji-159	178	10	,	,	PUNCT
aji-159	178	11	and	and	CCONJ
aji-159	178	12	epidemiological	epidemiological	ADJ
aji-159	178	13	studies	study	NOUN
aji-159	178	14	were	be	AUX
aji-159	178	15	included	include	VERB
aji-159	178	16	.	.	PUNCT
aji-159	179	1	letters	letter	NOUN
aji-159	179	2	to	to	ADP
aji-159	179	3	the	the	DET
aji-159	179	4	editor	editor	NOUN
aji-159	179	5	,	,	PUNCT
aji-159	179	6	editorials	editorial	NOUN
aji-159	179	7	,	,	PUNCT
aji-159	179	8	case	case	NOUN
aji-159	179	9	reports	report	NOUN
aji-159	179	10	,	,	PUNCT
aji-159	179	11	hypotheses	hypothesis	NOUN
aji-159	179	12	,	,	PUNCT
aji-159	179	13	studies	study	NOUN
aji-159	179	14	on	on	ADP
aji-159	179	15	animals	animal	NOUN
aji-159	179	16	or	or	CCONJ
aji-159	179	17	cell	cell	NOUN
aji-159	179	18	lines	line	NOUN
aji-159	179	19	,	,	PUNCT
aji-159	179	20	and	and	CCONJ
aji-159	179	21	unpublished	unpublished	ADJ
aji-159	179	22	reports	report	NOUN
aji-159	179	23	were	be	AUX
aji-159	179	24	excluded	exclude	VERB
aji-159	179	25	.	.	PUNCT
aji-159	180	1	studies	study	NOUN
aji-159	180	2	were	be	AUX
aji-159	180	3	eligible	eligible	ADJ
aji-159	180	4	for	for	ADP
aji-159	180	5	review	review	NOUN
aji-159	180	6	if	if	SCONJ
aji-159	180	7	they	they	PRON
aji-159	180	8	reported	report	VERB
aji-159	180	9	hiv	hiv	PROPN
aji-159	180	10	epidemiology	epidemiology	NOUN
aji-159	180	11	in	in	ADP
aji-159	180	12	pwid	pwid	NOUN
aji-159	180	13	and	and	CCONJ
aji-159	180	14	fsw	fsw	PROPN
aji-159	180	15	.	.	PUNCT
aji-159	181	1	therefore	therefore	ADV
aji-159	181	2	,	,	PUNCT
aji-159	181	3	studies	study	NOUN
aji-159	181	4	reporting	report	VERB
aji-159	181	5	the	the	DET
aji-159	181	6	prevalence	prevalence	NOUN
aji-159	181	7	of	of	ADP
aji-159	181	8	hiv	hiv	PROPN
aji-159	181	9	in	in	ADP
aji-159	181	10	prisoners	prisoner	NOUN
aji-159	181	11	,	,	PUNCT
aji-159	181	12	man	man	NOUN
aji-159	181	13	who	who	PRON
aji-159	181	14	have	have	VERB
aji-159	181	15	se	se	ADV
aji-159	181	16	with	with	ADP
aji-159	181	17	man	man	NOUN
aji-159	181	18	,	,	PUNCT
aji-159	181	19	hemodialysis	hemodialysis	NOUN
aji-159	181	20	,	,	PUNCT
aji-159	181	21	hiv	hiv	PROPN
aji-159	181	22	in	in	ADP
aji-159	181	23	patients	patient	NOUN
aji-159	181	24	with	with	ADP
aji-159	181	25	tb	tb	NOUN
aji-159	181	26	or	or	CCONJ
aji-159	181	27	cancer	cancer	NOUN
aji-159	181	28	were	be	AUX
aji-159	181	29	excluded	exclude	VERB
aji-159	181	30	(	(	PUNCT
aji-159	181	31	fig	fig	NOUN
aji-159	181	32	.	.	NOUN
aji-159	181	33	1	1	NUM
aji-159	181	34	)	)	PUNCT
aji-159	181	35	.	.	PUNCT
aji-159	182	1	data	datum	NOUN
aji-159	182	2	extraction	extraction	NOUN
aji-159	182	3	:	:	PUNCT
aji-159	182	4	relevant	relevant	ADJ
aji-159	182	5	information	information	NOUN
aji-159	182	6	from	from	ADP
aji-159	182	7	articles	article	NOUN
aji-159	182	8	reporting	report	VERB
aji-159	182	9	the	the	DET
aji-159	182	10	prevalence	prevalence	NOUN
aji-159	182	11	of	of	ADP
aji-159	182	12	hiv	hiv	PROPN
aji-159	182	13	and	and	CCONJ
aji-159	182	14	its	its	PRON
aji-159	182	15	epidemiology	epidemiology	NOUN
aji-159	182	16	in	in	ADP
aji-159	182	17	north	north	ADJ
aji-159	182	18	african	african	ADJ
aji-159	182	19	countries	country	NOUN
aji-159	182	20	were	be	AUX
aji-159	182	21	extracted	extract	VERB
aji-159	182	22	.	.	PUNCT
aji-159	183	1	data	datum	NOUN
aji-159	183	2	on	on	ADP
aji-159	183	3	the	the	DET
aji-159	183	4	number	number	NOUN
aji-159	183	5	of	of	ADP
aji-159	183	6	participants	participant	NOUN
aji-159	183	7	in	in	ADP
aji-159	183	8	each	each	DET
aji-159	183	9	eligible	eligible	ADJ
aji-159	183	10	study	study	NOUN
aji-159	183	11	,	,	PUNCT
aji-159	183	12	study	study	NOUN
aji-159	183	13	country	country	NOUN
aji-159	183	14	,	,	PUNCT
aji-159	183	15	prevalence	prevalence	NOUN
aji-159	183	16	of	of	ADP
aji-159	183	17	hiv	hiv	PROPN
aji-159	183	18	infection	infection	NOUN
aji-159	183	19	population	population	NOUN
aji-159	183	20	age	age	NOUN
aji-159	183	21	group	group	NOUN
aji-159	183	22	,	,	PUNCT
aji-159	183	23	and	and	CCONJ
aji-159	183	24	year	year	NOUN
aji-159	183	25	of	of	ADP
aji-159	183	26	study	study	NOUN
aji-159	183	27	were	be	AUX
aji-159	183	28	collected	collect	VERB
aji-159	183	29	and	and	CCONJ
aji-159	183	30	classified	classify	VERB
aji-159	183	31	in	in	ADP
aji-159	183	32	divide	divide	NOUN
aji-159	183	33	tables	table	NOUN
aji-159	183	34	.	.	PUNCT
aji-159	184	1	3	3	X
aji-159	184	2	.	.	NOUN
aji-159	184	3	results	result	VERB
aji-159	184	4	a	a	DET
aji-159	184	5	total	total	NOUN
aji-159	184	6	of	of	ADP
aji-159	184	7	3605	3605	NUM
aji-159	184	8	records	record	NOUN
aji-159	184	9	were	be	AUX
aji-159	184	10	identified	identify	VERB
aji-159	184	11	from	from	ADP
aji-159	184	12	three	three	NUM
aji-159	184	13	databases	database	NOUN
aji-159	184	14	.	.	PUNCT
aji-159	185	1	duplicates	duplicate	VERB
aji-159	185	2	studies	study	NOUN
aji-159	185	3	were	be	AUX
aji-159	185	4	identified	identify	VERB
aji-159	185	5	and	and	CCONJ
aji-159	185	6	removed	remove	VERB
aji-159	185	7	,	,	PUNCT
aji-159	185	8	leaving	leave	VERB
aji-159	185	9	166	166	NUM
aji-159	185	10	potential	potential	ADJ
aji-159	185	11	records	record	NOUN
aji-159	185	12	,	,	PUNCT
aji-159	185	13	after	after	SCONJ
aji-159	185	14	review	review	NOUN
aji-159	185	15	of	of	ADP
aji-159	185	16	titles	title	NOUN
aji-159	185	17	and	and	CCONJ
aji-159	185	18	abstracts	abstract	NOUN
aji-159	185	19	records	record	NOUN
aji-159	185	20	were	be	AUX
aji-159	185	21	excluded	exclude	VERB
aji-159	185	22	based	base	VERB
aji-159	185	23	on	on	ADP
aji-159	185	24	selection	selection	NOUN
aji-159	185	25	criteria	criterion	NOUN
aji-159	185	26	,	,	PUNCT
aji-159	185	27	and	and	CCONJ
aji-159	185	28	a	a	DET
aji-159	185	29	total	total	NOUN
aji-159	185	30	of	of	ADP
aji-159	185	31	10	10	NUM
aji-159	185	32	reports	report	NOUN
aji-159	185	33	on	on	ADP
aji-159	185	34	the	the	DET
aji-159	185	35	prevalence	prevalence	NOUN
aji-159	185	36	of	of	ADP
aji-159	185	37	hiv	hiv	PROPN
aji-159	185	38	among	among	ADP
aji-159	185	39	pwid	pwid	NOUN
aji-159	185	40	and	and	CCONJ
aji-159	185	41	fsws	fsws	ADJ
aji-159	185	42	covering	cover	VERB
aji-159	185	43	4	4	NUM
aji-159	185	44	countries	country	NOUN
aji-159	185	45	were	be	AUX
aji-159	185	46	included	include	VERB
aji-159	185	47	.	.	PUNCT
aji-159	186	1	the	the	DET
aji-159	186	2	review	review	NOUN
aji-159	186	3	process	process	NOUN
aji-159	186	4	is	be	AUX
aji-159	186	5	presented	present	VERB
aji-159	186	6	in	in	ADP
aji-159	186	7	fig	fig	NOUN
aji-159	186	8	.	.	PUNCT
aji-159	187	1	1	1	NUM
aji-159	187	2	.	.	X
aji-159	187	3	seven	seven	NUM
aji-159	187	4	studies	study	NOUN
aji-159	187	5	recorded	record	VERB
aji-159	187	6	hiv	hiv	PROPN
aji-159	187	7	positive	positive	ADJ
aji-159	187	8	among	among	ADP
aji-159	187	9	pwid	pwid	NOUN
aji-159	187	10	,	,	PUNCT
aji-159	187	11	5	5	NUM
aji-159	187	12	recorded	record	VERB
aji-159	187	13	the	the	DET
aji-159	187	14	hiv	hiv	PROPN
aji-159	187	15	positive	positive	ADJ
aji-159	187	16	among	among	ADP
aji-159	187	17	fsws	fsws	ADJ
aji-159	187	18	sample	sample	NOUN
aji-159	187	19	sizes	size	NOUN
aji-159	187	20	ranged	range	VERB
aji-159	187	21	from	from	ADP
aji-159	187	22	113	113	NUM
aji-159	187	23	to	to	ADP
aji-159	187	24	12,981	12,981	NUM
aji-159	187	25	pwid	pwid	NOUN
aji-159	187	26	,	,	PUNCT
aji-159	187	27	and	and	CCONJ
aji-159	187	28	69	69	NUM
aji-159	187	29	to1447	to1447	NOUN
aji-159	187	30	fsws	fsws	ADJ
aji-159	187	31	.	.	PUNCT
aji-159	188	1	pwid	pwid	NOUN
aji-159	188	2	and	and	CCONJ
aji-159	188	3	fsws	fsws	ADJ
aji-159	188	4	data	datum	NOUN
aji-159	188	5	were	be	AUX
aji-159	188	6	obtainable	obtainable	ADJ
aji-159	188	7	for	for	ADP
aji-159	188	8	4	4	NUM
aji-159	188	9	of	of	ADP
aji-159	188	10	the	the	DET
aji-159	188	11	5	5	NUM
aji-159	188	12	na	na	NOUN
aji-159	188	13	countries	country	NOUN
aji-159	188	14	.	.	PUNCT
aji-159	189	1	no	no	DET
aji-159	189	2	studies	study	NOUN
aji-159	189	3	were	be	AUX
aji-159	189	4	available	available	ADJ
aji-159	189	5	for	for	ADP
aji-159	189	6	algeria	algeria	PROPN
aji-159	189	7	.	.	PUNCT
aji-159	190	1	egypt	egypt	PROPN
aji-159	190	2	contributed	contribute	VERB
aji-159	190	3	the	the	DET
aji-159	190	4	largest	large	ADJ
aji-159	190	5	number	number	NOUN
aji-159	190	6	of	of	ADP
aji-159	190	7	data	datum	NOUN
aji-159	190	8	points	point	NOUN
aji-159	190	9	of	of	ADP
aji-159	190	10	hiv	hiv	PROPN
aji-159	190	11	prevalence	prevalence	NOUN
aji-159	190	12	measures	measure	NOUN
aji-159	190	13	where	where	SCONJ
aji-159	190	14	,	,	PUNCT
aji-159	190	15	there	there	PRON
aji-159	190	16	were	be	VERB
aji-159	190	17	4	4	NUM
aji-159	190	18	studies	study	NOUN
aji-159	190	19	from	from	ADP
aji-159	190	20	egypt	egypt	PROPN
aji-159	190	21	,	,	PUNCT
aji-159	190	22	2	2	NUM
aji-159	190	23	from	from	ADP
aji-159	190	24	tunisia	tunisia	PROPN
aji-159	190	25	,	,	PUNCT
aji-159	190	26	morocco	morocco	PROPN
aji-159	190	27	,	,	PUNCT
aji-159	190	28	and	and	CCONJ
aji-159	190	29	libya	libya	PROPN
aji-159	190	30	,	,	PUNCT
aji-159	190	31	respectively	respectively	ADV
aji-159	190	32	.	.	PUNCT
aji-159	191	1	the	the	DET
aji-159	191	2	prevalence	prevalence	NOUN
aji-159	191	3	of	of	ADP
aji-159	191	4	hiv	hiv	PROPN
aji-159	191	5	across	across	ADP
aji-159	191	6	the	the	DET
aji-159	191	7	key	key	ADJ
aji-159	191	8	populations	population	NOUN
aji-159	191	9	such	such	ADJ
aji-159	191	10	as	as	ADP
aji-159	191	11	pwid	pwid	NOUN
aji-159	191	12	and	and	CCONJ
aji-159	191	13	fsws	fsws	ADJ
aji-159	191	14	reported	report	VERB
aji-159	191	15	by	by	ADP
aji-159	191	16	the	the	DET
aji-159	191	17	10	10	NUM
aji-159	191	18	studies	study	NOUN
aji-159	191	19	was	be	AUX
aji-159	191	20	range	range	NOUN
aji-159	191	21	between	between	ADP
aji-159	191	22	0	0	NUM
aji-159	191	23	and	and	CCONJ
aji-159	191	24	87.1	87.1	NUM
aji-159	191	25	%	%	NOUN
aji-159	191	26	.	.	PUNCT
aji-159	192	1	when	when	SCONJ
aji-159	192	2	divided	divide	VERB
aji-159	192	3	according	accord	VERB
aji-159	192	4	to	to	ADP
aji-159	192	5	population	population	NOUN
aji-159	192	6	categories	category	NOUN
aji-159	192	7	,	,	PUNCT
aji-159	192	8	injecting	inject	VERB
aji-159	192	9	drugs	drug	NOUN
aji-159	192	10	is	be	AUX
aji-159	192	11	a	a	DET
aji-159	192	12	primary	primary	ADJ
aji-159	192	13	way	way	NOUN
aji-159	192	14	hiv	hiv	PROPN
aji-159	192	15	is	be	AUX
aji-159	192	16	transmitted	transmit	VERB
aji-159	192	17	globally	globally	ADV
aji-159	192	18	(	(	PUNCT
aji-159	192	19	who	who	PRON
aji-159	192	20	,	,	PUNCT
aji-159	192	21	2024b	2024b	NUM
aji-159	192	22	)	)	PUNCT
aji-159	192	23	.	.	PUNCT
aji-159	193	1	study	study	NOUN
aji-159	193	2	population	population	NOUN
aji-159	193	3	hiv	hiv	PROPN
aji-159	193	4	prevalence	prevalence	NOUN
aji-159	193	5	ranged	range	VERB
aji-159	193	6	from	from	ADP
aji-159	193	7	0.15	0.15	NUM
aji-159	193	8	%	%	NOUN
aji-159	193	9	in	in	ADP
aji-159	193	10	a	a	DET
aji-159	193	11	study	study	NOUN
aji-159	193	12	from	from	ADP
aji-159	193	13	egypt	egypt	PROPN
aji-159	193	14	to	to	ADP
aji-159	193	15	87.1	87.1	NUM
aji-159	193	16	%	%	NOUN
aji-159	193	17	in	in	ADP
aji-159	193	18	a	a	DET
aji-159	193	19	study	study	NOUN
aji-159	193	20	from	from	ADP
aji-159	193	21	libya	libya	PROPN
aji-159	193	22	(	(	PUNCT
aji-159	193	23	table	table	NOUN
aji-159	193	24	1	1	NUM
aji-159	193	25	)	)	PUNCT
aji-159	193	26	.	.	PUNCT
aji-159	194	1	the	the	DET
aji-159	194	2	median	median	PROPN
aji-159	194	3	hiv	hiv	PROPN
aji-159	194	4	prevalence	prevalence	NOUN
aji-159	194	5	among	among	ADP
aji-159	194	6	pwid	pwid	NOUN
aji-159	194	7	in	in	ADP
aji-159	194	8	all	all	DET
aji-159	194	9	studies	study	NOUN
aji-159	194	10	was	be	AUX
aji-159	194	11	0.91	0.91	NUM
aji-159	194	12	%	%	NOUN
aji-159	194	13	.	.	PUNCT
aji-159	195	1	sexual	sexual	ADJ
aji-159	195	2	khalaf	khalaf	PROPN
aji-159	195	3	;	;	PUNCT
aji-159	195	4	asian	asian	PROPN
aji-159	195	5	j.	j.	PROPN
aji-159	195	6	immunol	immunol	PROPN
aji-159	195	7	.	.	PROPN
aji-159	195	8	,	,	PUNCT
aji-159	195	9	vol	vol	NOUN
aji-159	195	10	.	.	PROPN
aji-159	195	11	8	8	NUM
aji-159	195	12	,	,	PUNCT
aji-159	195	13	no	no	INTJ
aji-159	195	14	.	.	NOUN
aji-159	195	15	1	1	NUM
aji-159	195	16	,	,	PUNCT
aji-159	195	17	pp	pp	ADJ
aji-159	195	18	.	.	PUNCT
aji-159	196	1	50	50	NUM
aji-159	196	2	-	-	SYM
aji-159	196	3	59	59	NUM
aji-159	196	4	,	,	PUNCT
aji-159	196	5	2025	2025	NUM
aji-159	196	6	;	;	PUNCT
aji-159	196	7	article	article	NOUN
aji-159	196	8	no.aji.125999	no.aji.125999	NOUN
aji-159	196	9	53	53	NUM
aji-159	196	10	hazard	hazard	NOUN
aji-159	196	11	behavior	behavior	NOUN
aji-159	196	12	associated	associate	VERB
aji-159	196	13	with	with	ADP
aji-159	196	14	hiv	hiv	PROPN
aji-159	196	15	infection	infection	NOUN
aji-159	196	16	among	among	ADP
aji-159	196	17	fsws	fsws	ADJ
aji-159	196	18	,	,	PUNCT
aji-159	196	19	the	the	DET
aji-159	196	20	country	country	NOUN
aji-159	196	21	-	-	PUNCT
aji-159	196	22	specific	specific	ADJ
aji-159	196	23	estimate	estimate	NOUN
aji-159	196	24	fsws	fsws	NOUN
aji-159	196	25	ranged	range	VERB
aji-159	196	26	from	from	ADP
aji-159	196	27	0	0	NUM
aji-159	196	28	%	%	NOUN
aji-159	196	29	in	in	ADP
aji-159	196	30	tunisia	tunisia	NOUN
aji-159	196	31	to	to	ADP
aji-159	196	32	15.7	15.7	NUM
aji-159	196	33	%	%	NOUN
aji-159	196	34	in	in	ADP
aji-159	196	35	libya	libya	PROPN
aji-159	196	36	.	.	PUNCT
aji-159	197	1	egypt	egypt	PROPN
aji-159	197	2	and	and	CCONJ
aji-159	197	3	morocco	morocco	PROPN
aji-159	197	4	had	have	VERB
aji-159	197	5	a	a	DET
aji-159	197	6	prevalence	prevalence	NOUN
aji-159	197	7	estimate	estimate	NOUN
aji-159	197	8	<	<	X
aji-159	197	9	9	9	NUM
aji-159	197	10	%	%	NOUN
aji-159	197	11	(	(	PUNCT
aji-159	197	12	table	table	NOUN
aji-159	197	13	2	2	NUM
aji-159	197	14	)	)	PUNCT
aji-159	197	15	.	.	PUNCT
aji-159	198	1	the	the	DET
aji-159	198	2	median	median	PROPN
aji-159	198	3	hiv	hiv	PROPN
aji-159	198	4	prevalence	prevalence	NOUN
aji-159	198	5	among	among	ADP
aji-159	198	6	fsws	fsws	NOUN
aji-159	198	7	in	in	ADP
aji-159	198	8	all	all	DET
aji-159	198	9	studies	study	NOUN
aji-159	198	10	was	be	AUX
aji-159	198	11	1.25	1.25	NUM
aji-159	198	12	%	%	NOUN
aji-159	198	13	.	.	PUNCT
aji-159	199	1	fig	fig	NOUN
aji-159	199	2	.	.	PUNCT
aji-159	200	1	1	1	X
aji-159	200	2	.	.	X
aji-159	200	3	flowchart	flowchart	NOUN
aji-159	200	4	of	of	ADP
aji-159	200	5	study	study	NOUN
aji-159	200	6	selection	selection	NOUN
aji-159	200	7	two	two	NUM
aji-159	200	8	studies	study	NOUN
aji-159	200	9	were	be	AUX
aji-159	200	10	found	find	VERB
aji-159	200	11	in	in	ADP
aji-159	200	12	this	this	DET
aji-159	200	13	review	review	NOUN
aji-159	200	14	that	that	PRON
aji-159	200	15	recorded	record	VERB
aji-159	200	16	hiv	hiv	PROPN
aji-159	200	17	/	/	SYM
aji-159	200	18	hcv	hcv	PROPN
aji-159	200	19	and	and	CCONJ
aji-159	200	20	hiv	hiv	PROPN
aji-159	200	21	/	/	SYM
aji-159	200	22	hbv	hbv	PROPN
aji-159	200	23	co	co	NOUN
aji-159	200	24	-	-	NOUN
aji-159	200	25	infection	infection	NOUN
aji-159	200	26	,	,	PUNCT
aji-159	200	27	prevalence	prevalence	NOUN
aji-159	200	28	of	of	ADP
aji-159	200	29	hiv	hiv	PROPN
aji-159	200	30	/	/	SYM
aji-159	200	31	hcv	hcv	PROPN
aji-159	200	32	and	and	CCONJ
aji-159	200	33	hiv	hiv	PROPN
aji-159	200	34	/	/	SYM
aji-159	200	35	hbv	hbv	PROPN
aji-159	200	36	co	co	NOUN
aji-159	200	37	infections	infection	NOUN
aji-159	200	38	among	among	ADP
aji-159	200	39	pwid	pwid	NOUN
aji-159	200	40	was	be	AUX
aji-159	200	41	83.2	83.2	NUM
aji-159	200	42	%	%	NOUN
aji-159	200	43	and	and	CCONJ
aji-159	200	44	3.7	3.7	NUM
aji-159	200	45	%	%	NOUN
aji-159	200	46	,	,	PUNCT
aji-159	200	47	respectively	respectively	ADV
aji-159	200	48	.	.	PUNCT
aji-159	201	1	beside	beside	ADV
aji-159	201	2	,	,	PUNCT
aji-159	201	3	the	the	DET
aji-159	201	4	prevalence	prevalence	NOUN
aji-159	201	5	of	of	ADP
aji-159	201	6	hiv	hiv	PROPN
aji-159	201	7	/	/	SYM
aji-159	201	8	hcv	hcv	PROPN
aji-159	201	9	and	and	CCONJ
aji-159	201	10	hiv	hiv	PROPN
aji-159	201	11	/	/	SYM
aji-159	201	12	hbv	hbv	PROPN
aji-159	201	13	co	co	NOUN
aji-159	201	14	-	-	NOUN
aji-159	201	15	infections	infection	NOUN
aji-159	201	16	among	among	ADP
aji-159	201	17	fsws	fsws	ADJ
aji-159	201	18	was	be	AUX
aji-159	201	19	3.7	3.7	NUM
aji-159	201	20	%	%	NOUN
aji-159	201	21	and	and	CCONJ
aji-159	201	22	0	0	NUM
aji-159	201	23	%	%	NOUN
aji-159	201	24	,	,	PUNCT
aji-159	201	25	respectively	respectively	ADV
aji-159	201	26	.	.	PUNCT
aji-159	202	1	4	4	X
aji-159	202	2	.	.	X
aji-159	202	3	discussion	discussion	NOUN
aji-159	202	4	hiv	hiv	PROPN
aji-159	202	5	infection	infection	NOUN
aji-159	202	6	among	among	ADP
aji-159	202	7	pwid	pwid	NOUN
aji-159	202	8	and	and	CCONJ
aji-159	202	9	fsws	fsws	ADJ
aji-159	202	10	continues	continue	VERB
aji-159	202	11	to	to	PART
aji-159	202	12	be	be	AUX
aji-159	202	13	a	a	DET
aji-159	202	14	major	major	ADJ
aji-159	202	15	public	public	ADJ
aji-159	202	16	health	health	NOUN
aji-159	202	17	issue	issue	NOUN
aji-159	202	18	worldwide	worldwide	ADV
aji-159	202	19	(	(	PUNCT
aji-159	202	20	mirzoyan	mirzoyan	NOUN
aji-159	202	21	et	et	PROPN
aji-159	202	22	al	al	PROPN
aji-159	202	23	.	.	PROPN
aji-159	202	24	,	,	PUNCT
aji-159	202	25	2013	2013	NUM
aji-159	202	26	)	)	PUNCT
aji-159	202	27	.	.	PUNCT
aji-159	203	1	understanding	understand	VERB
aji-159	203	2	the	the	DET
aji-159	203	3	epidemiological	epidemiological	ADJ
aji-159	203	4	characteristics	characteristic	NOUN
aji-159	203	5	of	of	ADP
aji-159	203	6	hiv	hiv	PROPN
aji-159	203	7	infection	infection	NOUN
aji-159	203	8	are	be	AUX
aji-159	203	9	crucial	crucial	ADJ
aji-159	203	10	and	and	CCONJ
aji-159	203	11	beneficial	beneficial	ADJ
aji-159	203	12	in	in	ADP
aji-159	203	13	defining	define	VERB
aji-159	203	14	the	the	DET
aji-159	203	15	implications	implication	NOUN
aji-159	203	16	and	and	CCONJ
aji-159	203	17	problems	problem	NOUN
aji-159	203	18	of	of	ADP
aji-159	203	19	the	the	DET
aji-159	203	20	infection	infection	NOUN
aji-159	203	21	.	.	PUNCT
aji-159	204	1	injecting	inject	VERB
aji-159	204	2	drugs	drug	NOUN
aji-159	204	3	is	be	AUX
aji-159	204	4	a	a	DET
aji-159	204	5	primary	primary	ADJ
aji-159	204	6	way	way	NOUN
aji-159	204	7	hiv	hiv	PROPN
aji-159	204	8	is	be	AUX
aji-159	204	9	transmitted	transmit	VERB
aji-159	204	10	globally	globally	ADV
aji-159	204	11	(	(	PUNCT
aji-159	204	12	who	who	PRON
aji-159	204	13	,	,	PUNCT
aji-159	204	14	2024b	2024b	NUM
aji-159	204	15	)	)	PUNCT
aji-159	204	16	.	.	PUNCT
aji-159	205	1	the	the	DET
aji-159	205	2	findings	finding	NOUN
aji-159	205	3	revealed	reveal	VERB
aji-159	205	4	that	that	SCONJ
aji-159	205	5	the	the	DET
aji-159	205	6	hiv	hiv	PROPN
aji-159	205	7	prevalence	prevalence	NOUN
aji-159	205	8	among	among	ADP
aji-159	205	9	north	north	ADJ
aji-159	205	10	african	african	ADJ
aji-159	205	11	pwid	pwid	NOUN
aji-159	205	12	population	population	NOUN
aji-159	205	13	groups	group	NOUN
aji-159	205	14	ranged	range	VERB
aji-159	205	15	from	from	ADP
aji-159	205	16	0	0	NUM
aji-159	205	17	%	%	NOUN
aji-159	205	18	to	to	ADP
aji-159	205	19	87.1	87.1	NUM
aji-159	205	20	%	%	NOUN
aji-159	205	21	,	,	PUNCT
aji-159	205	22	this	this	DET
aji-159	205	23	results	result	NOUN
aji-159	205	24	is	be	AUX
aji-159	205	25	higher	high	ADJ
aji-159	205	26	than	than	ADP
aji-159	205	27	the	the	DET
aji-159	205	28	previous	previous	ADJ
aji-159	205	29	estimates	estimate	NOUN
aji-159	205	30	of	of	ADP
aji-159	205	31	global	global	ADJ
aji-159	205	32	prevalence	prevalence	NOUN
aji-159	205	33	(	(	PUNCT
aji-159	205	34	mathers	mather	NOUN
aji-159	205	35	et	et	PROPN
aji-159	205	36	al	al	PROPN
aji-159	205	37	.	.	PROPN
aji-159	205	38	,	,	PUNCT
aji-159	205	39	2008	2008	NUM
aji-159	205	40	;	;	PUNCT
aji-159	205	41	rashti	rashti	NOUN
aji-159	205	42	et	et	PROPN
aji-159	205	43	al	al	PROPN
aji-159	205	44	.	.	PROPN
aji-159	205	45	,	,	PUNCT
aji-159	205	46	2020	2020	NUM
aji-159	205	47	)	)	PUNCT
aji-159	205	48	.	.	PUNCT
aji-159	206	1	it	it	PRON
aji-159	206	2	is	be	AUX
aji-159	206	3	also	also	ADV
aji-159	206	4	higher	high	ADJ
aji-159	206	5	than	than	ADP
aji-159	206	6	the	the	DET
aji-159	206	7	findings	finding	NOUN
aji-159	206	8	of	of	ADP
aji-159	206	9	studies	study	NOUN
aji-159	206	10	conducted	conduct	VERB
aji-159	206	11	in	in	ADP
aji-159	206	12	europe	europe	PROPN
aji-159	206	13	(	(	PUNCT
aji-159	206	14	wenz	wenz	PROPN
aji-159	206	15	et	et	PROPN
aji-159	206	16	al	al	PROPN
aji-159	206	17	.	.	PROPN
aji-159	206	18	,	,	PUNCT
aji-159	206	19	2016	2016	NUM
aji-159	206	20	;	;	PUNCT
aji-159	206	21	handanagic	handanagic	PROPN
aji-159	206	22	et	et	PROPN
aji-159	206	23	al	al	PROPN
aji-159	206	24	.	.	PROPN
aji-159	206	25	,	,	PUNCT
aji-159	206	26	2016	2016	NUM
aji-159	206	27	;	;	PUNCT
aji-159	206	28	hatzakis	hatzaki	NOUN
aji-159	206	29	et	et	NOUN
aji-159	206	30	al	al	PROPN
aji-159	206	31	.	.	PROPN
aji-159	206	32	,	,	PUNCT
aji-159	206	33	2015	2015	NUM
aji-159	206	34	)	)	PUNCT
aji-159	206	35	,	,	PUNCT
aji-159	206	36	china	china	PROPN
aji-159	206	37	(	(	PUNCT
aji-159	206	38	zhang	zhang	PROPN
aji-159	206	39	et	et	PROPN
aji-159	206	40	al	al	PROPN
aji-159	206	41	.	.	PROPN
aji-159	206	42	,	,	PUNCT
aji-159	206	43	2007	2007	NUM
aji-159	206	44	)	)	PUNCT
aji-159	206	45	,	,	PUNCT
aji-159	206	46	bangladesh	bangladesh	NOUN
aji-159	206	47	(	(	PUNCT
aji-159	206	48	azim	azim	PROPN
aji-159	206	49	et	et	PROPN
aji-159	206	50	al	al	PROPN
aji-159	206	51	.	.	PROPN
aji-159	206	52	,	,	PUNCT
aji-159	206	53	2008	2008	NUM
aji-159	206	54	)	)	PUNCT
aji-159	206	55	and	and	CCONJ
aji-159	206	56	brazil	brazil	PROPN
aji-159	206	57	(	(	PUNCT
aji-159	206	58	oliveira	oliveira	PROPN
aji-159	206	59	-	-	PUNCT
aji-159	206	60	filho	filho	PROPN
aji-159	206	61	et	et	PROPN
aji-159	206	62	al	al	PROPN
aji-159	206	63	.	.	PROPN
aji-159	206	64	,	,	PUNCT
aji-159	206	65	2020	2020	NUM
aji-159	206	66	)	)	PUNCT
aji-159	206	67	.	.	PUNCT
aji-159	207	1	by	by	ADP
aji-159	207	2	contrast	contrast	NOUN
aji-159	207	3	,	,	PUNCT
aji-159	207	4	it	it	PRON
aji-159	207	5	is	be	AUX
aji-159	207	6	relatively	relatively	ADV
aji-159	207	7	low	low	ADJ
aji-159	207	8	compared	compare	VERB
aji-159	207	9	with	with	ADP
aji-159	207	10	other	other	ADJ
aji-159	207	11	studies	study	NOUN
aji-159	207	12	reported	report	VERB
aji-159	207	13	from	from	ADP
aji-159	207	14	the	the	DET
aji-159	207	15	usa	usa	PROPN
aji-159	207	16	(	(	PUNCT
aji-159	207	17	peters	peters	PROPN
aji-159	207	18	et	et	PROPN
aji-159	207	19	al	al	PROPN
aji-159	207	20	.	.	PROPN
aji-159	207	21	,	,	PUNCT
aji-159	207	22	2016	2016	NUM
aji-159	207	23	)	)	PUNCT
aji-159	207	24	,	,	PUNCT
aji-159	207	25	and	and	CCONJ
aji-159	207	26	estonia	estonia	PROPN
aji-159	207	27	(	(	PUNCT
aji-159	207	28	platt	platt	PROPN
aji-159	207	29	et	et	PROPN
aji-159	207	30	al	al	PROPN
aji-159	207	31	.	.	PROPN
aji-159	207	32	,	,	PUNCT
aji-159	207	33	2006	2006	NUM
aji-159	207	34	)	)	PUNCT
aji-159	207	35	.	.	PUNCT
aji-159	208	1	the	the	DET
aji-159	208	2	differences	difference	NOUN
aji-159	208	3	that	that	PRON
aji-159	208	4	were	be	AUX
aji-159	208	5	noticed	notice	VERB
aji-159	208	6	in	in	ADP
aji-159	208	7	hiv	hiv	PROPN
aji-159	208	8	prevalence	prevalence	NOUN
aji-159	208	9	among	among	ADP
aji-159	208	10	studies	study	NOUN
aji-159	208	11	,	,	PUNCT
aji-159	208	12	nations	nation	NOUN
aji-159	208	13	,	,	PUNCT
aji-159	208	14	and	and	CCONJ
aji-159	208	15	areas	area	NOUN
aji-159	208	16	could	could	AUX
aji-159	208	17	arise	arise	VERB
aji-159	208	18	from	from	ADP
aji-159	208	19	diverse	diverse	ADJ
aji-159	208	20	factors	factor	NOUN
aji-159	208	21	like	like	ADP
aji-159	208	22	compliance	compliance	NOUN
aji-159	208	23	with	with	ADP
aji-159	208	24	prevention	prevention	NOUN
aji-159	208	25	methods	method	NOUN
aji-159	208	26	and	and	CCONJ
aji-159	208	27	variations	variation	NOUN
aji-159	208	28	in	in	ADP
aji-159	208	29	community	community	NOUN
aji-159	208	30	spread	spread	NOUN
aji-159	208	31	.	.	PUNCT
aji-159	209	1	in	in	ADP
aji-159	209	2	this	this	DET
aji-159	209	3	study	study	NOUN
aji-159	209	4	,	,	PUNCT
aji-159	209	5	hiv	hiv	PROPN
aji-159	209	6	prevalence	prevalence	NOUN
aji-159	209	7	among	among	ADP
aji-159	209	8	pwid	pwid	NOUN
aji-159	209	9	is	be	AUX
aji-159	209	10	high	high	ADJ
aji-159	209	11	in	in	ADP
aji-159	209	12	the	the	DET
aji-159	209	13	northern	northern	ADJ
aji-159	209	14	countries	country	NOUN
aji-159	209	15	of	of	ADP
aji-159	209	16	africa	africa	PROPN
aji-159	209	17	,	,	PUNCT
aji-159	209	18	particularly	particularly	ADV
aji-159	209	19	libya	libya	PROPN
aji-159	209	20	(	(	PUNCT
aji-159	209	21	mirzoyan	mirzoyan	NOUN
aji-159	209	22	et	et	PROPN
aji-159	209	23	al	al	PROPN
aji-159	209	24	.	.	PROPN
aji-159	209	25	,	,	PUNCT
aji-159	209	26	2013	2013	NUM
aji-159	209	27	)	)	PUNCT
aji-159	209	28	.	.	PUNCT
aji-159	210	1	this	this	DET
aji-159	210	2	occurrence	occurrence	NOUN
aji-159	210	3	can	can	AUX
aji-159	210	4	be	be	AUX
aji-159	210	5	ascribed	ascribe	VERB
aji-159	210	6	to	to	ADP
aji-159	210	7	its	its	PRON
aji-159	210	8	geographical	geographical	ADJ
aji-159	210	9	positioning	positioning	NOUN
aji-159	210	10	,	,	PUNCT
aji-159	210	11	which	which	PRON
aji-159	210	12	borders	border	VERB
aji-159	210	13	three	three	NUM
aji-159	210	14	sub	sub	ADJ
aji-159	210	15	-	-	ADJ
aji-159	210	16	saharan	saharan	ADJ
aji-159	210	17	nations	nation	NOUN
aji-159	210	18	,	,	PUNCT
aji-159	210	19	along	along	ADP
aji-159	210	20	with	with	ADP
aji-159	210	21	socio	socio	NOUN
aji-159	210	22	-	-	PUNCT
aji-159	210	23	political	political	ADJ
aji-159	210	24	challenges	challenge	NOUN
aji-159	210	25	that	that	PRON
aji-159	210	26	have	have	AUX
aji-159	210	27	significantly	significantly	ADV
aji-159	210	28	facilitated	facilitate	VERB
aji-159	210	29	the	the	DET
aji-159	210	30	spread	spread	NOUN
aji-159	210	31	of	of	ADP
aji-159	210	32	hiv	hiv	PROPN
aji-159	210	33	and	and	CCONJ
aji-159	210	34	hindered	hinder	VERB
aji-159	210	35	the	the	DET
aji-159	210	36	adherence	adherence	NOUN
aji-159	210	37	to	to	ADP
aji-159	210	38	hiv	hiv	PROPN
aji-159	210	39	control	control	NOUN
aji-159	210	40	measures	measure	NOUN
aji-159	210	41	.	.	PUNCT
aji-159	211	1	these	these	DET
aji-159	211	2	results	result	NOUN
aji-159	211	3	highlight	highlight	VERB
aji-159	211	4	a	a	DET
aji-159	211	5	need	need	NOUN
aji-159	211	6	for	for	ADP
aji-159	211	7	continuing	continue	VERB
aji-159	211	8	prevention	prevention	NOUN
aji-159	211	9	of	of	ADP
aji-159	211	10	hiv	hiv	PROPN
aji-159	211	11	transmission	transmission	NOUN
aji-159	211	12	among	among	ADP
aji-159	211	13	pwid	pwid	NOUN
aji-159	211	14	.	.	PUNCT
aji-159	212	1	the	the	DET
aji-159	212	2	hiv	hiv	PROPN
aji-159	212	3	epidemic	epidemic	NOUN
aji-159	212	4	,	,	PUNCT
aji-159	212	5	similar	similar	ADJ
aji-159	212	6	to	to	ADP
aji-159	212	7	other	other	ADJ
aji-159	212	8	epidemics	epidemic	NOUN
aji-159	212	9	,	,	PUNCT
aji-159	212	10	arises	arise	VERB
aji-159	212	11	within	within	ADP
aji-159	212	12	an	an	DET
aji-159	212	13	intricate	intricate	ADJ
aji-159	212	14	social	social	ADJ
aji-159	212	15	setting	setting	NOUN
aji-159	212	16	.	.	PUNCT
aji-159	213	1	social	social	ADJ
aji-159	213	2	norms	norm	NOUN
aji-159	213	3	impacting	impact	VERB
aji-159	213	4	transmission	transmission	NOUN
aji-159	213	5	include	include	VERB
aji-159	213	6	sexual	sexual	ADJ
aji-159	213	7	behaviors	behavior	NOUN
aji-159	213	8	.	.	PUNCT
aji-159	214	1	between	between	SCONJ
aji-159	214	2	75	75	NUM
aji-159	214	3	and	and	CCONJ
aji-159	214	4	85	85	NUM
aji-159	214	5	percent	percent	NOUN
aji-159	214	6	of	of	ADP
aji-159	214	7	the	the	DET
aji-159	214	8	approximately	approximately	ADV
aji-159	214	9	28	28	NUM
aji-159	214	10	million	million	NUM
aji-159	214	11	hiv	hiv	PROPN
aji-159	214	12	infections	infection	NOUN
aji-159	214	13	that	that	PRON
aji-159	214	14	have	have	AUX
aji-159	214	15	happened	happen	VERB
aji-159	214	16	thus	thus	ADV
aji-159	214	17	far	far	ADV
aji-159	214	18	are	be	AUX
aji-159	214	19	due	due	ADJ
aji-159	214	20	to	to	ADP
aji-159	214	21	transmission	transmission	NOUN
aji-159	214	22	through	through	ADP
aji-159	214	23	sexual	sexual	ADJ
aji-159	214	24	contact	contact	NOUN
aji-159	214	25	(	(	PUNCT
aji-159	214	26	royce	royce	PROPN
aji-159	214	27	et	et	PROPN
aji-159	214	28	al	al	PROPN
aji-159	214	29	.	.	PROPN
aji-159	214	30	,	,	PUNCT
aji-159	214	31	1997	1997	NUM
aji-159	214	32	)	)	PUNCT
aji-159	214	33	.	.	PUNCT
aji-159	215	1	concerning	concern	VERB
aji-159	215	2	the	the	DET
aji-159	215	3	investigation	investigation	NOUN
aji-159	215	4	of	of	ADP
aji-159	215	5	hiv	hiv	PROPN
aji-159	215	6	and	and	CCONJ
aji-159	215	7	related	relate	VERB
aji-159	215	8	sexual	sexual	ADJ
aji-159	215	9	risk	risk	NOUN
aji-159	215	10	like	like	ADP
aji-159	215	11	sex	sex	NOUN
aji-159	215	12	work	work	NOUN
aji-159	215	13	,	,	PUNCT
aji-159	215	14	this	this	DET
aji-159	215	15	systematic	systematic	ADJ
aji-159	215	16	review	review	NOUN
aji-159	215	17	shows	show	VERB
aji-159	215	18	that	that	SCONJ
aji-159	215	19	the	the	DET
aji-159	215	20	hiv	hiv	PROPN
aji-159	215	21	prevalence	prevalence	NOUN
aji-159	215	22	amongst	amongst	ADP
aji-159	215	23	north	north	ADJ
aji-159	215	24	african	african	ADJ
aji-159	215	25	fsws	fsws	ADJ
aji-159	215	26	population	population	NOUN
aji-159	215	27	groups	group	NOUN
aji-159	215	28	ranged	range	VERB
aji-159	215	29	from	from	ADP
aji-159	215	30	0	0	NUM
aji-159	215	31	%	%	NOUN
aji-159	215	32	to	to	PART
aji-159	215	33	15.7	15.7	NUM
aji-159	215	34	%	%	NOUN
aji-159	215	35	.	.	PUNCT
aji-159	216	1	these	these	DET
aji-159	216	2	outcomes	outcome	NOUN
aji-159	216	3	are	be	AUX
aji-159	216	4	similar	similar	ADJ
aji-159	216	5	to	to	ADP
aji-159	216	6	numerous	numerous	ADJ
aji-159	216	7	other	other	ADJ
aji-159	216	8	systematic	systematic	ADJ
aji-159	216	9	reviews	review	NOUN
aji-159	216	10	conducted	conduct	VERB
aji-159	216	11	(	(	PUNCT
aji-159	216	12	paz	paz	NOUN
aji-159	216	13	-	-	PUNCT
aji-159	216	14	bailey	bailey	PROPN
aji-159	216	15	et	et	PROPN
aji-159	216	16	al	al	PROPN
aji-159	216	17	.	.	PROPN
aji-159	216	18	,	,	PUNCT
aji-159	216	19	2016	2016	NUM
aji-159	216	20	;	;	PUNCT
aji-159	216	21	leili	leili	NOUN
aji-159	216	22	et	et	PROPN
aji-159	216	23	al	al	PROPN
aji-159	216	24	.	.	PROPN
aji-159	216	25	,	,	PUNCT
aji-159	216	26	2021	2021	NUM
aji-159	216	27	)	)	PUNCT
aji-159	216	28	.	.	PUNCT
aji-159	217	1	however	however	ADV
aji-159	217	2	,	,	PUNCT
aji-159	217	3	it	it	PRON
aji-159	217	4	is	be	AUX
aji-159	217	5	low	low	ADJ
aji-159	217	6	compared	compare	VERB
aji-159	217	7	to	to	ADP
aji-159	217	8	what	what	PRON
aji-159	217	9	is	be	AUX
aji-159	217	10	observed	observe	VERB
aji-159	217	11	in	in	ADP
aji-159	217	12	india	india	PROPN
aji-159	217	13	(	(	PUNCT
aji-159	217	14	wayal	wayal	PROPN
aji-159	217	15	et	et	PROPN
aji-159	217	16	al	al	PROPN
aji-159	217	17	.	.	PROPN
aji-159	217	18	,	,	PUNCT
aji-159	217	19	2011	2011	NUM
aji-159	217	20	)	)	PUNCT
aji-159	217	21	,	,	PUNCT
aji-159	217	22	kenya	kenya	PROPN
aji-159	217	23	(	(	PUNCT
aji-159	217	24	luchters	luchter	NOUN
aji-159	217	25	et	et	PROPN
aji-159	217	26	al	al	PROPN
aji-159	217	27	.	.	PROPN
aji-159	217	28	,	,	PUNCT
aji-159	217	29	2008	2008	NUM
aji-159	217	30	)	)	PUNCT
aji-159	217	31	.	.	PUNCT
aji-159	218	1	additionally	additionally	ADV
aji-159	218	2	,	,	PUNCT
aji-159	218	3	it	it	PRON
aji-159	218	4	is	be	AUX
aji-159	218	5	higher	high	ADJ
aji-159	218	6	than	than	ADP
aji-159	218	7	the	the	DET
aji-159	218	8	results	result	NOUN
aji-159	218	9	of	of	ADP
aji-159	218	10	studies	study	NOUN
aji-159	218	11	conducted	conduct	VERB
aji-159	218	12	in	in	ADP
aji-159	218	13	china	china	PROPN
aji-159	218	14	(	(	PUNCT
aji-159	218	15	wang	wang	PROPN
aji-159	218	16	et	et	PROPN
aji-159	218	17	al	al	PROPN
aji-159	218	18	.	.	PROPN
aji-159	218	19	,	,	PUNCT
aji-159	218	20	2009	2009	NUM
aji-159	218	21	)	)	PUNCT
aji-159	218	22	,	,	PUNCT
aji-159	218	23	central	central	PROPN
aji-159	218	24	america	america	PROPN
aji-159	218	25	(	(	PUNCT
aji-159	218	26	soto	soto	PROPN
aji-159	218	27	et	et	PROPN
aji-159	218	28	al	al	PROPN
aji-159	218	29	.	.	PROPN
aji-159	218	30	,	,	PUNCT
aji-159	218	31	2007	2007	NUM
aji-159	218	32	)	)	PUNCT
aji-159	218	33	,	,	PUNCT
aji-159	218	34	and	and	CCONJ
aji-159	218	35	the	the	DET
aji-159	218	36	democratic	democratic	PROPN
aji-159	218	37	republic	republic	NOUN
aji-159	218	38	of	of	ADP
aji-159	218	39	the	the	DET
aji-159	218	40	congo	congo	NOUN
aji-159	218	41	(	(	PUNCT
aji-159	218	42	vandepitte	vandepitte	PROPN
aji-159	218	43	et	et	PROPN
aji-159	218	44	al	al	PROPN
aji-159	218	45	.	.	PROPN
aji-159	218	46	,	,	PUNCT
aji-159	218	47	2007	2007	NUM
aji-159	218	48	)	)	PUNCT
aji-159	218	49	.	.	PUNCT
aji-159	219	1	women	woman	NOUN
aji-159	219	2	engaging	engage	VERB
aji-159	219	3	in	in	ADP
aji-159	219	4	sex	sex	NOUN
aji-159	219	5	work	work	NOUN
aji-159	219	6	networks	network	NOUN
aji-159	219	7	appear	appear	VERB
aji-159	219	8	to	to	PART
aji-159	219	9	be	be	AUX
aji-159	219	10	the	the	DET
aji-159	219	11	main	main	ADJ
aji-159	219	12	drivers	driver	NOUN
aji-159	219	13	of	of	ADP
aji-159	219	14	considerable	considerable	ADJ
aji-159	219	15	hiv	hiv	PROPN
aji-159	219	16	transmission	transmission	NOUN
aji-159	219	17	in	in	ADP
aji-159	219	18	libya	libya	PROPN
aji-159	219	19	,	,	PUNCT
aji-159	219	20	morocco	morocco	PROPN
aji-159	219	21	,	,	PUNCT
aji-159	219	22	and	and	CCONJ
aji-159	219	23	egypt	egypt	PROPN
aji-159	219	24	,	,	PUNCT
aji-159	219	25	which	which	PRON
aji-159	219	26	may	may	AUX
aji-159	219	27	have	have	AUX
aji-159	219	28	been	be	AUX
aji-159	219	29	due	due	ADJ
aji-159	219	30	to	to	ADP
aji-159	219	31	the	the	DET
aji-159	219	32	extensive	extensive	ADJ
aji-159	219	33	scale	scale	NOUN
aji-159	219	34	of	of	ADP
aji-159	219	35	commercial	commercial	ADJ
aji-159	219	36	sex	sex	NOUN
aji-159	219	37	networks	network	NOUN
aji-159	219	38	in	in	ADP
aji-159	219	39	these	these	DET
aji-159	219	40	environments	environment	NOUN
aji-159	219	41	,	,	PUNCT
aji-159	219	42	coupled	couple	VERB
aji-159	219	43	with	with	ADP
aji-159	219	44	the	the	DET
aji-159	219	45	elevated	elevated	ADJ
aji-159	219	46	levels	level	NOUN
aji-159	219	47	of	of	ADP
aji-159	219	48	hazard	hazard	NOUN
aji-159	219	49	manners	manner	NOUN
aji-159	219	50	exhibited	exhibit	VERB
aji-159	219	51	within	within	ADP
aji-159	219	52	these	these	DET
aji-159	219	53	networks	network	NOUN
aji-159	219	54	.	.	PUNCT
aji-159	220	1	fsws	fsws	PROPN
aji-159	220	2	and	and	CCONJ
aji-159	220	3	their	their	PRON
aji-159	220	4	male	male	ADJ
aji-159	220	5	clients	client	NOUN
aji-159	220	6	are	be	AUX
aji-159	220	7	at	at	ADP
aji-159	220	8	high	high	ADJ
aji-159	220	9	hazardous	hazardous	ADJ
aji-159	220	10	for	for	ADP
aji-159	220	11	hiv	hiv	PROPN
aji-159	220	12	and	and	CCONJ
aji-159	220	13	have	have	AUX
aji-159	220	14	been	be	AUX
aji-159	220	15	significant	significant	ADJ
aji-159	220	16	in	in	ADP
aji-159	220	17	starting	start	VERB
aji-159	220	18	the	the	DET
aji-159	220	19	epidemic	epidemic	NOUN
aji-159	220	20	in	in	ADP
aji-159	220	21	many	many	ADJ
aji-159	220	22	african	african	ADJ
aji-159	220	23	countries	country	NOUN
aji-159	220	24	(	(	PUNCT
aji-159	220	25	hunter	hunter	NOUN
aji-159	220	26	,	,	PUNCT
aji-159	220	27	1993	1993	NUM
aji-159	220	28	)	)	PUNCT
aji-159	220	29	.	.	PUNCT
aji-159	221	1	the	the	DET
aji-159	221	2	hiv	hiv	PROPN
aji-159	221	3	epidemic	epidemic	NOUN
aji-159	221	4	is	be	AUX
aji-159	221	5	very	very	ADV
aji-159	221	6	fluid	fluid	ADJ
aji-159	221	7	and	and	CCONJ
aji-159	221	8	has	have	AUX
aji-159	221	9	expanded	expand	VERB
aji-159	221	10	quickly	quickly	ADV
aji-159	221	11	;	;	PUNCT
aji-159	221	12	nearly	nearly	ADV
aji-159	221	13	every	every	PRON
aji-159	221	14	country	country	NOUN
aji-159	221	15	worldwide	worldwide	ADV
aji-159	221	16	is	be	AUX
aji-159	221	17	impacted	impact	VERB
aji-159	221	18	.	.	PUNCT
aji-159	222	1	however	however	ADV
aji-159	222	2	,	,	PUNCT
aji-159	222	3	prevalence	prevalence	NOUN
aji-159	222	4	investigations	investigation	NOUN
aji-159	222	5	have	have	AUX
aji-159	222	6	been	be	AUX
aji-159	222	7	conducted	conduct	VERB
aji-159	222	8	on	on	ADP
aji-159	222	9	a	a	DET
aji-159	222	10	global	global	ADJ
aji-159	222	11	level	level	NOUN
aji-159	222	12	to	to	PART
aji-159	222	13	gain	gain	VERB
aji-159	222	14	understanding	understanding	NOUN
aji-159	222	15	of	of	ADP
aji-159	222	16	hiv	hiv	PROPN
aji-159	222	17	epidemiology	epidemiology	NOUN
aji-159	222	18	.	.	PUNCT
aji-159	223	1	monitoring	monitor	VERB
aji-159	223	2	prevalence	prevalence	NOUN
aji-159	223	3	changes	change	NOUN
aji-159	223	4	is	be	AUX
aji-159	223	5	crucial	crucial	ADJ
aji-159	223	6	for	for	ADP
aji-159	223	7	predicting	predict	VERB
aji-159	223	8	pandemic	pandemic	ADJ
aji-159	223	9	evolution	evolution	NOUN
aji-159	223	10	and	and	CCONJ
aji-159	223	11	developing	develop	VERB
aji-159	223	12	a	a	DET
aji-159	223	13	successful	successful	ADJ
aji-159	223	14	public	public	ADJ
aji-159	223	15	health	health	NOUN
aji-159	223	16	strategy	strategy	NOUN
aji-159	223	17	(	(	PUNCT
aji-159	223	18	bokazhanova	bokazhanova	PROPN
aji-159	223	19	&	&	CCONJ
aji-159	223	20	rutherford	rutherford	PROPN
aji-159	223	21	,	,	PUNCT
aji-159	223	22	2006	2006	NUM
aji-159	223	23	)	)	PUNCT
aji-159	223	24	.	.	PUNCT
aji-159	224	1	khalaf	khalaf	PROPN
aji-159	224	2	;	;	PUNCT
aji-159	224	3	asian	asian	PROPN
aji-159	224	4	j.	j.	PROPN
aji-159	224	5	immunol	immunol	PROPN
aji-159	224	6	.	.	PROPN
aji-159	224	7	,	,	PUNCT
aji-159	224	8	vol	vol	NOUN
aji-159	224	9	.	.	PROPN
aji-159	224	10	8	8	NUM
aji-159	224	11	,	,	PUNCT
aji-159	224	12	no	no	INTJ
aji-159	224	13	.	.	NOUN
aji-159	224	14	1	1	NUM
aji-159	224	15	,	,	PUNCT
aji-159	224	16	pp	pp	ADJ
aji-159	224	17	.	.	PUNCT
aji-159	225	1	50	50	NUM
aji-159	225	2	-	-	SYM
aji-159	225	3	59	59	NUM
aji-159	225	4	,	,	PUNCT
aji-159	225	5	2025	2025	NUM
aji-159	225	6	;	;	PUNCT
aji-159	225	7	article	article	NOUN
aji-159	225	8	no.aji.125999	no.aji.125999	NOUN
aji-159	225	9	54	54	NUM
aji-159	225	10	table	table	NOUN
aji-159	225	11	1	1	NUM
aji-159	225	12	.	.	PUNCT
aji-159	225	13	studies	study	NOUN
aji-159	225	14	reporting	report	VERB
aji-159	225	15	hiv	hiv	PROPN
aji-159	225	16	prevalence	prevalence	NOUN
aji-159	225	17	among	among	ADP
aji-159	225	18	people	people	NOUN
aji-159	225	19	who	who	PRON
aji-159	225	20	inject	inject	VERB
aji-159	225	21	drugs	drug	NOUN
aji-159	225	22	(	(	PUNCT
aji-159	225	23	pwid	pwid	NOUN
aji-159	225	24	)	)	PUNCT
aji-159	225	25	across	across	ADP
aji-159	225	26	the	the	DET
aji-159	225	27	north	north	PROPN
aji-159	225	28	africa	africa	PROPN
aji-159	225	29	study	study	PROPN
aji-159	225	30	/	/	SYM
aji-159	225	31	references	reference	NOUN
aji-159	225	32	sampling	sample	VERB
aji-159	225	33	location	location	NOUN
aji-159	225	34	year	year	NOUN
aji-159	225	35	of	of	ADP
aji-159	225	36	study	study	NOUN
aji-159	225	37	study	study	NOUN
aji-159	225	38	population	population	NOUN
aji-159	225	39	age	age	NOUN
aji-159	225	40	group	group	PROPN
aji-159	225	41	hiv	hiv	PROPN
aji-159	225	42	prevalence	prevalence	NOUN
aji-159	225	43	among	among	ADP
aji-159	225	44	pwid	pwid	PROPN
aji-159	225	45	anan	anan	PROPN
aji-159	225	46	a	a	PRON
aji-159	225	47	et	et	PROPN
aji-159	225	48	al	al	PROPN
aji-159	225	49	.	.	PROPN
aji-159	226	1	(	(	PUNCT
aji-159	226	2	2024	2024	NUM
aji-159	226	3	)	)	PUNCT
aji-159	226	4	egypt	egypt	PROPN
aji-159	226	5	2019	2019	NUM
aji-159	226	6	-	-	SYM
aji-159	226	7	2022	2022	NUM
aji-159	226	8	146	146	NUM
aji-159	226	9	11	11	NUM
aji-159	226	10	-	-	SYM
aji-159	226	11	50	50	NUM
aji-159	226	12	31.5	31.5	NUM
aji-159	226	13	%	%	NOUN
aji-159	226	14	ghrabi	ghrabi	NOUN
aji-159	226	15	a	a	PRON
aji-159	226	16	et	et	NOUN
aji-159	226	17	al	al	PROPN
aji-159	226	18	.	.	PROPN
aji-159	227	1	(	(	PUNCT
aji-159	227	2	2018	2018	NUM
aji-159	227	3	)	)	PUNCT
aji-159	227	4	tunisia	tunisia	NOUN
aji-159	227	5	2017	2017	NUM
aji-159	227	6	-	-	SYM
aji-159	227	7	2018	2018	NUM
aji-159	227	8	113	113	NUM
aji-159	227	9	32	32	NUM
aji-159	227	10	-	-	SYM
aji-159	227	11	47	47	NUM
aji-159	227	12	10	10	NUM
aji-159	227	13	%	%	NOUN
aji-159	227	14	mirzoyan	mirzoyan	NOUN
aji-159	227	15	l	l	NOUN
aji-159	227	16	et	et	PROPN
aji-159	227	17	al	al	PROPN
aji-159	227	18	.	.	PROPN
aji-159	228	1	(	(	PUNCT
aji-159	228	2	2013	2013	NUM
aji-159	228	3	)	)	PUNCT
aji-159	228	4	libya	libya	PROPN
aji-159	228	5	2010	2010	NUM
aji-159	228	6	328	328	NUM
aji-159	228	7	15-≥50	15-≥50	NOUN
aji-159	228	8	87.1	87.1	NUM
aji-159	228	9	%	%	NOUN
aji-159	228	10	wahdan	wahdan	NOUN
aji-159	229	1	i	i	PRON
aji-159	229	2	et	et	PROPN
aji-159	229	3	al	al	PROPN
aji-159	229	4	.	.	PROPN
aji-159	230	1	(	(	PUNCT
aji-159	230	2	2013	2013	NUM
aji-159	230	3	)	)	PUNCT
aji-159	230	4	egypt	egypt	PROPN
aji-159	230	5	2012	2012	NUM
aji-159	230	6	338	338	NUM
aji-159	230	7	<	<	X
aji-159	230	8	25->45	25->45	NOUN
aji-159	230	9	12.4	12.4	NUM
aji-159	230	10	%	%	NOUN
aji-159	230	11	soliman	soliman	NOUN
aji-159	230	12	c	c	PROPN
aji-159	230	13	et	et	PROPN
aji-159	230	14	al	al	PROPN
aji-159	230	15	.	.	PROPN
aji-159	231	1	(	(	PUNCT
aji-159	231	2	2010	2010	NUM
aji-159	231	3	)	)	PUNCT
aji-159	231	4	egypt	egypt	PROPN
aji-159	231	5	2006	2006	NUM
aji-159	231	6	413	413	NUM
aji-159	231	7	18	18	NUM
aji-159	231	8	-	-	SYM
aji-159	231	9	65	65	NUM
aji-159	231	10	1	1	NUM
aji-159	231	11	%	%	NOUN
aji-159	231	12	elmir	elmir	NOUN
aji-159	231	13	e	e	PROPN
aji-159	231	14	et	et	NOUN
aji-159	231	15	al	al	PROPN
aji-159	231	16	.	.	PROPN
aji-159	232	1	(	(	PUNCT
aji-159	232	2	2002	2002	NUM
aji-159	232	3	)	)	PUNCT
aji-159	232	4	morocco	morocco	PROPN
aji-159	232	5	1991	1991	NUM
aji-159	232	6	-	-	SYM
aji-159	232	7	1999	1999	NUM
aji-159	232	8	12981	12981	NUM
aji-159	232	9	30-≥40	30-≥40	NOUN
aji-159	232	10	11.1	11.1	NUM
aji-159	232	11	%	%	NOUN
aji-159	232	12	watts	watt	NOUN
aji-159	232	13	dm	dm	INTJ
aji-159	232	14	et	et	NOUN
aji-159	232	15	al	al	PROPN
aji-159	232	16	.	.	PUNCT
aji-159	233	1	(	(	PUNCT
aji-159	233	2	1993	1993	NUM
aji-159	233	3	)	)	PUNCT
aji-159	233	4	egypt	egypt	PROPN
aji-159	233	5	1986	1986	NUM
aji-159	233	6	-	-	SYM
aji-159	233	7	1990	1990	NUM
aji-159	233	8	1961	1961	NUM
aji-159	233	9	any	any	DET
aji-159	233	10	age	age	NOUN
aji-159	233	11	0.15	0.15	NUM
aji-159	233	12	%	%	NOUN
aji-159	233	13	table	table	NOUN
aji-159	233	14	2	2	NUM
aji-159	233	15	.	.	PUNCT
aji-159	233	16	studies	study	NOUN
aji-159	233	17	reporting	report	VERB
aji-159	233	18	hiv	hiv	PROPN
aji-159	233	19	prevalence	prevalence	NOUN
aji-159	233	20	among	among	ADP
aji-159	233	21	female	female	ADJ
aji-159	233	22	sex	sex	NOUN
aji-159	233	23	workers	worker	NOUN
aji-159	233	24	(	(	PUNCT
aji-159	233	25	fsws	fsws	ADJ
aji-159	233	26	)	)	PUNCT
aji-159	233	27	across	across	ADP
aji-159	233	28	the	the	DET
aji-159	233	29	north	north	PROPN
aji-159	233	30	africa	africa	PROPN
aji-159	233	31	study	study	PROPN
aji-159	233	32	/	/	SYM
aji-159	233	33	references	reference	NOUN
aji-159	233	34	sampling	sample	VERB
aji-159	233	35	location	location	NOUN
aji-159	233	36	year	year	NOUN
aji-159	233	37	of	of	ADP
aji-159	233	38	study	study	NOUN
aji-159	233	39	study	study	NOUN
aji-159	233	40	population	population	NOUN
aji-159	233	41	age	age	NOUN
aji-159	233	42	group	group	PROPN
aji-159	233	43	hiv	hiv	PROPN
aji-159	233	44	prevalence	prevalence	NOUN
aji-159	233	45	among	among	ADP
aji-159	233	46	fsws	fsws	ADJ
aji-159	233	47	johnston	johnston	PROPN
aji-159	233	48	l	l	PROPN
aji-159	233	49	et	et	PROPN
aji-159	233	50	al	al	PROPN
aji-159	233	51	.	.	PROPN
aji-159	234	1	(	(	PUNCT
aji-159	234	2	2013	2013	NUM
aji-159	234	3	)	)	PUNCT
aji-159	234	4	morocco	morocco	PROPN
aji-159	234	5	2010	2010	NUM
aji-159	234	6	-	-	SYM
aji-159	234	7	211	211	NUM
aji-159	234	8	1447	1447	NUM
aji-159	234	9	18	18	NUM
aji-159	234	10	≥	≥	NOUN
aji-159	234	11	8.3	8.3	NUM
aji-159	234	12	%	%	NOUN
aji-159	234	13	valadez	valadez	PROPN
aji-159	234	14	jj	jj	PROPN
aji-159	234	15	,	,	PUNCT
aji-159	234	16	et	et	PROPN
aji-159	234	17	al	al	PROPN
aji-159	234	18	.	.	PROPN
aji-159	235	1	(	(	PUNCT
aji-159	235	2	2013	2013	NUM
aji-159	235	3	)	)	PUNCT
aji-159	235	4	libya	libya	PROPN
aji-159	235	5	2010	2010	NUM
aji-159	235	6	69	69	NUM
aji-159	235	7	15-≥50	15-≥50	NOUN
aji-159	235	8	15.7	15.7	NUM
aji-159	235	9	%	%	NOUN
aji-159	235	10	wahdan	wahdan	NOUN
aji-159	236	1	i	i	PRON
aji-159	236	2	et	et	PROPN
aji-159	236	3	al	al	PROPN
aji-159	236	4	.	.	PROPN
aji-159	237	1	(	(	PUNCT
aji-159	237	2	2013	2013	NUM
aji-159	237	3	)	)	PUNCT
aji-159	237	4	egypt	egypt	PROPN
aji-159	237	5	2012	2012	NUM
aji-159	237	6	338	338	NUM
aji-159	237	7	<	<	X
aji-159	237	8	25	25	NUM
aji-159	237	9	-	-	SYM
aji-159	237	10	45	45	NUM
aji-159	237	11	+	+	NUM
aji-159	237	12	5.9	5.9	NUM
aji-159	237	13	%	%	NOUN
aji-159	237	14	znazen	znazen	NOUN
aji-159	237	15	a	a	PRON
aji-159	237	16	et	et	PROPN
aji-159	237	17	al	al	PROPN
aji-159	237	18	.	.	PROPN
aji-159	238	1	(	(	PUNCT
aji-159	238	2	2010	2010	NUM
aji-159	238	3	)	)	PUNCT
aji-159	238	4	tunisia	tunisia	NOUN
aji-159	238	5	2007	2007	NUM
aji-159	238	6	188	188	NUM
aji-159	238	7	14-≥34	14-≥34	NOUN
aji-159	238	8	0	0	NUM
aji-159	238	9	%	%	NOUN
aji-159	238	10	watts	watt	VERB
aji-159	238	11	dm	dm	INTJ
aji-159	238	12	et	et	NOUN
aji-159	238	13	al	al	PROPN
aji-159	238	14	.	.	PUNCT
aji-159	239	1	(	(	PUNCT
aji-159	239	2	1993	1993	NUM
aji-159	239	3	)	)	PUNCT
aji-159	239	4	egypt	egypt	PROPN
aji-159	239	5	1986	1986	NUM
aji-159	239	6	-	-	SYM
aji-159	239	7	1990	1990	NUM
aji-159	239	8	349	349	NUM
aji-159	239	9	any	any	DET
aji-159	239	10	age	age	NOUN
aji-159	239	11	0	0	NUM
aji-159	239	12	%	%	NOUN
aji-159	239	13	khalaf	khalaf	PROPN
aji-159	239	14	;	;	PUNCT
aji-159	239	15	asian	asian	PROPN
aji-159	239	16	j.	j.	PROPN
aji-159	239	17	immunol	immunol	PROPN
aji-159	239	18	.	.	PROPN
aji-159	239	19	,	,	PUNCT
aji-159	239	20	vol	vol	NOUN
aji-159	239	21	.	.	PROPN
aji-159	239	22	8	8	NUM
aji-159	239	23	,	,	PUNCT
aji-159	239	24	no	no	INTJ
aji-159	239	25	.	.	NOUN
aji-159	239	26	1	1	NUM
aji-159	239	27	,	,	PUNCT
aji-159	239	28	pp	pp	ADJ
aji-159	239	29	.	.	PUNCT
aji-159	240	1	50	50	NUM
aji-159	240	2	-	-	SYM
aji-159	240	3	59	59	NUM
aji-159	240	4	,	,	PUNCT
aji-159	240	5	2025	2025	NUM
aji-159	240	6	;	;	PUNCT
aji-159	240	7	article	article	NOUN
aji-159	240	8	no.aji.125999	no.aji.125999	NOUN
aji-159	240	9	55	55	NUM
aji-159	240	10	situation	situation	NOUN
aji-159	240	11	in	in	ADP
aji-159	240	12	north	north	PROPN
aji-159	240	13	africa	africa	PROPN
aji-159	240	14	and	and	CCONJ
aji-159	240	15	the	the	DET
aji-159	240	16	middle	middle	PROPN
aji-159	240	17	east	east	PROPN
aji-159	240	18	regarding	regard	VERB
aji-159	240	19	hiv	hiv	PROPN
aji-159	240	20	/	/	SYM
aji-159	240	21	aids	aids	PROPN
aji-159	240	22	:	:	PUNCT
aji-159	240	23	according	accord	VERB
aji-159	240	24	to	to	ADP
aji-159	240	25	statistics	statistic	NOUN
aji-159	240	26	from	from	ADP
aji-159	240	27	the	the	DET
aji-159	240	28	united	united	PROPN
aji-159	240	29	nations	nations	PROPN
aji-159	240	30	(	(	PUNCT
aji-159	240	31	un	un	PROPN
aji-159	240	32	)	)	PUNCT
aji-159	240	33	,	,	PUNCT
aji-159	240	34	around	around	ADP
aji-159	240	35	180,000	180,000	NUM
aji-159	240	36	people	people	NOUN
aji-159	240	37	were	be	AUX
aji-159	240	38	estimated	estimate	VERB
aji-159	240	39	to	to	PART
aji-159	240	40	be	be	AUX
aji-159	240	41	living	live	VERB
aji-159	240	42	with	with	ADP
aji-159	240	43	hiv	hiv	PROPN
aji-159	240	44	,	,	PUNCT
aji-159	240	45	approximately	approximately	ADV
aji-159	240	46	14000	14000	NUM
aji-159	240	47	people	people	NOUN
aji-159	240	48	became	become	VERB
aji-159	240	49	newly	newly	ADV
aji-159	240	50	infected	infect	VERB
aji-159	240	51	with	with	ADP
aji-159	240	52	hivv	hivv	NOUN
aji-159	240	53	.	.	PUNCT
aji-159	241	1	furthermore	furthermore	ADV
aji-159	241	2	,	,	PUNCT
aji-159	241	3	roughly	roughly	ADV
aji-159	241	4	5100	5100	NUM
aji-159	241	5	fatalities	fatality	NOUN
aji-159	241	6	were	be	AUX
aji-159	241	7	linked	link	VERB
aji-159	241	8	to	to	ADP
aji-159	241	9	diseases	disease	NOUN
aji-159	241	10	related	relate	VERB
aji-159	241	11	to	to	ADP
aji-159	241	12	aids	aid	NOUN
aji-159	241	13	in	in	ADP
aji-159	241	14	2021	2021	NUM
aji-159	241	15	(	(	PUNCT
aji-159	241	16	unaids	unaid	NOUN
aji-159	241	17	,	,	PUNCT
aji-159	241	18	2022	2022	NUM
aji-159	241	19	)	)	PUNCT
aji-159	241	20	.	.	PUNCT
aji-159	242	1	sub	sub	ADJ
aji-159	242	2	-	-	ADJ
aji-159	242	3	saharan	saharan	ADJ
aji-159	242	4	africa	africa	PROPN
aji-159	242	5	,	,	PUNCT
aji-159	242	6	this	this	DET
aji-159	242	7	region	region	NOUN
aji-159	242	8	is	be	AUX
aji-159	242	9	the	the	DET
aji-159	242	10	most	most	ADV
aji-159	242	11	heavily	heavily	ADV
aji-159	242	12	affected	affect	VERB
aji-159	242	13	by	by	ADP
aji-159	242	14	hiv	hiv	PROPN
aji-159	242	15	worldwide	worldwide	ADV
aji-159	242	16	,	,	PUNCT
aji-159	242	17	accounting	account	VERB
aji-159	242	18	for	for	ADP
aji-159	242	19	52.6	52.6	NUM
aji-159	242	20	million	million	NUM
aji-159	242	21	people	people	NOUN
aji-159	242	22	living	live	VERB
aji-159	242	23	with	with	ADP
aji-159	242	24	hiv	hiv	PROPN
aji-159	242	25	and	and	CCONJ
aji-159	242	26	42000	42000	NUM
aji-159	242	27	of	of	ADP
aji-159	242	28	aids	aids	PROPN
aji-159	242	29	deaths	death	NOUN
aji-159	242	30	in	in	ADP
aji-159	242	31	2021	2021	NUM
aji-159	242	32	(	(	PUNCT
aji-159	242	33	unaids	unaid	NOUN
aji-159	242	34	,	,	PUNCT
aji-159	242	35	2022	2022	NUM
aji-159	242	36	)	)	PUNCT
aji-159	242	37	.	.	PUNCT
aji-159	243	1	this	this	DET
aji-159	243	2	region	region	NOUN
aji-159	243	3	borders	border	VERB
aji-159	243	4	north	north	PROPN
aji-159	243	5	africa	africa	PROPN
aji-159	243	6	,	,	PUNCT
aji-159	243	7	and	and	CCONJ
aji-159	243	8	many	many	ADJ
aji-159	243	9	illegal	illegal	ADJ
aji-159	243	10	immigrants	immigrant	NOUN
aji-159	243	11	come	come	VERB
aji-159	243	12	from	from	ADP
aji-159	243	13	it	it	PRON
aji-159	243	14	to	to	ADP
aji-159	243	15	north	north	ADJ
aji-159	243	16	african	african	ADJ
aji-159	243	17	countries	country	NOUN
aji-159	243	18	.	.	PUNCT
aji-159	244	1	therefore	therefore	ADV
aji-159	244	2	,	,	PUNCT
aji-159	244	3	individuals	individual	NOUN
aji-159	244	4	in	in	ADP
aji-159	244	5	communities	community	NOUN
aji-159	244	6	with	with	ADP
aji-159	244	7	hiv	hiv	PROPN
aji-159	244	8	may	may	AUX
aji-159	244	9	not	not	PART
aji-159	244	10	know	know	VERB
aji-159	244	11	they	they	PRON
aji-159	244	12	are	be	AUX
aji-159	244	13	infected	infect	VERB
aji-159	244	14	or	or	CCONJ
aji-159	244	15	carry	carry	VERB
aji-159	244	16	the	the	DET
aji-159	244	17	virus	virus	NOUN
aji-159	244	18	,	,	PUNCT
aji-159	244	19	leading	lead	VERB
aji-159	244	20	to	to	ADP
aji-159	244	21	potential	potential	ADJ
aji-159	244	22	transmission	transmission	NOUN
aji-159	244	23	to	to	ADP
aji-159	244	24	family	family	NOUN
aji-159	244	25	members	member	NOUN
aji-159	244	26	or	or	CCONJ
aji-159	244	27	other	other	ADJ
aji-159	244	28	people	people	NOUN
aji-159	244	29	.	.	PUNCT
aji-159	245	1	on	on	ADP
aji-159	245	2	the	the	DET
aji-159	245	3	basis	basis	NOUN
aji-159	245	4	of	of	ADP
aji-159	245	5	the	the	DET
aji-159	245	6	geographical	geographical	ADJ
aji-159	245	7	countries	country	NOUN
aji-159	245	8	of	of	ADP
aji-159	245	9	north	north	PROPN
aji-159	245	10	africa	africa	PROPN
aji-159	245	11	,	,	PUNCT
aji-159	245	12	the	the	DET
aji-159	245	13	results	result	NOUN
aji-159	245	14	indicated	indicate	VERB
aji-159	245	15	that	that	SCONJ
aji-159	245	16	libya	libya	PROPN
aji-159	245	17	(	(	PUNCT
aji-159	245	18	mirzoyan	mirzoyan	NOUN
aji-159	245	19	et	et	PROPN
aji-159	245	20	al	al	PROPN
aji-159	245	21	.	.	PROPN
aji-159	245	22	,	,	PUNCT
aji-159	245	23	2013	2013	NUM
aji-159	245	24	)	)	PUNCT
aji-159	245	25	,	,	PUNCT
aji-159	245	26	egypt	egypt	PROPN
aji-159	245	27	(	(	PUNCT
aji-159	245	28	anan	anan	PROPN
aji-159	245	29	et	et	PROPN
aji-159	245	30	al	al	PROPN
aji-159	245	31	.	.	PROPN
aji-159	245	32	,	,	PUNCT
aji-159	245	33	2024	2024	NUM
aji-159	245	34	)	)	PUNCT
aji-159	245	35	,	,	PUNCT
aji-159	245	36	morocco	morocco	PROPN
aji-159	245	37	(	(	PUNCT
aji-159	245	38	elmir	elmir	NOUN
aji-159	245	39	et	et	PROPN
aji-159	245	40	al	al	PROPN
aji-159	245	41	.	.	PROPN
aji-159	245	42	,	,	PUNCT
aji-159	245	43	2002	2002	NUM
aji-159	245	44	)	)	PUNCT
aji-159	245	45	and	and	CCONJ
aji-159	245	46	tunisia	tunisia	NOUN
aji-159	245	47	(	(	PUNCT
aji-159	245	48	ghrabi	ghrabi	NOUN
aji-159	245	49	et	et	PROPN
aji-159	245	50	al	al	PROPN
aji-159	245	51	.	.	PROPN
aji-159	245	52	,	,	PUNCT
aji-159	245	53	2018	2018	NUM
aji-159	245	54	)	)	PUNCT
aji-159	245	55	,	,	PUNCT
aji-159	245	56	respectively	respectively	ADV
aji-159	245	57	had	have	VERB
aji-159	245	58	higher	high	ADJ
aji-159	245	59	prevalence	prevalence	NOUN
aji-159	245	60	hiv	hiv	PROPN
aji-159	245	61	among	among	ADP
aji-159	245	62	pwid	pwid	NOUN
aji-159	245	63	.	.	PUNCT
aji-159	246	1	moreover	moreover	ADV
aji-159	246	2	,	,	PUNCT
aji-159	246	3	prevalence	prevalence	NOUN
aji-159	246	4	estimates	estimate	NOUN
aji-159	246	5	at	at	ADP
aji-159	246	6	the	the	DET
aji-159	246	7	country	country	NOUN
aji-159	246	8	level	level	NOUN
aji-159	246	9	indicate	indicate	VERB
aji-159	246	10	a	a	DET
aji-159	246	11	high	high	ADJ
aji-159	246	12	burden	burden	NOUN
aji-159	246	13	of	of	ADP
aji-159	246	14	infection	infection	NOUN
aji-159	246	15	in	in	ADP
aji-159	246	16	libya	libya	PROPN
aji-159	246	17	(	(	PUNCT
aji-159	246	18	valadez	valadez	PROPN
aji-159	246	19	et	et	PROPN
aji-159	246	20	al	al	PROPN
aji-159	246	21	.	.	PROPN
aji-159	246	22	,	,	PUNCT
aji-159	246	23	2013	2013	NUM
aji-159	246	24	)	)	PUNCT
aji-159	246	25	,	,	PUNCT
aji-159	246	26	morocco	morocco	PROPN
aji-159	246	27	(	(	PUNCT
aji-159	246	28	johnston	johnston	PROPN
aji-159	246	29	et	et	PROPN
aji-159	246	30	al	al	PROPN
aji-159	246	31	.	.	PROPN
aji-159	246	32	,	,	PUNCT
aji-159	246	33	2013	2013	NUM
aji-159	246	34	)	)	PUNCT
aji-159	246	35	and	and	CCONJ
aji-159	246	36	egypt	egypt	PROPN
aji-159	246	37	(	(	PUNCT
aji-159	246	38	wahdan	wahdan	PROPN
aji-159	246	39	et	et	PROPN
aji-159	246	40	al	al	PROPN
aji-159	246	41	.	.	PROPN
aji-159	246	42	,	,	PUNCT
aji-159	246	43	2013	2013	NUM
aji-159	246	44	)	)	PUNCT
aji-159	246	45	,	,	PUNCT
aji-159	246	46	respectively	respectively	ADV
aji-159	246	47	,	,	PUNCT
aji-159	246	48	among	among	ADP
aji-159	246	49	fsws	fsws	NOUN
aji-159	246	50	.	.	PUNCT
aji-159	247	1	the	the	DET
aji-159	247	2	observed	observe	VERB
aji-159	247	3	variation	variation	NOUN
aji-159	247	4	in	in	ADP
aji-159	247	5	the	the	DET
aji-159	247	6	estimates	estimate	NOUN
aji-159	247	7	of	of	ADP
aji-159	247	8	hiv	hiv	PROPN
aji-159	247	9	prevalence	prevalence	NOUN
aji-159	247	10	among	among	ADP
aji-159	247	11	fsws	fsws	NOUN
aji-159	247	12	across	across	ADP
aji-159	247	13	various	various	ADJ
aji-159	247	14	countries	country	NOUN
aji-159	247	15	may	may	AUX
aji-159	247	16	be	be	AUX
aji-159	247	17	partially	partially	ADV
aji-159	247	18	attributed	attribute	VERB
aji-159	247	19	to	to	ADP
aji-159	247	20	the	the	DET
aji-159	247	21	diverse	diverse	ADJ
aji-159	247	22	risk	risk	NOUN
aji-159	247	23	factors	factor	NOUN
aji-159	247	24	and	and	CCONJ
aji-159	247	25	spread	spread	VERB
aji-159	247	26	pathways	pathway	NOUN
aji-159	247	27	present	present	ADJ
aji-159	247	28	in	in	ADP
aji-159	247	29	each	each	DET
aji-159	247	30	nation	nation	NOUN
aji-159	247	31	.	.	PUNCT
aji-159	248	1	these	these	DET
aji-159	248	2	results	result	NOUN
aji-159	248	3	emphasize	emphasize	VERB
aji-159	248	4	a	a	DET
aji-159	248	5	continuous	continuous	ADJ
aji-159	248	6	need	need	NOUN
aji-159	248	7	for	for	ADP
aji-159	248	8	ongoing	ongoing	ADJ
aji-159	248	9	prevention	prevention	NOUN
aji-159	248	10	of	of	ADP
aji-159	248	11	hiv	hiv	PROPN
aji-159	248	12	spread	spread	VERB
aji-159	248	13	among	among	ADP
aji-159	248	14	fsws	fsws	NOUN
aji-159	248	15	between	between	ADP
aji-159	248	16	north	north	ADJ
aji-159	248	17	african	african	ADJ
aji-159	248	18	countries	country	NOUN
aji-159	248	19	.	.	PUNCT
aji-159	249	1	in	in	ADP
aji-159	249	2	africa	africa	PROPN
aji-159	249	3	,	,	PUNCT
aji-159	249	4	despite	despite	SCONJ
aji-159	249	5	the	the	DET
aji-159	249	6	high	high	ADJ
aji-159	249	7	hiv	hiv	PROPN
aji-159	249	8	prevalence	prevalence	NOUN
aji-159	249	9	,	,	PUNCT
aji-159	249	10	the	the	DET
aji-159	249	11	reported	report	VERB
aji-159	249	12	occurrence	occurrence	NOUN
aji-159	249	13	of	of	ADP
aji-159	249	14	hiv	hiv	PROPN
aji-159	249	15	infection	infection	NOUN
aji-159	249	16	among	among	ADP
aji-159	249	17	pwid	pwid	NOUN
aji-159	249	18	and	and	CCONJ
aji-159	249	19	fsws	fsws	ADJ
aji-159	249	20	in	in	ADP
aji-159	249	21	north	north	PROPN
aji-159	249	22	africa	africa	PROPN
aji-159	249	23	was	be	AUX
aji-159	249	24	considerably	considerably	ADV
aji-159	249	25	lower	low	ADJ
aji-159	249	26	compared	compare	VERB
aji-159	249	27	with	with	ADP
aji-159	249	28	south	south	PROPN
aji-159	249	29	africa	africa	PROPN
aji-159	249	30	(	(	PUNCT
aji-159	249	31	jones	jones	PROPN
aji-159	249	32	et	et	PROPN
aji-159	249	33	al	al	PROPN
aji-159	249	34	.	.	PROPN
aji-159	249	35	,	,	PUNCT
aji-159	249	36	2023	2023	NUM
aji-159	249	37	;	;	PUNCT
aji-159	249	38	asher	asher	PROPN
aji-159	249	39	et	et	PROPN
aji-159	249	40	al	al	PROPN
aji-159	249	41	.	.	PROPN
aji-159	249	42	,	,	PUNCT
aji-159	249	43	2013	2013	NUM
aji-159	249	44	)	)	PUNCT
aji-159	249	45	.	.	PUNCT
aji-159	250	1	the	the	DET
aji-159	250	2	north	north	PROPN
aji-159	250	3	africa	africa	PROPN
aji-159	250	4	region	region	NOUN
aji-159	250	5	is	be	AUX
aji-159	250	6	still	still	ADV
aji-159	250	7	lacks	lack	VERB
aji-159	250	8	sufficient	sufficient	ADJ
aji-159	250	9	hiv	hiv	PROPN
aji-159	250	10	epidemiological	epidemiological	ADJ
aji-159	250	11	information	information	NOUN
aji-159	250	12	,	,	PUNCT
aji-159	250	13	leading	lead	VERB
aji-159	250	14	to	to	ADP
aji-159	250	15	debates	debate	NOUN
aji-159	250	16	regarding	regard	VERB
aji-159	250	17	the	the	DET
aji-159	250	18	epidemic	epidemic	NOUN
aji-159	250	19	's	's	PART
aji-159	250	20	prevalence	prevalence	NOUN
aji-159	250	21	in	in	ADP
aji-159	250	22	this	this	DET
aji-159	250	23	part	part	NOUN
aji-159	250	24	of	of	ADP
aji-159	250	25	the	the	DET
aji-159	250	26	globe	globe	NOUN
aji-159	250	27	.	.	PUNCT
aji-159	251	1	it	it	PRON
aji-159	251	2	's	be	AUX
aji-159	251	3	crucial	crucial	ADJ
aji-159	251	4	to	to	PART
aji-159	251	5	have	have	VERB
aji-159	251	6	current	current	ADJ
aji-159	251	7	hiv	hiv	PROPN
aji-159	251	8	prevalence	prevalence	NOUN
aji-159	251	9	data	datum	NOUN
aji-159	251	10	for	for	ADP
aji-159	251	11	north	north	ADJ
aji-159	251	12	african	african	ADJ
aji-159	251	13	countries	country	NOUN
aji-159	251	14	to	to	PART
aji-159	251	15	understand	understand	VERB
aji-159	251	16	the	the	DET
aji-159	251	17	virus	virus	NOUN
aji-159	251	18	's	's	PART
aji-159	251	19	spread	spread	NOUN
aji-159	251	20	.	.	PUNCT
aji-159	252	1	hence	hence	ADV
aji-159	252	2	,	,	PUNCT
aji-159	252	3	additional	additional	ADJ
aji-159	252	4	monitoring	monitoring	NOUN
aji-159	252	5	of	of	ADP
aji-159	252	6	hiv	hiv	PROPN
aji-159	252	7	prevalence	prevalence	NOUN
aji-159	252	8	is	be	AUX
aji-159	252	9	necessary	necessary	ADJ
aji-159	252	10	to	to	PART
aji-159	252	11	evaluate	evaluate	VERB
aji-159	252	12	and	and	CCONJ
aji-159	252	13	track	track	VERB
aji-159	252	14	the	the	DET
aji-159	252	15	escalating	escalate	VERB
aji-159	252	16	hiv	hiv	PROPN
aji-159	252	17	impact	impact	NOUN
aji-159	252	18	(	(	PUNCT
aji-159	252	19	abu	abu	NOUN
aji-159	252	20	-	-	PUNCT
aji-159	252	21	raddad	raddad	PROPN
aji-159	252	22	et	et	PROPN
aji-159	252	23	al	al	PROPN
aji-159	252	24	.	.	PROPN
aji-159	252	25	,	,	PUNCT
aji-159	252	26	2010	2010	NUM
aji-159	252	27	)	)	PUNCT
aji-159	252	28	.	.	PUNCT
aji-159	253	1	the	the	DET
aji-159	253	2	environments	environment	NOUN
aji-159	253	3	where	where	SCONJ
aji-159	253	4	the	the	DET
aji-159	253	5	hiv	hiv	PROPN
aji-159	253	6	pandemic	pandemic	NOUN
aji-159	253	7	is	be	AUX
aji-159	253	8	happening	happen	VERB
aji-159	253	9	are	be	AUX
aji-159	253	10	becoming	become	VERB
aji-159	253	11	more	more	ADV
aji-159	253	12	varied	varied	ADJ
aji-159	253	13	.	.	PUNCT
aji-159	254	1	the	the	DET
aji-159	254	2	epidemics	epidemic	NOUN
aji-159	254	3	are	be	AUX
aji-159	254	4	primarily	primarily	ADV
aji-159	254	5	influenced	influence	VERB
aji-159	254	6	by	by	ADP
aji-159	254	7	social	social	ADJ
aji-159	254	8	,	,	PUNCT
aji-159	254	9	structural	structural	ADJ
aji-159	254	10	,	,	PUNCT
aji-159	254	11	and	and	CCONJ
aji-159	254	12	population	population	NOUN
aji-159	254	13	-	-	PUNCT
aji-159	254	14	level	level	NOUN
aji-159	254	15	risks	risk	NOUN
aji-159	254	16	and	and	CCONJ
aji-159	254	17	protections	protection	NOUN
aji-159	254	18	,	,	PUNCT
aji-159	254	19	which	which	PRON
aji-159	254	20	in	in	ADP
aji-159	254	21	turn	turn	NOUN
aji-159	254	22	affect	affect	VERB
aji-159	254	23	the	the	DET
aji-159	254	24	individual	individual	ADJ
aji-159	254	25	risks	risk	NOUN
aji-159	254	26	of	of	ADP
aji-159	254	27	hiv	hiv	PROPN
aji-159	254	28	infection	infection	NOUN
aji-159	254	29	(	(	PUNCT
aji-159	254	30	beyrer	beyrer	PROPN
aji-159	254	31	,	,	PUNCT
aji-159	254	32	2007	2007	NUM
aji-159	254	33	)	)	PUNCT
aji-159	254	34	.	.	PUNCT
aji-159	255	1	the	the	DET
aji-159	255	2	field	field	NOUN
aji-159	255	3	of	of	ADP
aji-159	255	4	hiv	hiv	PROPN
aji-159	255	5	prevention	prevention	NOUN
aji-159	255	6	is	be	AUX
aji-159	255	7	constantly	constantly	ADV
aji-159	255	8	changing	change	VERB
aji-159	255	9	,	,	PUNCT
aji-159	255	10	and	and	CCONJ
aji-159	255	11	there	there	PRON
aji-159	255	12	is	be	VERB
aji-159	255	13	now	now	ADV
aji-159	255	14	discussion	discussion	NOUN
aji-159	255	15	about	about	ADP
aji-159	255	16	the	the	DET
aji-159	255	17	potential	potential	NOUN
aji-159	255	18	for	for	ADP
aji-159	255	19	worldwide	worldwide	ADJ
aji-159	255	20	virtual	virtual	ADJ
aji-159	255	21	eradication	eradication	NOUN
aji-159	255	22	of	of	ADP
aji-159	255	23	hiv	hiv	PROPN
aji-159	255	24	(	(	PUNCT
aji-159	255	25	mutevedzi	mutevedzi	PROPN
aji-159	255	26	&	&	CCONJ
aji-159	255	27	newell	newell	PROPN
aji-159	255	28	,	,	PUNCT
aji-159	255	29	2014	2014	NUM
aji-159	255	30	)	)	PUNCT
aji-159	255	31	.	.	PUNCT
aji-159	256	1	mitigation	mitigation	NOUN
aji-159	256	2	of	of	ADP
aji-159	256	3	hiv	hiv	PROPN
aji-159	256	4	disease	disease	NOUN
aji-159	256	5	strategies	strategy	NOUN
aji-159	256	6	will	will	AUX
aji-159	256	7	expected	expect	VERB
aji-159	256	8	be	be	AUX
aji-159	256	9	required	require	VERB
aji-159	256	10	to	to	PART
aji-159	256	11	decrease	decrease	VERB
aji-159	256	12	hiv	hiv	PROPN
aji-159	256	13	prevalence	prevalence	NOUN
aji-159	256	14	in	in	ADP
aji-159	256	15	north	north	PROPN
aji-159	256	16	africa	africa	PROPN
aji-159	256	17	,	,	PUNCT
aji-159	256	18	where	where	SCONJ
aji-159	256	19	there	there	PRON
aji-159	256	20	might	might	AUX
aji-159	256	21	be	be	AUX
aji-159	256	22	restrictions	restriction	NOUN
aji-159	256	23	on	on	ADP
aji-159	256	24	getting	get	VERB
aji-159	256	25	health	health	NOUN
aji-159	256	26	care	care	NOUN
aji-159	256	27	and	and	CCONJ
aji-159	256	28	accessing	access	VERB
aji-159	256	29	resources	resource	NOUN
aji-159	256	30	.	.	PUNCT
aji-159	257	1	the	the	DET
aji-159	257	2	suitable	suitable	ADJ
aji-159	257	3	approach	approach	NOUN
aji-159	257	4	can	can	AUX
aji-159	257	5	vary	vary	VERB
aji-159	257	6	from	from	ADP
aji-159	257	7	one	one	NUM
aji-159	257	8	country	country	NOUN
aji-159	257	9	to	to	ADP
aji-159	257	10	another	another	PRON
aji-159	257	11	and	and	CCONJ
aji-159	257	12	additionally	additionally	ADV
aji-159	257	13	have	have	VERB
aji-159	257	14	to	to	PART
aji-159	257	15	be	be	AUX
aji-159	257	16	justifiably	justifiably	ADV
aji-159	257	17	focused	focus	VERB
aji-159	257	18	on	on	ADP
aji-159	257	19	prevention	prevention	NOUN
aji-159	257	20	of	of	ADP
aji-159	257	21	hiv	hiv	PROPN
aji-159	257	22	transmission	transmission	NOUN
aji-159	257	23	.	.	PUNCT
aji-159	258	1	while	while	SCONJ
aji-159	258	2	countries	country	NOUN
aji-159	258	3	must	must	AUX
aji-159	258	4	focus	focus	VERB
aji-159	258	5	on	on	ADP
aji-159	258	6	addressing	address	VERB
aji-159	258	7	the	the	DET
aji-159	258	8	underlying	underlie	VERB
aji-159	258	9	causes	cause	NOUN
aji-159	258	10	of	of	ADP
aji-159	258	11	hiv	hiv	PROPN
aji-159	258	12	exposure	exposure	NOUN
aji-159	258	13	risk	risk	NOUN
aji-159	258	14	,	,	PUNCT
aji-159	258	15	the	the	DET
aji-159	258	16	main	main	ADJ
aji-159	258	17	emphasis	emphasis	NOUN
aji-159	258	18	should	should	AUX
aji-159	258	19	be	be	AUX
aji-159	258	20	on	on	ADP
aji-159	258	21	addressing	address	VERB
aji-159	258	22	the	the	DET
aji-159	258	23	immediate	immediate	ADJ
aji-159	258	24	factors	factor	NOUN
aji-159	258	25	that	that	PRON
aji-159	258	26	increase	increase	VERB
aji-159	258	27	individuals	individual	NOUN
aji-159	258	28	'	'	PART
aji-159	258	29	risk	risk	NOUN
aji-159	258	30	of	of	ADP
aji-159	258	31	hiv	hiv	PROPN
aji-159	258	32	exposure	exposure	NOUN
aji-159	258	33	,	,	PUNCT
aji-159	258	34	as	as	SCONJ
aji-159	258	35	dealing	deal	VERB
aji-159	258	36	with	with	ADP
aji-159	258	37	structural	structural	ADJ
aji-159	258	38	factors	factor	NOUN
aji-159	258	39	is	be	AUX
aji-159	258	40	time	time	NOUN
aji-159	258	41	-	-	PUNCT
aji-159	258	42	consuming	consume	VERB
aji-159	258	43	and	and	CCONJ
aji-159	258	44	outside	outside	ADP
aji-159	258	45	the	the	DET
aji-159	258	46	purview	purview	NOUN
aji-159	258	47	of	of	ADP
aji-159	258	48	the	the	DET
aji-159	258	49	public	public	ADJ
aji-159	258	50	health	health	NOUN
aji-159	258	51	sector	sector	NOUN
aji-159	258	52	.	.	PUNCT
aji-159	259	1	hence	hence	ADV
aji-159	259	2	,	,	PUNCT
aji-159	259	3	there	there	PRON
aji-159	259	4	is	be	VERB
aji-159	259	5	an	an	DET
aji-159	259	6	opportunity	opportunity	NOUN
aji-159	259	7	for	for	ADP
aji-159	259	8	prevention	prevention	NOUN
aji-159	259	9	that	that	PRON
aji-159	259	10	should	should	AUX
aji-159	259	11	not	not	PART
aji-159	259	12	be	be	AUX
aji-159	259	13	missed	miss	VERB
aji-159	259	14	to	to	PART
aji-159	259	15	control	control	VERB
aji-159	259	16	the	the	DET
aji-159	259	17	epidemic	epidemic	NOUN
aji-159	259	18	in	in	ADP
aji-159	259	19	this	this	DET
aji-159	259	20	region	region	NOUN
aji-159	259	21	(	(	PUNCT
aji-159	259	22	abu	abu	PROPN
aji-159	259	23	-	-	PUNCT
aji-159	259	24	raddad	raddad	PROPN
aji-159	259	25	et	et	PROPN
aji-159	259	26	al	al	PROPN
aji-159	259	27	.	.	PROPN
aji-159	259	28	,	,	PUNCT
aji-159	259	29	2010	2010	NUM
aji-159	259	30	)	)	PUNCT
aji-159	259	31	.	.	PUNCT
aji-159	260	1	this	this	DET
aji-159	260	2	systematic	systematic	ADJ
aji-159	260	3	review	review	NOUN
aji-159	260	4	offers	offer	VERB
aji-159	260	5	the	the	DET
aji-159	260	6	latest	late	ADJ
aji-159	260	7	extensive	extensive	ADJ
aji-159	260	8	assessment	assessment	NOUN
aji-159	260	9	of	of	ADP
aji-159	260	10	hiv	hiv	PROPN
aji-159	260	11	prevalence	prevalence	NOUN
aji-159	260	12	by	by	ADP
aji-159	260	13	carefully	carefully	ADV
aji-159	260	14	evaluating	evaluate	VERB
aji-159	260	15	existing	exist	VERB
aji-159	260	16	literature	literature	NOUN
aji-159	260	17	.	.	PUNCT
aji-159	261	1	when	when	SCONJ
aji-159	261	2	interpreting	interpreting	NOUN
aji-159	261	3	results	result	NOUN
aji-159	261	4	,	,	PUNCT
aji-159	261	5	it	it	PRON
aji-159	261	6	's	be	AUX
aji-159	261	7	vital	vital	ADJ
aji-159	261	8	to	to	PART
aji-159	261	9	consider	consider	VERB
aji-159	261	10	and	and	CCONJ
aji-159	261	11	navigate	navigate	VERB
aji-159	261	12	through	through	ADP
aji-159	261	13	various	various	ADJ
aji-159	261	14	constraints	constraint	NOUN
aji-159	261	15	in	in	ADP
aji-159	261	16	order	order	NOUN
aji-159	261	17	to	to	PART
aji-159	261	18	gain	gain	VERB
aji-159	261	19	a	a	DET
aji-159	261	20	comprehensive	comprehensive	ADJ
aji-159	261	21	and	and	CCONJ
aji-159	261	22	robust	robust	ADJ
aji-159	261	23	understanding	understanding	NOUN
aji-159	261	24	of	of	ADP
aji-159	261	25	the	the	DET
aji-159	261	26	outcomes	outcome	NOUN
aji-159	261	27	.	.	PUNCT
aji-159	262	1	the	the	DET
aji-159	262	2	primary	primary	ADJ
aji-159	262	3	limitations	limitation	NOUN
aji-159	262	4	come	come	VERB
aji-159	262	5	from	from	ADP
aji-159	262	6	the	the	DET
aji-159	262	7	data	datum	NOUN
aji-159	262	8	that	that	PRON
aji-159	262	9	is	be	AUX
aji-159	262	10	currently	currently	ADV
aji-159	262	11	available	available	ADJ
aji-159	262	12	,	,	PUNCT
aji-159	262	13	with	with	ADP
aji-159	262	14	a	a	DET
aji-159	262	15	scarcity	scarcity	NOUN
aji-159	262	16	of	of	ADP
aji-159	262	17	studies	study	NOUN
aji-159	262	18	on	on	ADP
aji-159	262	19	prevalence	prevalence	NOUN
aji-159	262	20	.	.	PUNCT
aji-159	263	1	despite	despite	SCONJ
aji-159	263	2	these	these	DET
aji-159	263	3	limitations	limitation	NOUN
aji-159	263	4	,	,	PUNCT
aji-159	263	5	the	the	DET
aji-159	263	6	present	present	ADJ
aji-159	263	7	systematic	systematic	ADJ
aji-159	263	8	review	review	NOUN
aji-159	263	9	demonstrated	demonstrate	VERB
aji-159	263	10	that	that	SCONJ
aji-159	263	11	there	there	PRON
aji-159	263	12	is	be	VERB
aji-159	263	13	a	a	DET
aji-159	263	14	significant	significant	ADJ
aji-159	263	15	burden	burden	NOUN
aji-159	263	16	of	of	ADP
aji-159	263	17	hiv	hiv	PROPN
aji-159	263	18	infection	infection	NOUN
aji-159	263	19	in	in	ADP
aji-159	263	20	pwid	pwid	NOUN
aji-159	263	21	and	and	CCONJ
aji-159	263	22	fsws	fsws	ADJ
aji-159	263	23	in	in	ADP
aji-159	263	24	most	most	ADJ
aji-159	263	25	of	of	ADP
aji-159	263	26	the	the	DET
aji-159	263	27	north	north	ADJ
aji-159	263	28	african	african	ADJ
aji-159	263	29	countries	country	NOUN
aji-159	263	30	.	.	PUNCT
aji-159	264	1	however	however	ADV
aji-159	264	2	,	,	PUNCT
aji-159	264	3	additional	additional	ADJ
aji-159	264	4	investigation	investigation	NOUN
aji-159	264	5	is	be	AUX
aji-159	264	6	required	require	VERB
aji-159	264	7	to	to	PART
aji-159	264	8	fill	fill	VERB
aji-159	264	9	the	the	DET
aji-159	264	10	knowledge	knowledge	NOUN
aji-159	264	11	gaps	gap	NOUN
aji-159	264	12	.	.	PUNCT
aji-159	265	1	5	5	X
aji-159	265	2	.	.	X
aji-159	265	3	conclusion	conclusion	VERB
aji-159	265	4	the	the	DET
aji-159	265	5	findings	finding	NOUN
aji-159	265	6	of	of	ADP
aji-159	265	7	this	this	DET
aji-159	265	8	report	report	NOUN
aji-159	265	9	provide	provide	VERB
aji-159	265	10	a	a	DET
aji-159	265	11	comprehensive	comprehensive	ADJ
aji-159	265	12	overview	overview	NOUN
aji-159	265	13	of	of	ADP
aji-159	265	14	the	the	DET
aji-159	265	15	prevalence	prevalence	NOUN
aji-159	265	16	of	of	ADP
aji-159	265	17	hiv	hiv	PROPN
aji-159	265	18	among	among	ADP
aji-159	265	19	pwid	pwid	NOUN
aji-159	265	20	and	and	CCONJ
aji-159	265	21	fsws	fsws	ADJ
aji-159	265	22	.	.	PUNCT
aji-159	266	1	variation	variation	NOUN
aji-159	266	2	in	in	ADP
aji-159	266	3	prevalence	prevalence	NOUN
aji-159	266	4	of	of	ADP
aji-159	266	5	hiv	hiv	PROPN
aji-159	266	6	observed	observe	VERB
aji-159	266	7	in	in	ADP
aji-159	266	8	different	different	ADJ
aji-159	266	9	regions	region	NOUN
aji-159	266	10	in	in	ADP
aji-159	266	11	north	north	PROPN
aji-159	266	12	africa	africa	PROPN
aji-159	266	13	.	.	PUNCT
aji-159	267	1	pwid	pwid	NOUN
aji-159	267	2	and	and	CCONJ
aji-159	267	3	fsws	fsws	ADJ
aji-159	267	4	has	have	AUX
aji-159	267	5	been	be	AUX
aji-159	267	6	identified	identify	VERB
aji-159	267	7	as	as	ADP
aji-159	267	8	the	the	DET
aji-159	267	9	dominant	dominant	ADJ
aji-159	267	10	method	method	NOUN
aji-159	267	11	of	of	ADP
aji-159	267	12	transmission	transmission	NOUN
aji-159	267	13	in	in	ADP
aji-159	267	14	various	various	ADJ
aji-159	267	15	north	north	ADJ
aji-159	267	16	african	african	ADJ
aji-159	267	17	countries	country	NOUN
aji-159	267	18	like	like	ADP
aji-159	267	19	libya	libya	PROPN
aji-159	267	20	,	,	PUNCT
aji-159	267	21	egypt	egypt	PROPN
aji-159	267	22	,	,	PUNCT
aji-159	267	23	morocco	morocco	PROPN
aji-159	267	24	and	and	CCONJ
aji-159	267	25	tunisia	tunisia	PROPN
aji-159	267	26	.	.	PUNCT
aji-159	268	1	as	as	SCONJ
aji-159	268	2	the	the	DET
aji-159	268	3	hiv	hiv	PROPN
aji-159	268	4	pandemic	pandemic	ADJ
aji-159	268	5	is	be	AUX
aji-159	268	6	still	still	ADV
aji-159	268	7	evolving	evolve	VERB
aji-159	268	8	,	,	PUNCT
aji-159	268	9	more	more	ADJ
aji-159	268	10	studies	study	NOUN
aji-159	268	11	need	need	VERB
aji-159	268	12	to	to	PART
aji-159	268	13	be	be	AUX
aji-159	268	14	conducted	conduct	VERB
aji-159	268	15	in	in	ADP
aji-159	268	16	this	this	DET
aji-159	268	17	part	part	NOUN
aji-159	268	18	of	of	ADP
aji-159	268	19	the	the	DET
aji-159	268	20	african	african	ADJ
aji-159	268	21	continent	continent	NOUN
aji-159	268	22	to	to	PART
aji-159	268	23	comprehend	comprehend	VERB
aji-159	268	24	the	the	DET
aji-159	268	25	right	right	ADJ
aji-159	268	26	burden	burden	NOUN
aji-159	268	27	of	of	ADP
aji-159	268	28	the	the	DET
aji-159	268	29	illness	illness	NOUN
aji-159	268	30	.	.	PUNCT
aji-159	269	1	studies	study	NOUN
aji-159	269	2	in	in	ADP
aji-159	269	3	this	this	DET
aji-159	269	4	region	region	NOUN
aji-159	269	5	need	need	VERB
aji-159	269	6	to	to	PART
aji-159	269	7	take	take	VERB
aji-159	269	8	into	into	ADP
aji-159	269	9	consideration	consideration	NOUN
aji-159	269	10	societal	societal	ADJ
aji-159	269	11	and	and	CCONJ
aji-159	269	12	institutional	institutional	ADJ
aji-159	269	13	factors	factor	NOUN
aji-159	269	14	.	.	PUNCT
aji-159	270	1	the	the	DET
aji-159	270	2	extensive	extensive	ADJ
aji-159	270	3	programs	program	NOUN
aji-159	270	4	of	of	ADP
aji-159	270	5	monitoring	monitoring	NOUN
aji-159	270	6	of	of	ADP
aji-159	270	7	hiv	hiv	PROPN
aji-159	270	8	prevalence	prevalence	NOUN
aji-159	270	9	are	be	AUX
aji-159	270	10	necessary	necessary	ADJ
aji-159	270	11	to	to	PART
aji-159	270	12	prevent	prevent	VERB
aji-159	270	13	these	these	DET
aji-159	270	14	high	high	ADJ
aji-159	270	15	khalaf	khalaf	PROPN
aji-159	270	16	;	;	PUNCT
aji-159	270	17	asian	asian	PROPN
aji-159	270	18	j.	j.	PROPN
aji-159	270	19	immunol	immunol	PROPN
aji-159	270	20	.	.	PROPN
aji-159	270	21	,	,	PUNCT
aji-159	270	22	vol	vol	NOUN
aji-159	270	23	.	.	PROPN
aji-159	270	24	8	8	NUM
aji-159	270	25	,	,	PUNCT
aji-159	270	26	no	no	INTJ
aji-159	270	27	.	.	NOUN
aji-159	270	28	1	1	NUM
aji-159	270	29	,	,	PUNCT
aji-159	270	30	pp	pp	ADJ
aji-159	270	31	.	.	PUNCT
aji-159	271	1	50	50	NUM
aji-159	271	2	-	-	SYM
aji-159	271	3	59	59	NUM
aji-159	271	4	,	,	PUNCT
aji-159	271	5	2025	2025	NUM
aji-159	271	6	;	;	PUNCT
aji-159	271	7	article	article	NOUN
aji-159	271	8	no.aji.125999	no.aji.125999	NOUN
aji-159	271	9	56	56	NUM
aji-159	271	10	risk	risk	NOUN
aji-159	271	11	groups	group	NOUN
aji-159	271	12	from	from	ADP
aji-159	271	13	further	far	ADV
aji-159	271	14	spreading	spread	VERB
aji-159	271	15	the	the	DET
aji-159	271	16	infection	infection	NOUN
aji-159	271	17	of	of	ADP
aji-159	271	18	hiv	hiv	PROPN
aji-159	271	19	.	.	PUNCT
aji-159	272	1	emphasize	emphasize	VERB
aji-159	272	2	health	health	NOUN
aji-159	272	3	education	education	NOUN
aji-159	272	4	as	as	ADP
aji-159	272	5	a	a	DET
aji-159	272	6	means	means	NOUN
aji-159	272	7	to	to	PART
aji-159	272	8	reduce	reduce	VERB
aji-159	272	9	prevalence	prevalence	NOUN
aji-159	272	10	of	of	ADP
aji-159	272	11	hiv	hiv	PROPN
aji-159	272	12	infections	infection	NOUN
aji-159	272	13	among	among	ADP
aji-159	272	14	pwid	pwid	NOUN
aji-159	272	15	and	and	CCONJ
aji-159	272	16	fsws	fsws	ADJ
aji-159	272	17	.	.	PUNCT
aji-159	273	1	this	this	DET
aji-159	273	2	review	review	NOUN
aji-159	273	3	demonstrates	demonstrate	VERB
aji-159	273	4	epidemiological	epidemiological	ADJ
aji-159	273	5	hiv	hiv	PROPN
aji-159	273	6	infection	infection	NOUN
aji-159	273	7	in	in	ADP
aji-159	273	8	pwid	pwid	NOUN
aji-159	273	9	and	and	CCONJ
aji-159	273	10	fsws	fsws	ADJ
aji-159	273	11	.	.	PUNCT
aji-159	274	1	these	these	DET
aji-159	274	2	data	datum	NOUN
aji-159	274	3	can	can	AUX
aji-159	274	4	be	be	AUX
aji-159	274	5	used	use	VERB
aji-159	274	6	to	to	PART
aji-159	274	7	develop	develop	VERB
aji-159	274	8	customized	customized	ADJ
aji-159	274	9	strategies	strategy	NOUN
aji-159	274	10	for	for	ADP
aji-159	274	11	reducing	reduce	VERB
aji-159	274	12	the	the	DET
aji-159	274	13	prevalence	prevalence	NOUN
aji-159	274	14	of	of	ADP
aji-159	274	15	hiv	hiv	PROPN
aji-159	274	16	in	in	ADP
aji-159	274	17	the	the	DET
aji-159	274	18	north	north	ADJ
aji-159	274	19	african	african	ADJ
aji-159	274	20	regions	region	NOUN
aji-159	274	21	.	.	PUNCT
aji-159	275	1	disclaimer	disclaimer	NOUN
aji-159	275	2	(	(	PUNCT
aji-159	275	3	artificial	artificial	ADJ
aji-159	275	4	intelligence	intelligence	NOUN
aji-159	275	5	)	)	PUNCT
aji-159	275	6	author(s	author(s	NOUN
aji-159	275	7	)	)	PUNCT
aji-159	275	8	hereby	hereby	ADV
aji-159	275	9	declare	declare	VERB
aji-159	275	10	that	that	SCONJ
aji-159	275	11	no	no	DET
aji-159	275	12	generative	generative	NOUN
aji-159	275	13	ai	ai	VERB
aji-159	275	14	technologies	technology	NOUN
aji-159	275	15	such	such	ADJ
aji-159	275	16	as	as	ADP
aji-159	275	17	large	large	ADJ
aji-159	275	18	language	language	NOUN
aji-159	275	19	models	model	NOUN
aji-159	275	20	(	(	PUNCT
aji-159	275	21	chatgpt	chatgpt	NOUN
aji-159	275	22	,	,	PUNCT
aji-159	275	23	copilot	copilot	NOUN
aji-159	275	24	,	,	PUNCT
aji-159	275	25	etc	etc	X
aji-159	275	26	.	.	X
aji-159	275	27	)	)	PUNCT
aji-159	275	28	and	and	CCONJ
aji-159	275	29	text	text	NOUN
aji-159	275	30	-	-	PUNCT
aji-159	275	31	to	to	ADP
aji-159	275	32	-	-	PUNCT
aji-159	275	33	image	image	NOUN
aji-159	275	34	generators	generator	NOUN
aji-159	275	35	have	have	AUX
aji-159	275	36	been	be	AUX
aji-159	275	37	used	use	VERB
aji-159	275	38	during	during	ADP
aji-159	275	39	the	the	DET
aji-159	275	40	writing	writing	NOUN
aji-159	275	41	or	or	CCONJ
aji-159	275	42	editing	editing	NOUN
aji-159	275	43	of	of	ADP
aji-159	275	44	this	this	DET
aji-159	275	45	manuscript	manuscript	NOUN
aji-159	275	46	.	.	PUNCT
aji-159	276	1	consent	consent	NOUN
aji-159	276	2	and	and	CCONJ
aji-159	276	3	ethical	ethical	ADJ
aji-159	276	4	approval	approval	NOUN
aji-159	276	5	it	it	PRON
aji-159	276	6	is	be	AUX
aji-159	276	7	not	not	PART
aji-159	276	8	applicable	applicable	ADJ
aji-159	276	9	.	.	PUNCT
aji-159	277	1	competing	compete	VERB
aji-159	277	2	interests	interest	NOUN
aji-159	277	3	author	author	NOUN
aji-159	277	4	has	have	AUX
aji-159	277	5	declared	declare	VERB
aji-159	277	6	that	that	SCONJ
aji-159	277	7	no	no	DET
aji-159	277	8	competing	compete	VERB
aji-159	277	9	interests	interest	NOUN
aji-159	277	10	exist	exist	VERB
aji-159	277	11	.	.	PUNCT
aji-159	278	1	references	reference	NOUN
aji-159	278	2	abu	abu	PROPN
aji-159	278	3	-	-	PUNCT
aji-159	278	4	raddad	raddad	PROPN
aji-159	278	5	,	,	PUNCT
aji-159	278	6	l.	l.	PROPN
aji-159	278	7	j.	j.	PROPN
aji-159	278	8	,	,	PUNCT
aji-159	278	9	hilmi	hilmi	PROPN
aji-159	278	10	,	,	PUNCT
aji-159	278	11	n.	n.	PROPN
aji-159	278	12	,	,	PUNCT
aji-159	278	13	mumtaz	mumtaz	PROPN
aji-159	278	14	,	,	PUNCT
aji-159	278	15	g.	g.	PROPN
aji-159	278	16	,	,	PUNCT
aji-159	278	17	benkirane	benkirane	NOUN
aji-159	278	18	,	,	PUNCT
aji-159	278	19	m.	m.	NOUN
aji-159	278	20	,	,	PUNCT
aji-159	278	21	akala	akala	PROPN
aji-159	278	22	,	,	PUNCT
aji-159	278	23	f.	f.	PROPN
aji-159	278	24	a.	a.	PROPN
aji-159	278	25	,	,	PUNCT
aji-159	278	26	riedner	riedner	NOUN
aji-159	278	27	,	,	PUNCT
aji-159	278	28	g.	g.	PROPN
aji-159	278	29	,	,	PUNCT
aji-159	278	30	tawil	tawil	PROPN
aji-159	278	31	,	,	PUNCT
aji-159	278	32	o.	o.	PROPN
aji-159	278	33	,	,	PUNCT
aji-159	278	34	&	&	CCONJ
aji-159	278	35	wilson	wilson	PROPN
aji-159	278	36	,	,	PUNCT
aji-159	278	37	d.	d.	PROPN
aji-159	278	38	(	(	PUNCT
aji-159	278	39	2010	2010	NUM
aji-159	278	40	)	)	PUNCT
aji-159	278	41	.	.	PUNCT
aji-159	279	1	epidemiology	epidemiology	NOUN
aji-159	279	2	of	of	ADP
aji-159	279	3	hiv	hiv	PROPN
aji-159	279	4	infection	infection	NOUN
aji-159	279	5	in	in	ADP
aji-159	279	6	the	the	DET
aji-159	279	7	middle	middle	PROPN
aji-159	279	8	east	east	PROPN
aji-159	279	9	and	and	CCONJ
aji-159	279	10	north	north	PROPN
aji-159	279	11	africa	africa	PROPN
aji-159	279	12	.	.	PUNCT
aji-159	280	1	aids	aids	PROPN
aji-159	280	2	,	,	PUNCT
aji-159	280	3	24(suppl	24(suppl	NUM
aji-159	280	4	2	2	NUM
aji-159	280	5	)	)	PUNCT
aji-159	280	6	,	,	PUNCT
aji-159	280	7	s5	s5	PROPN
aji-159	280	8	–	–	PUNCT
aji-159	280	9	s23	s23	NOUN
aji-159	280	10	.	.	PUNCT
aji-159	281	1	anan	anan	PROPN
aji-159	281	2	,	,	PUNCT
aji-159	281	3	a.	a.	NOUN
aji-159	281	4	m.	m.	NOUN
aji-159	281	5	,	,	PUNCT
aji-159	281	6	alzahaby	alzahaby	PROPN
aji-159	281	7	,	,	PUNCT
aji-159	281	8	a.	a.	NOUN
aji-159	281	9	a.	a.	PROPN
aji-159	281	10	,	,	PUNCT
aji-159	281	11	ghazy	ghazy	PROPN
aji-159	281	12	,	,	PUNCT
aji-159	281	13	a.	a.	NOUN
aji-159	281	14	,	,	PUNCT
aji-159	281	15	&	&	CCONJ
aji-159	281	16	abdelrazik	abdelrazik	PROPN
aji-159	281	17	,	,	PUNCT
aji-159	281	18	o.	o.	NOUN
aji-159	281	19	m.	m.	NOUN
aji-159	281	20	(	(	PUNCT
aji-159	281	21	2024	2024	NUM
aji-159	281	22	)	)	PUNCT
aji-159	281	23	.	.	PUNCT
aji-159	282	1	clinicoepidemiological	clinicoepidemiological	ADJ
aji-159	282	2	study	study	NOUN
aji-159	282	3	of	of	ADP
aji-159	282	4	hiv	hiv	PROPN
aji-159	282	5	patients	patient	NOUN
aji-159	282	6	in	in	ADP
aji-159	282	7	el	el	PROPN
aji-159	282	8	beheira	beheira	PROPN
aji-159	282	9	governorate	governorate	PROPN
aji-159	282	10	.	.	PUNCT
aji-159	283	1	international	international	ADJ
aji-159	283	2	journal	journal	PROPN
aji-159	283	3	of	of	ADP
aji-159	283	4	medical	medical	ADJ
aji-159	283	5	arts	art	NOUN
aji-159	283	6	,	,	PUNCT
aji-159	283	7	6	6	NUM
aji-159	283	8	,	,	PUNCT
aji-159	283	9	4627–4634	4627–4634	NUM
aji-159	283	10	.	.	PUNCT
aji-159	284	1	asher	asher	PROPN
aji-159	284	2	,	,	PUNCT
aji-159	284	3	a.	a.	PROPN
aji-159	284	4	k.	k.	PROPN
aji-159	284	5	,	,	PUNCT
aji-159	284	6	hahn	hahn	PROPN
aji-159	284	7	,	,	PUNCT
aji-159	284	8	j.	j.	PROPN
aji-159	284	9	a.	a.	PROPN
aji-159	284	10	,	,	PUNCT
aji-159	284	11	couture	couture	NOUN
aji-159	284	12	,	,	PUNCT
aji-159	284	13	m.	m.	PROPN
aji-159	284	14	c.	c.	PROPN
aji-159	284	15	,	,	PUNCT
aji-159	284	16	maher	maher	PROPN
aji-159	284	17	,	,	PUNCT
aji-159	284	18	k.	k.	PROPN
aji-159	284	19	,	,	PUNCT
aji-159	284	20	&	&	CCONJ
aji-159	284	21	page	page	PROPN
aji-159	284	22	,	,	PUNCT
aji-159	284	23	k.	k.	PROPN
aji-159	284	24	(	(	PUNCT
aji-159	284	25	2013	2013	NUM
aji-159	284	26	)	)	PUNCT
aji-159	284	27	.	.	PUNCT
aji-159	285	1	people	people	NOUN
aji-159	285	2	who	who	PRON
aji-159	285	3	inject	inject	VERB
aji-159	285	4	drugs	drug	NOUN
aji-159	285	5	,	,	PUNCT
aji-159	285	6	hiv	hiv	PROPN
aji-159	285	7	risk	risk	NOUN
aji-159	285	8	,	,	PUNCT
aji-159	285	9	and	and	CCONJ
aji-159	285	10	hiv	hiv	PROPN
aji-159	285	11	testing	testing	NOUN
aji-159	285	12	uptake	uptake	NOUN
aji-159	285	13	in	in	ADP
aji-159	285	14	sub	sub	ADJ
aji-159	285	15	-	-	ADJ
aji-159	285	16	saharan	saharan	ADJ
aji-159	285	17	africa	africa	PROPN
aji-159	285	18	.	.	PUNCT
aji-159	286	1	journal	journal	PROPN
aji-159	286	2	of	of	ADP
aji-159	286	3	the	the	DET
aji-159	286	4	association	association	NOUN
aji-159	286	5	of	of	ADP
aji-159	286	6	nurses	nurse	NOUN
aji-159	286	7	in	in	ADP
aji-159	286	8	aids	aids	PROPN
aji-159	286	9	care	care	PROPN
aji-159	286	10	,	,	PUNCT
aji-159	286	11	24(6	24(6	NUM
aji-159	286	12	)	)	PUNCT
aji-159	286	13	,	,	PUNCT
aji-159	286	14	e35	e35	PROPN
aji-159	286	15	–	–	PUNCT
aji-159	286	16	e44	e44	PROPN
aji-159	286	17	.	.	PUNCT
aji-159	287	1	azim	azim	PROPN
aji-159	287	2	,	,	PUNCT
aji-159	287	3	t.	t.	PROPN
aji-159	287	4	,	,	PUNCT
aji-159	287	5	chowdhury	chowdhury	PROPN
aji-159	287	6	,	,	PUNCT
aji-159	287	7	e.	e.	PROPN
aji-159	287	8	i.	i.	PROPN
aji-159	287	9	,	,	PUNCT
aji-159	287	10	reza	reza	PROPN
aji-159	287	11	,	,	PUNCT
aji-159	287	12	m.	m.	NOUN
aji-159	287	13	,	,	PUNCT
aji-159	287	14	faruque	faruque	NOUN
aji-159	287	15	,	,	PUNCT
aji-159	287	16	m.	m.	NOUN
aji-159	287	17	o.	o.	PROPN
aji-159	287	18	,	,	PUNCT
aji-159	287	19	ahmed	ahmed	PROPN
aji-159	287	20	,	,	PUNCT
aji-159	287	21	g.	g.	PROPN
aji-159	287	22	,	,	PUNCT
aji-159	287	23	khan	khan	PROPN
aji-159	287	24	,	,	PUNCT
aji-159	287	25	r.	r.	PROPN
aji-159	287	26	,	,	PUNCT
aji-159	287	27	rahman	rahman	PROPN
aji-159	287	28	,	,	PUNCT
aji-159	287	29	m.	m.	NOUN
aji-159	287	30	,	,	PUNCT
aji-159	287	31	pervez	pervez	PROPN
aji-159	287	32	,	,	PUNCT
aji-159	287	33	m.	m.	NOUN
aji-159	287	34	m.	m.	NOUN
aji-159	287	35	,	,	PUNCT
aji-159	287	36	jana	jana	PROPN
aji-159	287	37	,	,	PUNCT
aji-159	287	38	s.	s.	PROPN
aji-159	287	39	,	,	PUNCT
aji-159	287	40	&	&	CCONJ
aji-159	287	41	strathdee	strathdee	PROPN
aji-159	287	42	,	,	PUNCT
aji-159	287	43	s.	s.	PROPN
aji-159	287	44	a.	a.	PROPN
aji-159	287	45	(	(	PUNCT
aji-159	287	46	2008	2008	NUM
aji-159	287	47	)	)	PUNCT
aji-159	287	48	.	.	PUNCT
aji-159	288	1	prevalence	prevalence	NOUN
aji-159	288	2	of	of	ADP
aji-159	288	3	infections	infection	NOUN
aji-159	288	4	,	,	PUNCT
aji-159	288	5	hiv	hiv	PROPN
aji-159	288	6	risk	risk	NOUN
aji-159	288	7	behaviors	behavior	NOUN
aji-159	288	8	and	and	CCONJ
aji-159	288	9	factors	factor	NOUN
aji-159	288	10	associated	associate	VERB
aji-159	288	11	with	with	ADP
aji-159	288	12	hiv	hiv	PROPN
aji-159	288	13	infection	infection	NOUN
aji-159	288	14	among	among	ADP
aji-159	288	15	male	male	NOUN
aji-159	288	16	injecting	inject	VERB
aji-159	288	17	drug	drug	NOUN
aji-159	288	18	users	user	NOUN
aji-159	288	19	attending	attend	VERB
aji-159	288	20	a	a	DET
aji-159	288	21	needle	needle	NOUN
aji-159	288	22	/	/	SYM
aji-159	288	23	syringe	syringe	NOUN
aji-159	288	24	exchange	exchange	NOUN
aji-159	288	25	program	program	NOUN
aji-159	288	26	in	in	ADP
aji-159	288	27	dhaka	dhaka	PROPN
aji-159	288	28	,	,	PUNCT
aji-159	288	29	bangladesh	bangladesh	NOUN
aji-159	288	30	.	.	PUNCT
aji-159	289	1	substance	substance	NOUN
aji-159	289	2	use	use	NOUN
aji-159	289	3	&	&	CCONJ
aji-159	289	4	misuse	misuse	NOUN
aji-159	289	5	,	,	PUNCT
aji-159	289	6	43(14	43(14	NOUN
aji-159	289	7	)	)	PUNCT
aji-159	289	8	,	,	PUNCT
aji-159	289	9	2124–2144	2124–2144	NUM
aji-159	289	10	.	.	PUNCT
aji-159	290	1	beyrer	beyrer	PROPN
aji-159	290	2	,	,	PUNCT
aji-159	290	3	c.	c.	PROPN
aji-159	290	4	(	(	PUNCT
aji-159	290	5	2007	2007	NUM
aji-159	290	6	)	)	PUNCT
aji-159	290	7	.	.	PUNCT
aji-159	291	1	hiv	hiv	PROPN
aji-159	291	2	epidemiology	epidemiology	NOUN
aji-159	291	3	update	update	NOUN
aji-159	291	4	and	and	CCONJ
aji-159	291	5	transmission	transmission	NOUN
aji-159	291	6	factors	factor	NOUN
aji-159	291	7	:	:	PUNCT
aji-159	291	8	risks	risk	NOUN
aji-159	291	9	and	and	CCONJ
aji-159	291	10	risk	risk	NOUN
aji-159	292	1	contexts—16th	contexts—16th	PROPN
aji-159	292	2	international	international	ADJ
aji-159	292	3	aids	aids	PROPN
aji-159	292	4	conference	conference	NOUN
aji-159	292	5	epidemiology	epidemiology	NOUN
aji-159	292	6	plenary	plenary	ADJ
aji-159	292	7	.	.	PUNCT
aji-159	293	1	clinical	clinical	ADJ
aji-159	293	2	infectious	infectious	ADJ
aji-159	293	3	diseases	disease	NOUN
aji-159	293	4	,	,	PUNCT
aji-159	293	5	44	44	NUM
aji-159	293	6	,	,	PUNCT
aji-159	293	7	981–987	981–987	NUM
aji-159	293	8	.	.	PUNCT
aji-159	294	1	bokazhanova	bokazhanova	PROPN
aji-159	294	2	,	,	PUNCT
aji-159	294	3	a.	a.	PROPN
aji-159	294	4	,	,	PUNCT
aji-159	294	5	&	&	CCONJ
aji-159	294	6	rutherford	rutherford	PROPN
aji-159	294	7	,	,	PUNCT
aji-159	294	8	g.	g.	PROPN
aji-159	294	9	w.	w.	PROPN
aji-159	294	10	(	(	PUNCT
aji-159	294	11	2006	2006	NUM
aji-159	294	12	)	)	PUNCT
aji-159	294	13	.	.	PUNCT
aji-159	295	1	the	the	DET
aji-159	295	2	epidemiology	epidemiology	NOUN
aji-159	295	3	of	of	ADP
aji-159	295	4	hiv	hiv	PROPN
aji-159	295	5	and	and	CCONJ
aji-159	295	6	aids	aid	NOUN
aji-159	295	7	in	in	ADP
aji-159	295	8	the	the	DET
aji-159	295	9	world	world	NOUN
aji-159	295	10	.	.	PUNCT
aji-159	296	1	collegium	collegium	NOUN
aji-159	296	2	antropologicum	antropologicum	NOUN
aji-159	296	3	,	,	PUNCT
aji-159	296	4	30(2	30(2	NUM
aji-159	296	5	)	)	PUNCT
aji-159	296	6	,	,	PUNCT
aji-159	296	7	3	3	NUM
aji-159	296	8	–	–	SYM
aji-159	296	9	10	10	NUM
aji-159	296	10	.	.	PUNCT
aji-159	297	1	campbell	campbell	PROPN
aji-159	297	2	-	-	PUNCT
aji-159	297	3	yesufu	yesufu	PROPN
aji-159	297	4	,	,	PUNCT
aji-159	297	5	o.	o.	PROPN
aji-159	297	6	t.	t.	PROPN
aji-159	297	7	,	,	PUNCT
aji-159	297	8	&	&	CCONJ
aji-159	297	9	gandhi	gandhi	PROPN
aji-159	297	10	,	,	PUNCT
aji-159	297	11	r.	r.	PROPN
aji-159	297	12	t.	t.	PROPN
aji-159	297	13	(	(	PUNCT
aji-159	297	14	2011	2011	NUM
aji-159	297	15	)	)	PUNCT
aji-159	297	16	.	.	PUNCT
aji-159	298	1	update	update	NOUN
aji-159	298	2	on	on	ADP
aji-159	298	3	human	human	ADJ
aji-159	298	4	immunodeficiency	immunodeficiency	NOUN
aji-159	298	5	virus	virus	NOUN
aji-159	298	6	(	(	PUNCT
aji-159	298	7	hiv)-2	hiv)-2	NOUN
aji-159	298	8	infection	infection	NOUN
aji-159	298	9	.	.	PUNCT
aji-159	299	1	clinical	clinical	ADJ
aji-159	299	2	infectious	infectious	ADJ
aji-159	299	3	diseases	disease	NOUN
aji-159	299	4	,	,	PUNCT
aji-159	299	5	52	52	NUM
aji-159	299	6	,	,	PUNCT
aji-159	299	7	780–787	780–787	NUM
aji-159	299	8	.	.	PUNCT
aji-159	300	1	comlan	comlan	PROPN
aji-159	300	2	,	,	PUNCT
aji-159	300	3	d.	d.	PROPN
aji-159	300	4	a.	a.	PROPN
aji-159	300	5	,	,	PUNCT
aji-159	300	6	cossi	cossi	PROPN
aji-159	300	7	,	,	PUNCT
aji-159	300	8	a.	a.	NOUN
aji-159	300	9	a.	a.	PROPN
aji-159	300	10	,	,	PUNCT
aji-159	300	11	angelo	angelo	PROPN
aji-159	300	12	,	,	PUNCT
aji-159	300	13	a.	a.	PROPN
aji-159	300	14	c.	c.	PROPN
aji-159	300	15	,	,	PUNCT
aji-159	300	16	kadidjatou	kadidjatou	PROPN
aji-159	300	17	,	,	PUNCT
aji-159	300	18	s.	s.	PROPN
aji-159	300	19	,	,	PUNCT
aji-159	300	20	serge	serge	PROPN
aji-159	300	21	,	,	PUNCT
aji-159	300	22	a.	a.	NOUN
aji-159	300	23	,	,	PUNCT
aji-159	300	24	séraphin	séraphin	PROPN
aji-159	300	25	,	,	PUNCT
aji-159	300	26	a.	a.	NOUN
aji-159	300	27	,	,	PUNCT
aji-159	300	28	jivather	jivather	PROPN
aji-159	300	29	,	,	PUNCT
aji-159	300	30	d.	d.	PROPN
aji-159	300	31	,	,	PUNCT
aji-159	300	32	francis	francis	PROPN
aji-159	300	33	,	,	PUNCT
aji-159	300	34	t.	t.	PROPN
aji-159	300	35	t.	t.	PROPN
aji-159	300	36	,	,	PUNCT
aji-159	300	37	zannou	zannou	PROPN
aji-159	300	38	,	,	PUNCT
aji-159	300	39	d.	d.	PROPN
aji-159	300	40	m.	m.	PROPN
aji-159	300	41	,	,	PUNCT
aji-159	300	42	gabriel	gabriel	PROPN
aji-159	300	43	,	,	PUNCT
aji-159	300	44	a.	a.	PROPN
aji-159	300	45	,	,	PUNCT
aji-159	300	46	&	&	CCONJ
aji-159	300	47	fabien	fabien	PROPN
aji-159	300	48	,	,	PUNCT
aji-159	300	49	h.	h.	PROPN
aji-159	300	50	(	(	PUNCT
aji-159	300	51	2017	2017	NUM
aji-159	300	52	)	)	PUNCT
aji-159	300	53	.	.	PUNCT
aji-159	301	1	clinical	clinical	ADJ
aji-159	301	2	and	and	CCONJ
aji-159	301	3	immunological	immunological	ADJ
aji-159	301	4	characteristics	characteristic	NOUN
aji-159	301	5	in	in	ADP
aji-159	301	6	hivinfected	hivinfecte	VERB
aji-159	301	7	patients	patient	NOUN
aji-159	301	8	at	at	ADP
aji-159	301	9	the	the	DET
aji-159	301	10	treatment	treatment	NOUN
aji-159	301	11	initiation	initiation	NOUN
aji-159	301	12	at	at	ADP
aji-159	301	13	the	the	DET
aji-159	301	14	university	university	NOUN
aji-159	301	15	hospital	hospital	NOUN
aji-159	301	16	of	of	ADP
aji-159	301	17	parakou	parakou	PROPN
aji-159	301	18	(	(	PUNCT
aji-159	301	19	benin	benin	PROPN
aji-159	301	20	)	)	PUNCT
aji-159	301	21	.	.	PUNCT
aji-159	302	1	open	open	ADJ
aji-159	302	2	journal	journal	NOUN
aji-159	302	3	of	of	ADP
aji-159	302	4	immunology	immunology	NOUN
aji-159	302	5	,	,	PUNCT
aji-159	302	6	7	7	NUM
aji-159	302	7	,	,	PUNCT
aji-159	302	8	51–58	51–58	NUM
aji-159	302	9	.	.	PUNCT
aji-159	303	1	elmir	elmir	PROPN
aji-159	303	2	,	,	PUNCT
aji-159	303	3	e.	e.	PROPN
aji-159	303	4	,	,	PUNCT
aji-159	303	5	nadia	nadia	PROPN
aji-159	303	6	,	,	PUNCT
aji-159	303	7	s.	s.	PROPN
aji-159	303	8	,	,	PUNCT
aji-159	303	9	ouafae	ouafae	PROPN
aji-159	303	10	,	,	PUNCT
aji-159	303	11	b.	b.	PROPN
aji-159	303	12	,	,	PUNCT
aji-159	303	13	rajae	rajae	PROPN
aji-159	303	14	,	,	PUNCT
aji-159	303	15	m.	m.	NOUN
aji-159	303	16	,	,	PUNCT
aji-159	303	17	amina	amina	PROPN
aji-159	303	18	,	,	PUNCT
aji-159	303	19	s.	s.	PROPN
aji-159	303	20	,	,	PUNCT
aji-159	303	21	&	&	CCONJ
aji-159	303	22	rajae	rajae	PROPN
aji-159	303	23	el	el	PROPN
aji-159	303	24	,	,	PUNCT
aji-159	303	25	a.	a.	PROPN
aji-159	303	26	(	(	PUNCT
aji-159	303	27	2002	2002	NUM
aji-159	303	28	)	)	PUNCT
aji-159	303	29	.	.	PUNCT
aji-159	304	1	hiv	hiv	PROPN
aji-159	304	2	epidemiology	epidemiology	NOUN
aji-159	304	3	in	in	ADP
aji-159	304	4	morocco	morocco	PROPN
aji-159	304	5	:	:	PUNCT
aji-159	304	6	a	a	DET
aji-159	304	7	nine	nine	NUM
aji-159	304	8	-	-	PUNCT
aji-159	304	9	year	year	NOUN
aji-159	304	10	survey	survey	NOUN
aji-159	304	11	(	(	PUNCT
aji-159	304	12	1991–1999	1991–1999	NUM
aji-159	304	13	)	)	PUNCT
aji-159	304	14	.	.	PUNCT
aji-159	305	1	international	international	ADJ
aji-159	305	2	journal	journal	NOUN
aji-159	305	3	of	of	ADP
aji-159	305	4	std	std	NOUN
aji-159	305	5	&	&	CCONJ
aji-159	305	6	aids	aids	PROPN
aji-159	305	7	,	,	PUNCT
aji-159	305	8	13(12	13(12	NUM
aji-159	305	9	)	)	PUNCT
aji-159	305	10	,	,	PUNCT
aji-159	305	11	839–842	839–842	NUM
aji-159	305	12	.	.	PUNCT
aji-159	306	1	fauci	fauci	ADJ
aji-159	306	2	,	,	PUNCT
aji-159	306	3	a.	a.	PROPN
aji-159	306	4	s.	s.	PROPN
aji-159	306	5	(	(	PUNCT
aji-159	306	6	1999	1999	NUM
aji-159	306	7	)	)	PUNCT
aji-159	306	8	.	.	PUNCT
aji-159	307	1	the	the	DET
aji-159	307	2	aids	aids	PROPN
aji-159	307	3	epidemic	epidemic	NOUN
aji-159	307	4	—	—	PUNCT
aji-159	307	5	considerations	consideration	NOUN
aji-159	307	6	for	for	ADP
aji-159	307	7	the	the	DET
aji-159	307	8	21st	21st	ADJ
aji-159	307	9	century	century	NOUN
aji-159	307	10	.	.	PUNCT
aji-159	308	1	new	new	PROPN
aji-159	308	2	england	england	PROPN
aji-159	308	3	journal	journal	PROPN
aji-159	308	4	of	of	ADP
aji-159	308	5	medicine	medicine	NOUN
aji-159	308	6	,	,	PUNCT
aji-159	308	7	341(14	341(14	NUM
aji-159	308	8	)	)	PUNCT
aji-159	308	9	,	,	PUNCT
aji-159	308	10	1046–1050	1046–1050	NUM
aji-159	308	11	.	.	PUNCT
aji-159	309	1	fearon	fearon	PROPN
aji-159	309	2	,	,	PUNCT
aji-159	309	3	m.	m.	NOUN
aji-159	309	4	(	(	PUNCT
aji-159	309	5	2005	2005	NUM
aji-159	309	6	)	)	PUNCT
aji-159	309	7	.	.	PUNCT
aji-159	310	1	the	the	DET
aji-159	310	2	laboratory	laboratory	NOUN
aji-159	310	3	diagnosis	diagnosis	NOUN
aji-159	310	4	of	of	ADP
aji-159	310	5	hiv	hiv	PROPN
aji-159	310	6	infections	infection	NOUN
aji-159	310	7	.	.	PUNCT
aji-159	311	1	canadian	canadian	ADJ
aji-159	311	2	journal	journal	NOUN
aji-159	311	3	of	of	ADP
aji-159	311	4	infectious	infectious	ADJ
aji-159	311	5	diseases	disease	NOUN
aji-159	311	6	and	and	CCONJ
aji-159	311	7	medical	medical	ADJ
aji-159	311	8	microbiology	microbiology	NOUN
aji-159	311	9	,	,	PUNCT
aji-159	311	10	16(1	16(1	NUM
aji-159	311	11	)	)	PUNCT
aji-159	311	12	,	,	PUNCT
aji-159	311	13	26–30	26–30	NUM
aji-159	311	14	.	.	PUNCT
aji-159	312	1	ghrabi	ghrabi	NOUN
aji-159	312	2	,	,	PUNCT
aji-159	312	3	a.	a.	NOUN
aji-159	312	4	,	,	PUNCT
aji-159	312	5	zaied	zaie	VERB
aji-159	312	6	,	,	PUNCT
aji-159	312	7	s.	s.	PROPN
aji-159	312	8	,	,	PUNCT
aji-159	312	9	turki	turki	NOUN
aji-159	312	10	,	,	PUNCT
aji-159	312	11	j.	j.	PROPN
aji-159	312	12	k.	k.	PROPN
aji-159	312	13	,	,	PUNCT
aji-159	312	14	chamakh	chamakh	PROPN
aji-159	312	15	,	,	PUNCT
aji-159	312	16	a.	a.	PROPN
aji-159	312	17	,	,	PUNCT
aji-159	312	18	taieb	taieb	PROPN
aji-159	312	19	,	,	PUNCT
aji-159	312	20	s.	s.	PROPN
aji-159	312	21	b.	b.	PROPN
aji-159	312	22	,	,	PUNCT
aji-159	312	23	&	&	CCONJ
aji-159	312	24	bouarrouj	bouarrouj	PROPN
aji-159	312	25	,	,	PUNCT
aji-159	312	26	s.	s.	PROPN
aji-159	312	27	(	(	PUNCT
aji-159	312	28	2018	2018	NUM
aji-159	312	29	)	)	PUNCT
aji-159	312	30	.	.	PUNCT
aji-159	313	1	hiv	hiv	PROPN
aji-159	313	2	and	and	CCONJ
aji-159	313	3	hepatitis	hepatitis	PROPN
aji-159	313	4	c	c	PROPN
aji-159	313	5	virus	virus	NOUN
aji-159	313	6	infections	infection	NOUN
aji-159	313	7	and	and	CCONJ
aji-159	313	8	associated	associated	ADJ
aji-159	313	9	risk	risk	NOUN
aji-159	313	10	behaviours	behaviour	NOUN
aji-159	313	11	among	among	ADP
aji-159	313	12	injecting	inject	VERB
aji-159	313	13	drug	drug	NOUN
aji-159	313	14	users	user	NOUN
aji-159	313	15	attending	attend	VERB
aji-159	313	16	a	a	DET
aji-159	313	17	syringe	syringe	NOUN
aji-159	313	18	service	service	NOUN
aji-159	313	19	program	program	NOUN
aji-159	313	20	:	:	PUNCT
aji-159	313	21	a	a	DET
aji-159	313	22	cross	cross	ADJ
aji-159	313	23	-	-	ADJ
aji-159	313	24	sectional	sectional	ADJ
aji-159	313	25	study	study	NOUN
aji-159	313	26	in	in	ADP
aji-159	313	27	tunis	tunis	PROPN
aji-159	313	28	,	,	PUNCT
aji-159	313	29	tunisia	tunisia	PROPN
aji-159	313	30	.	.	PUNCT
aji-159	314	1	journal	journal	PROPN
aji-159	314	2	of	of	ADP
aji-159	314	3	virus	virus	NOUN
aji-159	314	4	eradication	eradication	NOUN
aji-159	314	5	,	,	PUNCT
aji-159	314	6	4	4	NUM
aji-159	314	7	,	,	PUNCT
aji-159	314	8	24–25	24–25	NUM
aji-159	314	9	.	.	PUNCT
aji-159	315	1	gruters	gruter	NOUN
aji-159	315	2	,	,	PUNCT
aji-159	315	3	r.	r.	PROPN
aji-159	315	4	a.	a.	PROPN
aji-159	315	5	,	,	PUNCT
aji-159	315	6	neefjes	neefjes	PROPN
aji-159	315	7	,	,	PUNCT
aji-159	315	8	j.	j.	PROPN
aji-159	315	9	j.	j.	PROPN
aji-159	315	10	,	,	PUNCT
aji-159	315	11	tersmette	tersmette	NOUN
aji-159	315	12	,	,	PUNCT
aji-159	315	13	m.	m.	NOUN
aji-159	315	14	,	,	PUNCT
aji-159	315	15	de	de	PROPN
aji-159	315	16	goede	goede	PROPN
aji-159	315	17	,	,	PUNCT
aji-159	315	18	r.	r.	PROPN
aji-159	315	19	e.	e.	PROPN
aji-159	315	20	,	,	PUNCT
aji-159	315	21	tulp	tulp	PROPN
aji-159	315	22	,	,	PUNCT
aji-159	315	23	a.	a.	NOUN
aji-159	315	24	,	,	PUNCT
aji-159	315	25	huisman	huisman	PROPN
aji-159	315	26	,	,	PUNCT
aji-159	315	27	h.	h.	PROPN
aji-159	315	28	g.	g.	PROPN
aji-159	315	29	,	,	PUNCT
aji-159	315	30	miedema	miedema	PROPN
aji-159	315	31	,	,	PUNCT
aji-159	315	32	f.	f.	PROPN
aji-159	315	33	,	,	PUNCT
aji-159	315	34	&	&	CCONJ
aji-159	315	35	ploegh	ploegh	VERB
aji-159	315	36	,	,	PUNCT
aji-159	315	37	h.	h.	PROPN
aji-159	315	38	l.	l.	PROPN
aji-159	315	39	(	(	PUNCT
aji-159	315	40	1987	1987	NUM
aji-159	315	41	)	)	PUNCT
aji-159	315	42	.	.	PUNCT
aji-159	316	1	interference	interference	NOUN
aji-159	316	2	with	with	ADP
aji-159	316	3	hiv	hiv	NOUN
aji-159	316	4	-	-	PUNCT
aji-159	316	5	induced	induce	VERB
aji-159	316	6	syncytium	syncytium	NOUN
aji-159	316	7	formation	formation	NOUN
aji-159	316	8	and	and	CCONJ
aji-159	316	9	viral	viral	ADJ
aji-159	316	10	infectivity	infectivity	NOUN
aji-159	316	11	by	by	ADP
aji-159	316	12	inhibitors	inhibitor	NOUN
aji-159	316	13	of	of	ADP
aji-159	316	14	trimming	trim	VERB
aji-159	316	15	glucosidase	glucosidase	NOUN
aji-159	316	16	.	.	PUNCT
aji-159	317	1	nature	nature	NOUN
aji-159	317	2	,	,	PUNCT
aji-159	317	3	330(6143	330(6143	NOUN
aji-159	317	4	)	)	PUNCT
aji-159	317	5	,	,	PUNCT
aji-159	317	6	74–77	74–77	NOUN
aji-159	317	7	.	.	PUNCT
aji-159	318	1	gökengin	gökengin	NOUN
aji-159	318	2	,	,	PUNCT
aji-159	318	3	d.	d.	PROPN
aji-159	318	4	,	,	PUNCT
aji-159	318	5	doroudi	doroudi	PROPN
aji-159	318	6	,	,	PUNCT
aji-159	318	7	f.	f.	PROPN
aji-159	318	8	,	,	PUNCT
aji-159	318	9	tohme	tohme	PROPN
aji-159	318	10	,	,	PUNCT
aji-159	318	11	j.	j.	PROPN
aji-159	318	12	,	,	PUNCT
aji-159	318	13	collins	collins	PROPN
aji-159	318	14	,	,	PUNCT
aji-159	318	15	b.	b.	PROPN
aji-159	318	16	,	,	PUNCT
aji-159	318	17	&	&	CCONJ
aji-159	318	18	madani	madani	PROPN
aji-159	318	19	,	,	PUNCT
aji-159	318	20	n.	n.	PROPN
aji-159	318	21	(	(	PUNCT
aji-159	318	22	2016	2016	NUM
aji-159	318	23	)	)	PUNCT
aji-159	318	24	.	.	PUNCT
aji-159	319	1	hiv	hiv	PROPN
aji-159	319	2	/	/	SYM
aji-159	319	3	aids	aids	PROPN
aji-159	319	4	:	:	PUNCT
aji-159	319	5	trends	trend	NOUN
aji-159	319	6	in	in	ADP
aji-159	319	7	the	the	DET
aji-159	319	8	middle	middle	PROPN
aji-159	319	9	east	east	PROPN
aji-159	319	10	and	and	CCONJ
aji-159	319	11	north	north	PROPN
aji-159	319	12	africa	africa	PROPN
aji-159	319	13	region	region	PROPN
aji-159	319	14	.	.	PUNCT
aji-159	320	1	international	international	ADJ
aji-159	320	2	journal	journal	NOUN
aji-159	320	3	of	of	ADP
aji-159	320	4	infectious	infectious	ADJ
aji-159	320	5	diseases	disease	NOUN
aji-159	320	6	,	,	PUNCT
aji-159	320	7	44	44	NUM
aji-159	320	8	,	,	PUNCT
aji-159	320	9	66–73	66–73	NOUN
aji-159	320	10	.	.	PUNCT
aji-159	321	1	handanagic	handanagic	PROPN
aji-159	321	2	,	,	PUNCT
aji-159	321	3	s.	s.	PROPN
aji-159	321	4	,	,	PUNCT
aji-159	321	5	bozicevic	bozicevic	PROPN
aji-159	321	6	,	,	PUNCT
aji-159	321	7	i.	i.	PROPN
aji-159	321	8	,	,	PUNCT
aji-159	321	9	civljak	civljak	PROPN
aji-159	321	10	,	,	PUNCT
aji-159	321	11	m.	m.	NOUN
aji-159	321	12	,	,	PUNCT
aji-159	321	13	dominkovic	dominkovic	PROPN
aji-159	321	14	,	,	PUNCT
aji-159	321	15	z.	z.	PROPN
aji-159	321	16	,	,	PUNCT
aji-159	321	17	sevic	sevic	PROPN
aji-159	321	18	,	,	PUNCT
aji-159	321	19	s.	s.	PROPN
aji-159	321	20	,	,	PUNCT
aji-159	321	21	barbaric	barbaric	PROPN
aji-159	321	22	,	,	PUNCT
aji-159	321	23	j.	j.	PROPN
aji-159	321	24	,	,	PUNCT
aji-159	321	25	nemeth	nemeth	PROPN
aji-159	321	26	blazic	blazic	PROPN
aji-159	321	27	,	,	PUNCT
aji-159	321	28	t.	t.	PROPN
aji-159	321	29	,	,	PUNCT
aji-159	321	30	dakovic	dakovic	PROPN
aji-159	321	31	rode	ride	VERB
aji-159	321	32	,	,	PUNCT
aji-159	321	33	o.	o.	PROPN
aji-159	321	34	,	,	PUNCT
aji-159	321	35	&	&	CCONJ
aji-159	321	36	begovac	begovac	PROPN
aji-159	321	37	,	,	PUNCT
aji-159	321	38	j.	j.	PROPN
aji-159	321	39	(	(	PUNCT
aji-159	321	40	2016	2016	NUM
aji-159	321	41	)	)	PUNCT
aji-159	321	42	.	.	PUNCT
aji-159	322	1	hiv	hiv	PROPN
aji-159	322	2	and	and	CCONJ
aji-159	322	3	hepatitis	hepatitis	PROPN
aji-159	322	4	c	c	PROPN
aji-159	322	5	khalaf	khalaf	PROPN
aji-159	322	6	;	;	PUNCT
aji-159	322	7	asian	asian	PROPN
aji-159	322	8	j.	j.	PROPN
aji-159	322	9	immunol	immunol	PROPN
aji-159	322	10	.	.	PROPN
aji-159	322	11	,	,	PUNCT
aji-159	322	12	vol	vol	NOUN
aji-159	322	13	.	.	PROPN
aji-159	322	14	8	8	NUM
aji-159	322	15	,	,	PUNCT
aji-159	322	16	no	no	INTJ
aji-159	322	17	.	.	NOUN
aji-159	322	18	1	1	NUM
aji-159	322	19	,	,	PUNCT
aji-159	322	20	pp	pp	ADJ
aji-159	322	21	.	.	PUNCT
aji-159	323	1	50	50	NUM
aji-159	323	2	-	-	SYM
aji-159	323	3	59	59	NUM
aji-159	323	4	,	,	PUNCT
aji-159	323	5	2025	2025	NUM
aji-159	323	6	;	;	PUNCT
aji-159	323	7	article	article	NOUN
aji-159	323	8	no.aji.125999	no.aji.125999	NOUN
aji-159	323	9	57	57	NUM
aji-159	323	10	prevalence	prevalence	NOUN
aji-159	323	11	,	,	PUNCT
aji-159	323	12	and	and	CCONJ
aji-159	323	13	related	related	ADJ
aji-159	323	14	risk	risk	NOUN
aji-159	323	15	behaviours	behaviour	NOUN
aji-159	323	16	among	among	ADP
aji-159	323	17	people	people	NOUN
aji-159	323	18	who	who	PRON
aji-159	323	19	inject	inject	VERB
aji-159	323	20	drugs	drug	NOUN
aji-159	323	21	in	in	ADP
aji-159	323	22	three	three	NUM
aji-159	323	23	cities	city	NOUN
aji-159	323	24	in	in	ADP
aji-159	323	25	croatia	croatia	PROPN
aji-159	323	26	:	:	PUNCT
aji-159	323	27	findings	finding	NOUN
aji-159	323	28	from	from	ADP
aji-159	323	29	respondentdriven	respondentdriven	NOUN
aji-159	323	30	sampling	sample	VERB
aji-159	323	31	surveys	survey	NOUN
aji-159	323	32	.	.	PUNCT
aji-159	324	1	international	international	ADJ
aji-159	324	2	journal	journal	PROPN
aji-159	324	3	of	of	ADP
aji-159	324	4	drug	drug	NOUN
aji-159	324	5	policy	policy	NOUN
aji-159	324	6	,	,	PUNCT
aji-159	324	7	32	32	NUM
aji-159	324	8	,	,	PUNCT
aji-159	324	9	57–63	57–63	NUM
aji-159	324	10	.	.	PUNCT
aji-159	325	1	hatzakis	hatzaki	NOUN
aji-159	325	2	,	,	PUNCT
aji-159	325	3	a.	a.	NOUN
aji-159	325	4	,	,	PUNCT
aji-159	325	5	sypsa	sypsa	NOUN
aji-159	325	6	,	,	PUNCT
aji-159	325	7	v.	v.	PROPN
aji-159	325	8	,	,	PUNCT
aji-159	325	9	paraskevis	paraskevis	PROPN
aji-159	325	10	,	,	PUNCT
aji-159	325	11	d.	d.	PROPN
aji-159	325	12	,	,	PUNCT
aji-159	325	13	nikolopoulos	nikolopoulos	PROPN
aji-159	325	14	,	,	PUNCT
aji-159	325	15	g.	g.	PROPN
aji-159	325	16	,	,	PUNCT
aji-159	325	17	tsiara	tsiara	NOUN
aji-159	325	18	,	,	PUNCT
aji-159	325	19	c.	c.	PROPN
aji-159	325	20	,	,	PUNCT
aji-159	325	21	micha	micha	PROPN
aji-159	325	22	,	,	PUNCT
aji-159	325	23	k.	k.	PROPN
aji-159	325	24	,	,	PUNCT
aji-159	325	25	panopoulos	panopoulos	PROPN
aji-159	325	26	,	,	PUNCT
aji-159	325	27	a.	a.	NOUN
aji-159	325	28	,	,	PUNCT
aji-159	325	29	malliori	malliori	ADV
aji-159	325	30	,	,	PUNCT
aji-159	325	31	m.	m.	NOUN
aji-159	325	32	,	,	PUNCT
aji-159	325	33	psichogiou	psichogiou	NOUN
aji-159	325	34	,	,	PUNCT
aji-159	325	35	m.	m.	NOUN
aji-159	325	36	,	,	PUNCT
aji-159	325	37	pharris	pharris	PROPN
aji-159	325	38	,	,	PUNCT
aji-159	325	39	a.	a.	NOUN
aji-159	325	40	,	,	PUNCT
aji-159	325	41	wiessing	wiessing	NOUN
aji-159	325	42	,	,	PUNCT
aji-159	325	43	l.	l.	PROPN
aji-159	325	44	,	,	PUNCT
aji-159	325	45	van	van	PROPN
aji-159	325	46	de	de	X
aji-159	325	47	laar	laar	PROPN
aji-159	325	48	,	,	PUNCT
aji-159	325	49	m.	m.	NOUN
aji-159	325	50	,	,	PUNCT
aji-159	325	51	donoghoe	donoghoe	NOUN
aji-159	325	52	,	,	PUNCT
aji-159	325	53	m.	m.	NOUN
aji-159	325	54	,	,	PUNCT
aji-159	325	55	heckathorn	heckathorn	ADJ
aji-159	325	56	,	,	PUNCT
aji-159	325	57	d.	d.	PROPN
aji-159	325	58	d.	d.	PROPN
aji-159	325	59	,	,	PUNCT
aji-159	325	60	friedman	friedman	PROPN
aji-159	325	61	,	,	PUNCT
aji-159	325	62	s.	s.	PROPN
aji-159	325	63	r.	r.	PROPN
aji-159	325	64	,	,	PUNCT
aji-159	325	65	&	&	CCONJ
aji-159	325	66	des	des	PROPN
aji-159	325	67	jarlais	jarlais	PROPN
aji-159	325	68	,	,	PUNCT
aji-159	325	69	d.	d.	PROPN
aji-159	325	70	c.	c.	PROPN
aji-159	325	71	(	(	PUNCT
aji-159	325	72	2015	2015	NUM
aji-159	325	73	)	)	PUNCT
aji-159	325	74	.	.	PUNCT
aji-159	326	1	design	design	NOUN
aji-159	326	2	and	and	CCONJ
aji-159	326	3	baseline	baseline	NOUN
aji-159	326	4	findings	finding	NOUN
aji-159	326	5	of	of	ADP
aji-159	326	6	a	a	DET
aji-159	326	7	large	large	ADJ
aji-159	326	8	-	-	PUNCT
aji-159	326	9	scale	scale	NOUN
aji-159	326	10	rapid	rapid	ADJ
aji-159	326	11	response	response	NOUN
aji-159	326	12	to	to	ADP
aji-159	326	13	an	an	DET
aji-159	326	14	hiv	hiv	PROPN
aji-159	326	15	outbreak	outbreak	NOUN
aji-159	326	16	in	in	ADP
aji-159	326	17	people	people	NOUN
aji-159	326	18	who	who	PRON
aji-159	326	19	inject	inject	VERB
aji-159	326	20	drugs	drug	NOUN
aji-159	326	21	in	in	ADP
aji-159	326	22	athens	athens	PROPN
aji-159	326	23	,	,	PUNCT
aji-159	326	24	greece	greece	PROPN
aji-159	326	25	:	:	PUNCT
aji-159	326	26	the	the	DET
aji-159	326	27	aristotle	aristotle	PROPN
aji-159	326	28	programme	programme	PROPN
aji-159	326	29	.	.	PUNCT
aji-159	327	1	addiction	addiction	NOUN
aji-159	327	2	,	,	PUNCT
aji-159	327	3	110(9	110(9	NUM
aji-159	327	4	)	)	PUNCT
aji-159	327	5	,	,	PUNCT
aji-159	327	6	1453–1467	1453–1467	NUM
aji-159	327	7	.	.	PUNCT
aji-159	327	8	hunter	hunter	NOUN
aji-159	327	9	,	,	PUNCT
aji-159	327	10	d.	d.	PROPN
aji-159	327	11	j.	j.	PROPN
aji-159	327	12	(	(	PUNCT
aji-159	327	13	1993	1993	NUM
aji-159	327	14	)	)	PUNCT
aji-159	327	15	.	.	PUNCT
aji-159	328	1	aids	aid	NOUN
aji-159	328	2	in	in	ADP
aji-159	328	3	sub	sub	ADJ
aji-159	328	4	-	-	ADJ
aji-159	328	5	saharan	saharan	ADJ
aji-159	328	6	africa	africa	PROPN
aji-159	328	7	:	:	PUNCT
aji-159	328	8	the	the	DET
aji-159	328	9	epidemiology	epidemiology	NOUN
aji-159	328	10	of	of	ADP
aji-159	328	11	heterosexual	heterosexual	ADJ
aji-159	328	12	transmission	transmission	NOUN
aji-159	328	13	and	and	CCONJ
aji-159	328	14	the	the	DET
aji-159	328	15	prospects	prospect	NOUN
aji-159	328	16	for	for	ADP
aji-159	328	17	prevention	prevention	NOUN
aji-159	328	18	.	.	PUNCT
aji-159	329	1	epidemiology	epidemiology	NOUN
aji-159	329	2	,	,	PUNCT
aji-159	329	3	4(1	4(1	NUM
aji-159	329	4	)	)	PUNCT
aji-159	329	5	,	,	PUNCT
aji-159	329	6	63–72	63–72	NUM
aji-159	329	7	.	.	PUNCT
aji-159	330	1	johnston	johnston	PROPN
aji-159	330	2	,	,	PUNCT
aji-159	330	3	l.	l.	PROPN
aji-159	330	4	g.	g.	PROPN
aji-159	330	5	,	,	PUNCT
aji-159	330	6	bennani	bennani	PROPN
aji-159	330	7	,	,	PUNCT
aji-159	330	8	a.	a.	NOUN
aji-159	330	9	,	,	PUNCT
aji-159	330	10	latifi	latifi	PROPN
aji-159	330	11	,	,	PUNCT
aji-159	330	12	a.	a.	NOUN
aji-159	330	13	,	,	PUNCT
aji-159	330	14	oumzil	oumzil	PROPN
aji-159	330	15	,	,	PUNCT
aji-159	330	16	h.	h.	PROPN
aji-159	330	17	,	,	PUNCT
aji-159	330	18	el	el	PROPN
aji-159	330	19	-	-	PUNCT
aji-159	330	20	omari	omari	PROPN
aji-159	330	21	,	,	PUNCT
aji-159	330	22	b.	b.	PROPN
aji-159	330	23	,	,	PUNCT
aji-159	330	24	el	el	PROPN
aji-159	330	25	-	-	PUNCT
aji-159	330	26	rhoufrani	rhoufrani	PROPN
aji-159	330	27	,	,	PUNCT
aji-159	330	28	f.	f.	PROPN
aji-159	330	29	,	,	PUNCT
aji-159	330	30	ouarsas	ouarsas	PROPN
aji-159	330	31	,	,	PUNCT
aji-159	330	32	l.	l.	PROPN
aji-159	330	33	,	,	PUNCT
aji-159	330	34	alami	alami	PROPN
aji-159	330	35	,	,	PUNCT
aji-159	330	36	k.	k.	PROPN
aji-159	330	37	,	,	PUNCT
aji-159	330	38	&	&	CCONJ
aji-159	330	39	el	el	PROPN
aji-159	330	40	-	-	PUNCT
aji-159	330	41	rhilani	rhilani	PROPN
aji-159	330	42	,	,	PUNCT
aji-159	330	43	h.	h.	PROPN
aji-159	330	44	(	(	PUNCT
aji-159	330	45	2013	2013	NUM
aji-159	330	46	)	)	PUNCT
aji-159	330	47	.	.	PUNCT
aji-159	331	1	using	use	VERB
aji-159	331	2	respondent	respondent	NOUN
aji-159	331	3	-	-	PUNCT
aji-159	331	4	driven	drive	VERB
aji-159	331	5	sampling	sampling	NOUN
aji-159	331	6	to	to	PART
aji-159	331	7	estimate	estimate	VERB
aji-159	331	8	hiv	hiv	PROPN
aji-159	331	9	and	and	CCONJ
aji-159	331	10	syphilis	syphilis	PROPN
aji-159	331	11	prevalence	prevalence	NOUN
aji-159	331	12	among	among	ADP
aji-159	331	13	female	female	ADJ
aji-159	331	14	sex	sex	NOUN
aji-159	331	15	workers	worker	NOUN
aji-159	331	16	in	in	ADP
aji-159	331	17	agadir	agadir	PROPN
aji-159	331	18	,	,	PUNCT
aji-159	331	19	fes	fes	NOUN
aji-159	331	20	,	,	PUNCT
aji-159	331	21	rabat	rabat	NOUN
aji-159	331	22	and	and	CCONJ
aji-159	331	23	tangier	tangy	ADJ
aji-159	331	24	,	,	PUNCT
aji-159	331	25	morocco	morocco	PROPN
aji-159	331	26	.	.	PUNCT
aji-159	332	1	sexually	sexually	ADV
aji-159	332	2	transmitted	transmit	VERB
aji-159	332	3	infections	infection	NOUN
aji-159	332	4	,	,	PUNCT
aji-159	332	5	89(suppl	89(suppl	PROPN
aji-159	332	6	1	1	NUM
aji-159	332	7	)	)	PUNCT
aji-159	332	8	,	,	PUNCT
aji-159	332	9	a180	a180	PROPN
aji-159	332	10	–	–	PUNCT
aji-159	332	11	a180	a180	PROPN
aji-159	332	12	.	.	PUNCT
aji-159	332	13	jones	jones	PROPN
aji-159	332	14	,	,	PUNCT
aji-159	332	15	h.	h.	PROPN
aji-159	332	16	s.	s.	PROPN
aji-159	332	17	,	,	PUNCT
aji-159	332	18	anderson	anderson	PROPN
aji-159	332	19	,	,	PUNCT
aji-159	332	20	r.	r.	PROPN
aji-159	332	21	l.	l.	PROPN
aji-159	332	22	,	,	PUNCT
aji-159	332	23	cust	cust	PROPN
aji-159	332	24	,	,	PUNCT
aji-159	332	25	h.	h.	PROPN
aji-159	332	26	,	,	PUNCT
aji-159	332	27	mcclelland	mcclelland	PROPN
aji-159	332	28	,	,	PUNCT
aji-159	332	29	r.	r.	PROPN
aji-159	332	30	s.	s.	PROPN
aji-159	332	31	,	,	PUNCT
aji-159	332	32	richardson	richardson	PROPN
aji-159	332	33	,	,	PUNCT
aji-159	332	34	b.	b.	PROPN
aji-159	332	35	a.	a.	PROPN
aji-159	332	36	,	,	PUNCT
aji-159	332	37	thirumurthy	thirumurthy	ADV
aji-159	332	38	,	,	PUNCT
aji-159	332	39	h.	h.	PROPN
aji-159	332	40	,	,	PUNCT
aji-159	332	41	malama	malama	PROPN
aji-159	332	42	,	,	PUNCT
aji-159	332	43	k.	k.	PROPN
aji-159	332	44	,	,	PUNCT
aji-159	332	45	hensen	hensen	PROPN
aji-159	332	46	,	,	PUNCT
aji-159	332	47	b.	b.	PROPN
aji-159	332	48	,	,	PUNCT
aji-159	332	49	platt	platt	PROPN
aji-159	332	50	,	,	PUNCT
aji-159	332	51	l.	l.	PROPN
aji-159	332	52	,	,	PUNCT
aji-159	332	53	rice	rice	PROPN
aji-159	332	54	,	,	PUNCT
aji-159	332	55	b.	b.	PROPN
aji-159	332	56	,	,	PUNCT
aji-159	332	57	cowan	cowan	PROPN
aji-159	332	58	,	,	PUNCT
aji-159	332	59	f.	f.	PROPN
aji-159	332	60	m.	m.	PROPN
aji-159	332	61	,	,	PUNCT
aji-159	332	62	imaieaton	imaieaton	PROPN
aji-159	332	63	,	,	PUNCT
aji-159	332	64	j.	j.	PROPN
aji-159	332	65	w.	w.	PROPN
aji-159	332	66	,	,	PUNCT
aji-159	332	67	hargreaves	hargreaves	PROPN
aji-159	332	68	,	,	PUNCT
aji-159	332	69	j.	j.	PROPN
aji-159	332	70	r.	r.	PROPN
aji-159	332	71	,	,	PUNCT
aji-159	332	72	&	&	CCONJ
aji-159	332	73	stevens	stevens	PROPN
aji-159	332	74	,	,	PUNCT
aji-159	332	75	o.	o.	NOUN
aji-159	332	76	(	(	PUNCT
aji-159	332	77	2023	2023	NUM
aji-159	332	78	)	)	PUNCT
aji-159	332	79	.	.	PUNCT
aji-159	333	1	hiv	hiv	PROPN
aji-159	333	2	incidence	incidence	NOUN
aji-159	333	3	among	among	ADP
aji-159	333	4	women	woman	NOUN
aji-159	333	5	engaging	engage	VERB
aji-159	333	6	in	in	ADP
aji-159	333	7	sex	sex	NOUN
aji-159	333	8	work	work	NOUN
aji-159	333	9	in	in	ADP
aji-159	333	10	sub	sub	ADJ
aji-159	333	11	-	-	ADJ
aji-159	333	12	saharan	saharan	ADJ
aji-159	333	13	africa	africa	PROPN
aji-159	333	14	:	:	PUNCT
aji-159	333	15	a	a	DET
aji-159	333	16	systematic	systematic	ADJ
aji-159	333	17	review	review	NOUN
aji-159	333	18	and	and	CCONJ
aji-159	333	19	metaanalysis	metaanalysis	NOUN
aji-159	333	20	.	.	PUNCT
aji-159	334	1	medrxiv	medrxiv	X
aji-159	334	2	.	.	PUNCT
aji-159	335	1	https://doi.org/10.1101/2023.03.23.232971	https://doi.org/10.1101/2023.03.23.232971	PROPN
aji-159	335	2	08	08	NUM
aji-159	335	3	leili	leili	PROPN
aji-159	335	4	,	,	PUNCT
aji-159	335	5	a.	a.	NOUN
aji-159	335	6	,	,	PUNCT
aji-159	335	7	nargesk	nargesk	PROPN
aji-159	335	8	,	,	PUNCT
aji-159	335	9	&	&	CCONJ
aji-159	335	10	hamid	hamid	PROPN
aji-159	335	11	,	,	PUNCT
aji-159	335	12	s.	s.	PROPN
aji-159	335	13	(	(	PUNCT
aji-159	335	14	2021	2021	NUM
aji-159	335	15	)	)	PUNCT
aji-159	335	16	.	.	PUNCT
aji-159	336	1	prevalence	prevalence	NOUN
aji-159	336	2	of	of	ADP
aji-159	336	3	hiv	hiv	PROPN
aji-159	336	4	infection	infection	NOUN
aji-159	336	5	among	among	ADP
aji-159	336	6	female	female	ADJ
aji-159	336	7	sex	sex	NOUN
aji-159	336	8	workers	worker	NOUN
aji-159	336	9	in	in	ADP
aji-159	336	10	the	the	DET
aji-159	336	11	eastern	eastern	PROPN
aji-159	336	12	mediterranean	mediterranean	PROPN
aji-159	336	13	region	region	NOUN
aji-159	336	14	countries	country	NOUN
aji-159	336	15	:	:	PUNCT
aji-159	336	16	a	a	DET
aji-159	336	17	systematic	systematic	ADJ
aji-159	336	18	review	review	NOUN
aji-159	336	19	.	.	PUNCT
aji-159	337	1	hiv	hiv	PROPN
aji-159	337	2	&	&	CCONJ
aji-159	337	3	aids	aids	PROPN
aji-159	337	4	review	review	PROPN
aji-159	337	5	.	.	PUNCT
aji-159	338	1	international	international	ADJ
aji-159	338	2	journal	journal	PROPN
aji-159	338	3	of	of	ADP
aji-159	338	4	hiv	hiv	PROPN
aji-159	338	5	-	-	PUNCT
aji-159	338	6	related	relate	VERB
aji-159	338	7	problems	problem	NOUN
aji-159	338	8	,	,	PUNCT
aji-159	338	9	20(4	20(4	NOUN
aji-159	338	10	)	)	PUNCT
aji-159	338	11	,	,	PUNCT
aji-159	338	12	235–256	235–256	NUM
aji-159	338	13	.	.	PUNCT
aji-159	339	1	lima	lima	PROPN
aji-159	339	2	,	,	PUNCT
aji-159	339	3	r.	r.	PROPN
aji-159	339	4	t.	t.	PROPN
aji-159	339	5	,	,	PUNCT
aji-159	339	6	melo	melo	PROPN
aji-159	339	7	,	,	PUNCT
aji-159	339	8	m.	m.	PROPN
aji-159	339	9	c.	c.	PROPN
aji-159	339	10	,	,	PUNCT
aji-159	339	11	&	&	CCONJ
aji-159	339	12	donalísio	donalísio	PROPN
aji-159	339	13	,	,	PUNCT
aji-159	339	14	m.	m.	PROPN
aji-159	339	15	r.	r.	PROPN
aji-159	339	16	(	(	PUNCT
aji-159	339	17	2018	2018	NUM
aji-159	339	18	)	)	PUNCT
aji-159	339	19	.	.	PUNCT
aji-159	340	1	treatment	treatment	NOUN
aji-159	340	2	abandonment	abandonment	NOUN
aji-159	340	3	among	among	ADP
aji-159	340	4	patients	patient	NOUN
aji-159	340	5	with	with	ADP
aji-159	340	6	hiv	hiv	PROPN
aji-159	340	7	infection	infection	NOUN
aji-159	340	8	in	in	ADP
aji-159	340	9	a	a	DET
aji-159	340	10	reference	reference	NOUN
aji-159	340	11	center	center	NOUN
aji-159	340	12	in	in	ADP
aji-159	340	13	southeastern	southeastern	ADJ
aji-159	340	14	brazil	brazil	PROPN
aji-159	340	15	.	.	PUNCT
aji-159	341	1	inter	inter	PROPN
aji-159	341	2	american	american	PROPN
aji-159	341	3	journal	journal	PROPN
aji-159	341	4	of	of	ADP
aji-159	341	5	medicine	medicine	NOUN
aji-159	341	6	and	and	CCONJ
aji-159	341	7	health	health	NOUN
aji-159	341	8	,	,	PUNCT
aji-159	341	9	1(1	1(1	NUM
aji-159	341	10	)	)	PUNCT
aji-159	341	11	,	,	PUNCT
aji-159	341	12	e201801005	e201801005	PROPN
aji-159	341	13	.	.	PUNCT
aji-159	342	1	luchters	luchters	PROPN
aji-159	342	2	,	,	PUNCT
aji-159	342	3	s.	s.	PROPN
aji-159	342	4	,	,	PUNCT
aji-159	342	5	chersich	chersich	PROPN
aji-159	342	6	,	,	PUNCT
aji-159	342	7	m.	m.	PROPN
aji-159	342	8	f.	f.	PROPN
aji-159	342	9	,	,	PUNCT
aji-159	342	10	rinyiru	rinyiru	PROPN
aji-159	342	11	,	,	PUNCT
aji-159	342	12	a.	a.	NOUN
aji-159	342	13	,	,	PUNCT
aji-159	342	14	barasa	barasa	PROPN
aji-159	342	15	,	,	PUNCT
aji-159	342	16	m.	m.	PROPN
aji-159	342	17	s.	s.	PROPN
aji-159	342	18	,	,	PUNCT
aji-159	342	19	king'ola	king'ola	PROPN
aji-159	342	20	,	,	PUNCT
aji-159	342	21	n.	n.	PROPN
aji-159	342	22	,	,	PUNCT
aji-159	342	23	mandaliya	mandaliya	PROPN
aji-159	342	24	,	,	PUNCT
aji-159	342	25	k.	k.	PROPN
aji-159	342	26	,	,	PUNCT
aji-159	342	27	bosire	bosire	NOUN
aji-159	342	28	,	,	PUNCT
aji-159	342	29	w.	w.	NOUN
aji-159	342	30	,	,	PUNCT
aji-159	342	31	wambugu	wambugu	PROPN
aji-159	342	32	,	,	PUNCT
aji-159	342	33	s.	s.	PROPN
aji-159	342	34	,	,	PUNCT
aji-159	342	35	mwarogo	mwarogo	NOUN
aji-159	342	36	,	,	PUNCT
aji-159	342	37	p.	p.	NOUN
aji-159	342	38	,	,	PUNCT
aji-159	342	39	&	&	CCONJ
aji-159	342	40	temmerman	temmerman	NOUN
aji-159	342	41	,	,	PUNCT
aji-159	342	42	m.	m.	NOUN
aji-159	342	43	(	(	PUNCT
aji-159	342	44	2008	2008	NUM
aji-159	342	45	)	)	PUNCT
aji-159	342	46	.	.	PUNCT
aji-159	343	1	impact	impact	NOUN
aji-159	343	2	of	of	ADP
aji-159	343	3	five	five	NUM
aji-159	343	4	years	year	NOUN
aji-159	343	5	of	of	ADP
aji-159	343	6	peer	peer	NOUN
aji-159	343	7	-	-	PUNCT
aji-159	343	8	mediated	mediate	VERB
aji-159	343	9	interventions	intervention	NOUN
aji-159	343	10	on	on	ADP
aji-159	343	11	sexual	sexual	ADJ
aji-159	343	12	behavior	behavior	NOUN
aji-159	343	13	and	and	CCONJ
aji-159	343	14	sexually	sexually	ADV
aji-159	343	15	transmitted	transmit	VERB
aji-159	343	16	infections	infection	NOUN
aji-159	343	17	among	among	ADP
aji-159	343	18	female	female	ADJ
aji-159	343	19	sex	sex	NOUN
aji-159	343	20	workers	worker	NOUN
aji-159	343	21	in	in	ADP
aji-159	343	22	mombasa	mombasa	PROPN
aji-159	343	23	,	,	PUNCT
aji-159	343	24	kenya	kenya	PROPN
aji-159	343	25	.	.	PUNCT
aji-159	344	1	bmc	bmc	ADJ
aji-159	344	2	public	public	ADJ
aji-159	344	3	health	health	NOUN
aji-159	344	4	,	,	PUNCT
aji-159	344	5	8	8	NUM
aji-159	344	6	,	,	PUNCT
aji-159	344	7	143	143	NUM
aji-159	344	8	.	.	PUNCT
aji-159	345	1	mathers	mathers	PROPN
aji-159	345	2	,	,	PUNCT
aji-159	345	3	b.	b.	PROPN
aji-159	345	4	m.	m.	PROPN
aji-159	345	5	,	,	PUNCT
aji-159	345	6	degenhardt	degenhardt	PROPN
aji-159	345	7	,	,	PUNCT
aji-159	345	8	l.	l.	PROPN
aji-159	345	9	,	,	PUNCT
aji-159	345	10	phillips	phillips	PROPN
aji-159	345	11	,	,	PUNCT
aji-159	345	12	b.	b.	PROPN
aji-159	345	13	,	,	PUNCT
aji-159	345	14	wiessing	wiessing	PROPN
aji-159	345	15	,	,	PUNCT
aji-159	345	16	l.	l.	PROPN
aji-159	345	17	,	,	PUNCT
aji-159	345	18	hickman	hickman	PROPN
aji-159	345	19	,	,	PUNCT
aji-159	345	20	m.	m.	NOUN
aji-159	345	21	,	,	PUNCT
aji-159	345	22	strathdee	strathdee	PROPN
aji-159	345	23	,	,	PUNCT
aji-159	345	24	s.	s.	PROPN
aji-159	345	25	a.	a.	PROPN
aji-159	345	26	,	,	PUNCT
aji-159	345	27	wodak	wodak	PROPN
aji-159	345	28	,	,	PUNCT
aji-159	345	29	a.	a.	NOUN
aji-159	345	30	,	,	PUNCT
aji-159	345	31	panda	panda	NOUN
aji-159	345	32	,	,	PUNCT
aji-159	345	33	s.	s.	PROPN
aji-159	345	34	,	,	PUNCT
aji-159	345	35	tyndall	tyndall	PROPN
aji-159	345	36	,	,	PUNCT
aji-159	345	37	m.	m.	NOUN
aji-159	345	38	,	,	PUNCT
aji-159	345	39	toufik	toufik	PROPN
aji-159	345	40	,	,	PUNCT
aji-159	345	41	a.	a.	NOUN
aji-159	345	42	,	,	PUNCT
aji-159	345	43	&	&	CCONJ
aji-159	345	44	mattick	mattick	PROPN
aji-159	345	45	,	,	PUNCT
aji-159	345	46	r.	r.	PROPN
aji-159	345	47	p.	p.	PROPN
aji-159	345	48	;	;	PUNCT
aji-159	345	49	2007	2007	NUM
aji-159	345	50	reference	reference	NOUN
aji-159	345	51	group	group	NOUN
aji-159	345	52	to	to	ADP
aji-159	345	53	the	the	DET
aji-159	345	54	un	un	PROPN
aji-159	345	55	on	on	ADP
aji-159	345	56	hiv	hiv	PROPN
aji-159	345	57	and	and	CCONJ
aji-159	345	58	injecting	inject	VERB
aji-159	345	59	drug	drug	NOUN
aji-159	345	60	use	use	NOUN
aji-159	345	61	.	.	PUNCT
aji-159	346	1	(	(	PUNCT
aji-159	346	2	2008	2008	NUM
aji-159	346	3	)	)	PUNCT
aji-159	346	4	.	.	PUNCT
aji-159	347	1	global	global	ADJ
aji-159	347	2	epidemiology	epidemiology	NOUN
aji-159	347	3	of	of	ADP
aji-159	347	4	injecting	inject	VERB
aji-159	347	5	drug	drug	NOUN
aji-159	347	6	use	use	NOUN
aji-159	347	7	and	and	CCONJ
aji-159	347	8	hiv	hiv	PROPN
aji-159	347	9	among	among	ADP
aji-159	347	10	people	people	NOUN
aji-159	347	11	who	who	PRON
aji-159	347	12	inject	inject	VERB
aji-159	347	13	drugs	drug	NOUN
aji-159	347	14	:	:	PUNCT
aji-159	347	15	a	a	DET
aji-159	347	16	systematic	systematic	ADJ
aji-159	347	17	review	review	NOUN
aji-159	347	18	.	.	PUNCT
aji-159	348	1	lancet	lancet	PROPN
aji-159	348	2	,	,	PUNCT
aji-159	348	3	372(9651	372(9651	NUM
aji-159	348	4	)	)	PUNCT
aji-159	348	5	,	,	PUNCT
aji-159	348	6	1733–1745	1733–1745	NUM
aji-159	348	7	.	.	PUNCT
aji-159	349	1	mirzoyan	mirzoyan	PROPN
aji-159	349	2	,	,	PUNCT
aji-159	349	3	l.	l.	PROPN
aji-159	349	4	,	,	PUNCT
aji-159	349	5	berendes	berende	NOUN
aji-159	349	6	,	,	PUNCT
aji-159	349	7	s.	s.	PROPN
aji-159	349	8	,	,	PUNCT
aji-159	349	9	jeffery	jeffery	PROPN
aji-159	349	10	,	,	PUNCT
aji-159	349	11	c.	c.	PROPN
aji-159	349	12	,	,	PUNCT
aji-159	349	13	thomson	thomson	PROPN
aji-159	349	14	,	,	PUNCT
aji-159	349	15	j.	j.	PROPN
aji-159	349	16	,	,	PUNCT
aji-159	349	17	ben	ben	PROPN
aji-159	349	18	othman	othman	PROPN
aji-159	349	19	,	,	PUNCT
aji-159	349	20	h.	h.	PROPN
aji-159	349	21	,	,	PUNCT
aji-159	349	22	danon	danon	PROPN
aji-159	349	23	,	,	PUNCT
aji-159	349	24	l.	l.	PROPN
aji-159	349	25	,	,	PUNCT
aji-159	349	26	turki	turki	NOUN
aji-159	349	27	,	,	PUNCT
aji-159	349	28	a.	a.	NOUN
aji-159	349	29	a.	a.	PROPN
aji-159	349	30	,	,	PUNCT
aji-159	349	31	saffialden	saffialden	PROPN
aji-159	349	32	,	,	PUNCT
aji-159	349	33	r.	r.	PROPN
aji-159	349	34	,	,	PUNCT
aji-159	349	35	&	&	CCONJ
aji-159	349	36	valadez	valadez	PROPN
aji-159	349	37	,	,	PUNCT
aji-159	349	38	j.	j.	PROPN
aji-159	349	39	j.	j.	PROPN
aji-159	349	40	(	(	PUNCT
aji-159	349	41	2013	2013	NUM
aji-159	349	42	)	)	PUNCT
aji-159	349	43	.	.	PUNCT
aji-159	350	1	new	new	ADJ
aji-159	350	2	evidence	evidence	NOUN
aji-159	350	3	on	on	ADP
aji-159	350	4	the	the	DET
aji-159	350	5	hiv	hiv	PROPN
aji-159	350	6	epidemic	epidemic	NOUN
aji-159	350	7	in	in	ADP
aji-159	350	8	libya	libya	PROPN
aji-159	350	9	:	:	PUNCT
aji-159	350	10	why	why	SCONJ
aji-159	350	11	countries	country	NOUN
aji-159	350	12	must	must	AUX
aji-159	350	13	implement	implement	VERB
aji-159	350	14	prevention	prevention	NOUN
aji-159	350	15	programs	program	NOUN
aji-159	350	16	among	among	ADP
aji-159	350	17	people	people	NOUN
aji-159	350	18	who	who	PRON
aji-159	350	19	inject	inject	VERB
aji-159	350	20	drugs	drug	NOUN
aji-159	350	21	.	.	PUNCT
aji-159	351	1	journal	journal	PROPN
aji-159	351	2	of	of	ADP
aji-159	351	3	acquired	acquire	VERB
aji-159	351	4	immune	immune	ADJ
aji-159	351	5	deficiency	deficiency	NOUN
aji-159	351	6	syndromes	syndrome	NOUN
aji-159	351	7	,	,	PUNCT
aji-159	351	8	62(5	62(5	NOUN
aji-159	351	9	)	)	PUNCT
aji-159	351	10	,	,	PUNCT
aji-159	351	11	577–583	577–583	NUM
aji-159	351	12	.	.	PUNCT
aji-159	352	1	mutevedzi	mutevedzi	NOUN
aji-159	352	2	,	,	PUNCT
aji-159	352	3	p.	p.	PROPN
aji-159	352	4	c.	c.	PROPN
aji-159	352	5	,	,	PUNCT
aji-159	352	6	&	&	CCONJ
aji-159	352	7	newell	newell	PROPN
aji-159	352	8	,	,	PUNCT
aji-159	352	9	m.	m.	NOUN
aji-159	352	10	l.	l.	PROPN
aji-159	352	11	(	(	PUNCT
aji-159	352	12	2014	2014	NUM
aji-159	352	13	)	)	PUNCT
aji-159	352	14	.	.	PUNCT
aji-159	353	1	the	the	DET
aji-159	353	2	changing	change	VERB
aji-159	353	3	face	face	NOUN
aji-159	353	4	of	of	ADP
aji-159	353	5	the	the	DET
aji-159	353	6	hiv	hiv	PROPN
aji-159	353	7	epidemic	epidemic	NOUN
aji-159	353	8	in	in	ADP
aji-159	353	9	subsaharan	subsaharan	PROPN
aji-159	353	10	africa	africa	PROPN
aji-159	353	11	.	.	PUNCT
aji-159	354	1	tropical	tropical	ADJ
aji-159	354	2	medicine	medicine	PROPN
aji-159	354	3	&	&	CCONJ
aji-159	354	4	international	international	PROPN
aji-159	354	5	health	health	PROPN
aji-159	354	6	,	,	PUNCT
aji-159	354	7	19	19	NUM
aji-159	354	8	,	,	PUNCT
aji-159	354	9	1015–1028	1015–1028	NUM
aji-159	354	10	.	.	PUNCT
aji-159	354	11	naif	naif	NOUN
aji-159	354	12	,	,	PUNCT
aji-159	354	13	h.	h.	PROPN
aji-159	354	14	m.	m.	NOUN
aji-159	354	15	(	(	PUNCT
aji-159	354	16	2013	2013	NUM
aji-159	354	17	)	)	PUNCT
aji-159	354	18	.	.	PUNCT
aji-159	355	1	pathogenesis	pathogenesis	NOUN
aji-159	355	2	of	of	ADP
aji-159	355	3	hiv	hiv	PROPN
aji-159	355	4	infection	infection	NOUN
aji-159	355	5	.	.	PUNCT
aji-159	356	1	infectious	infectious	ADJ
aji-159	356	2	disease	disease	NOUN
aji-159	356	3	reports	report	VERB
aji-159	356	4	,	,	PUNCT
aji-159	356	5	5(s1	5(s1	NUM
aji-159	356	6	)	)	PUNCT
aji-159	356	7	,	,	PUNCT
aji-159	356	8	e6	e6	PROPN
aji-159	356	9	.	.	PUNCT
aji-159	357	1	oliveira	oliveira	PROPN
aji-159	357	2	-	-	PUNCT
aji-159	357	3	filho	filho	PROPN
aji-159	357	4	,	,	PUNCT
aji-159	357	5	a.	a.	PROPN
aji-159	357	6	b.	b.	PROPN
aji-159	357	7	,	,	PUNCT
aji-159	357	8	silva	silva	PROPN
aji-159	357	9	,	,	PUNCT
aji-159	357	10	f.	f.	PROPN
aji-159	357	11	q.	q.	PROPN
aji-159	357	12	,	,	PUNCT
aji-159	357	13	santos	santos	PROPN
aji-159	357	14	,	,	PUNCT
aji-159	357	15	f.	f.	PROPN
aji-159	357	16	j.	j.	PROPN
aji-159	357	17	a.	a.	PROPN
aji-159	357	18	,	,	PUNCT
aji-159	357	19	cardoso	cardoso	PROPN
aji-159	357	20	,	,	PUNCT
aji-159	357	21	y.	y.	PROPN
aji-159	357	22	m.	m.	PROPN
aji-159	357	23	n.	n.	PROPN
aji-159	357	24	,	,	PUNCT
aji-159	357	25	di	di	PROPN
aji-159	357	26	miceli	miceli	PROPN
aji-159	357	27	,	,	PUNCT
aji-159	357	28	j.	j.	PROPN
aji-159	357	29	f.	f.	PROPN
aji-159	357	30	f.	f.	PROPN
aji-159	357	31	,	,	PUNCT
aji-159	357	32	resque	resque	NOUN
aji-159	357	33	,	,	PUNCT
aji-159	357	34	r.	r.	PROPN
aji-159	357	35	l.	l.	PROPN
aji-159	357	36	,	,	PUNCT
aji-159	357	37	silva	silva	PROPN
aji-159	357	38	-	-	PUNCT
aji-159	357	39	oliveira	oliveira	PROPN
aji-159	357	40	,	,	PUNCT
aji-159	357	41	g.	g.	PROPN
aji-159	357	42	c.	c.	PROPN
aji-159	357	43	,	,	PUNCT
aji-159	357	44	martins	martins	PROPN
aji-159	357	45	,	,	PUNCT
aji-159	357	46	l.	l.	PROPN
aji-159	357	47	c.	c.	PROPN
aji-159	357	48	,	,	PUNCT
aji-159	357	49	pinheiro	pinheiro	PROPN
aji-159	357	50	,	,	PUNCT
aji-159	357	51	l.	l.	PROPN
aji-159	357	52	m.	m.	PROPN
aji-159	357	53	l.	l.	PROPN
aji-159	357	54	,	,	PUNCT
aji-159	357	55	machado	machado	PROPN
aji-159	357	56	,	,	PUNCT
aji-159	357	57	l.	l.	PROPN
aji-159	357	58	f.	f.	PROPN
aji-159	357	59	a.	a.	PROPN
aji-159	357	60	,	,	PUNCT
aji-159	357	61	pinto	pinto	NOUN
aji-159	357	62	,	,	PUNCT
aji-159	357	63	a.	a.	PROPN
aji-159	357	64	r.	r.	PROPN
aji-159	357	65	,	,	PUNCT
aji-159	357	66	lemos	lemos	PROPN
aji-159	357	67	,	,	PUNCT
aji-159	357	68	j.	j.	PROPN
aji-159	357	69	a.	a.	PROPN
aji-159	357	70	r.	r.	PROPN
aji-159	357	71	,	,	PUNCT
aji-159	357	72	fischer	fischer	PROPN
aji-159	357	73	,	,	PUNCT
aji-159	357	74	b.	b.	PROPN
aji-159	357	75	,	,	PUNCT
aji-159	357	76	&	&	CCONJ
aji-159	357	77	kupek	kupek	PROPN
aji-159	357	78	,	,	PUNCT
aji-159	357	79	e.	e.	PROPN
aji-159	357	80	(	(	PUNCT
aji-159	357	81	2020	2020	NUM
aji-159	357	82	)	)	PUNCT
aji-159	357	83	.	.	PUNCT
aji-159	358	1	prevalence	prevalence	NOUN
aji-159	358	2	and	and	CCONJ
aji-159	358	3	risk	risk	NOUN
aji-159	358	4	factors	factor	NOUN
aji-159	358	5	for	for	ADP
aji-159	358	6	hiv-1	hiv-1	ADJ
aji-159	358	7	infection	infection	NOUN
aji-159	358	8	in	in	ADP
aji-159	358	9	people	people	NOUN
aji-159	358	10	who	who	PRON
aji-159	358	11	use	use	VERB
aji-159	358	12	illicit	illicit	ADJ
aji-159	358	13	drugs	drug	NOUN
aji-159	358	14	in	in	ADP
aji-159	358	15	northern	northern	ADJ
aji-159	358	16	brazil	brazil	PROPN
aji-159	358	17	.	.	PUNCT
aji-159	359	1	transactions	transaction	NOUN
aji-159	359	2	of	of	ADP
aji-159	359	3	the	the	DET
aji-159	359	4	royal	royal	ADJ
aji-159	359	5	society	society	NOUN
aji-159	359	6	of	of	ADP
aji-159	359	7	tropical	tropical	ADJ
aji-159	359	8	medicine	medicine	NOUN
aji-159	359	9	and	and	CCONJ
aji-159	359	10	hygiene	hygiene	NOUN
aji-159	359	11	,	,	PUNCT
aji-159	359	12	114(3	114(3	NUM
aji-159	359	13	)	)	PUNCT
aji-159	359	14	,	,	PUNCT
aji-159	359	15	213–221	213–221	NUM
aji-159	359	16	.	.	PUNCT
aji-159	360	1	paz	paz	NOUN
aji-159	360	2	-	-	PUNCT
aji-159	360	3	bailey	bailey	NOUN
aji-159	360	4	,	,	PUNCT
aji-159	360	5	g.	g.	PROPN
aji-159	360	6	,	,	PUNCT
aji-159	360	7	noble	noble	ADJ
aji-159	360	8	,	,	PUNCT
aji-159	360	9	m.	m.	NOUN
aji-159	360	10	,	,	PUNCT
aji-159	360	11	salo	salo	PROPN
aji-159	360	12	,	,	PUNCT
aji-159	360	13	k.	k.	PROPN
aji-159	360	14	,	,	PUNCT
aji-159	360	15	&	&	CCONJ
aji-159	360	16	tregear	tregear	PROPN
aji-159	360	17	,	,	PUNCT
aji-159	360	18	s.	s.	PROPN
aji-159	360	19	j.	j.	PROPN
aji-159	360	20	(	(	PUNCT
aji-159	360	21	2016	2016	NUM
aji-159	360	22	)	)	PUNCT
aji-159	360	23	.	.	PUNCT
aji-159	361	1	prevalence	prevalence	NOUN
aji-159	361	2	of	of	ADP
aji-159	361	3	hiv	hiv	PROPN
aji-159	361	4	among	among	ADP
aji-159	361	5	u.s	u.s	PROPN
aji-159	361	6	.	.	PROPN
aji-159	361	7	female	female	ADJ
aji-159	361	8	sex	sex	NOUN
aji-159	361	9	workers	worker	NOUN
aji-159	361	10	:	:	PUNCT
aji-159	361	11	systematic	systematic	ADJ
aji-159	361	12	review	review	NOUN
aji-159	361	13	and	and	CCONJ
aji-159	361	14	meta	meta	ADJ
aji-159	361	15	-	-	PUNCT
aji-159	361	16	analysis	analysis	NOUN
aji-159	361	17	.	.	PUNCT
aji-159	362	1	aids	aid	NOUN
aji-159	362	2	and	and	CCONJ
aji-159	362	3	behavior	behavior	NOUN
aji-159	362	4	,	,	PUNCT
aji-159	362	5	20(10	20(10	NUM
aji-159	362	6	)	)	PUNCT
aji-159	362	7	,	,	PUNCT
aji-159	362	8	2318–2331	2318–2331	NUM
aji-159	362	9	.	.	PUNCT
aji-159	363	1	peters	peters	PROPN
aji-159	363	2	,	,	PUNCT
aji-159	363	3	p.	p.	PROPN
aji-159	363	4	j.	j.	PROPN
aji-159	363	5	,	,	PUNCT
aji-159	363	6	pontones	pontone	NOUN
aji-159	363	7	,	,	PUNCT
aji-159	363	8	p.	p.	NOUN
aji-159	363	9	,	,	PUNCT
aji-159	363	10	hoover	hoover	PROPN
aji-159	363	11	,	,	PUNCT
aji-159	363	12	k.	k.	PROPN
aji-159	363	13	w.	w.	PROPN
aji-159	363	14	,	,	PUNCT
aji-159	363	15	patel	patel	PROPN
aji-159	363	16	,	,	PUNCT
aji-159	363	17	m.	m.	PROPN
aji-159	363	18	r.	r.	PROPN
aji-159	363	19	,	,	PUNCT
aji-159	363	20	galang	galang	PROPN
aji-159	363	21	,	,	PUNCT
aji-159	363	22	r.	r.	PROPN
aji-159	363	23	r.	r.	PROPN
aji-159	363	24	,	,	PUNCT
aji-159	363	25	shields	shield	NOUN
aji-159	363	26	,	,	PUNCT
aji-159	363	27	j.	j.	PROPN
aji-159	363	28	,	,	PUNCT
aji-159	363	29	blosser	blosser	NOUN
aji-159	363	30	,	,	PUNCT
aji-159	363	31	s.	s.	PROPN
aji-159	363	32	j.	j.	PROPN
aji-159	363	33	,	,	PUNCT
aji-159	363	34	spiller	spiller	NOUN
aji-159	363	35	,	,	PUNCT
aji-159	363	36	m.	m.	PROPN
aji-159	363	37	w.	w.	PROPN
aji-159	363	38	,	,	PUNCT
aji-159	363	39	combs	combs	PROPN
aji-159	363	40	,	,	PUNCT
aji-159	363	41	b.	b.	PROPN
aji-159	363	42	,	,	PUNCT
aji-159	363	43	switzer	switzer	PROPN
aji-159	363	44	,	,	PUNCT
aji-159	363	45	w.	w.	PROPN
aji-159	363	46	m.	m.	PROPN
aji-159	363	47	,	,	PUNCT
aji-159	363	48	conrad	conrad	PROPN
aji-159	363	49	,	,	PUNCT
aji-159	363	50	c.	c.	PROPN
aji-159	363	51	,	,	PUNCT
aji-159	363	52	gentry	gentry	NOUN
aji-159	363	53	,	,	PUNCT
aji-159	363	54	j.	j.	PROPN
aji-159	363	55	,	,	PUNCT
aji-159	363	56	khudyakov	khudyakov	PROPN
aji-159	363	57	,	,	PUNCT
aji-159	363	58	y.	y.	PROPN
aji-159	363	59	,	,	PUNCT
aji-159	363	60	waterhouse	waterhouse	PROPN
aji-159	363	61	,	,	PUNCT
aji-159	363	62	d.	d.	PROPN
aji-159	363	63	,	,	PUNCT
aji-159	363	64	owen	owen	PROPN
aji-159	363	65	,	,	PUNCT
aji-159	363	66	s.	s.	PROPN
aji-159	363	67	m.	m.	PROPN
aji-159	363	68	,	,	PUNCT
aji-159	363	69	chapman	chapman	PROPN
aji-159	363	70	,	,	PUNCT
aji-159	363	71	e.	e.	PROPN
aji-159	363	72	,	,	PUNCT
aji-159	363	73	roseberry	roseberry	PROPN
aji-159	363	74	,	,	PUNCT
aji-159	363	75	j.	j.	PROPN
aji-159	363	76	c.	c.	PROPN
aji-159	363	77	,	,	PUNCT
aji-159	363	78	mccants	mccant	NOUN
aji-159	363	79	,	,	PUNCT
aji-159	363	80	v.	v.	PROPN
aji-159	363	81	,	,	PUNCT
aji-159	363	82	weidle	weidle	NOUN
aji-159	363	83	,	,	PUNCT
aji-159	363	84	p.	p.	PROPN
aji-159	363	85	j.	j.	PROPN
aji-159	363	86	,	,	PUNCT
aji-159	363	87	...	...	PUNCT
aji-159	364	1	duwve	duwve	PROPN
aji-159	364	2	,	,	PUNCT
aji-159	364	3	j.	j.	PROPN
aji-159	364	4	m.	m.	PROPN
aji-159	364	5	(	(	PUNCT
aji-159	364	6	2016	2016	NUM
aji-159	364	7	)	)	PUNCT
aji-159	364	8	.	.	PUNCT
aji-159	365	1	hiv	hiv	PROPN
aji-159	365	2	infection	infection	NOUN
aji-159	365	3	linked	link	VERB
aji-159	365	4	to	to	ADP
aji-159	365	5	injection	injection	NOUN
aji-159	365	6	use	use	NOUN
aji-159	365	7	of	of	ADP
aji-159	365	8	oxymorphone	oxymorphone	NOUN
aji-159	365	9	in	in	ADP
aji-159	365	10	indiana	indiana	PROPN
aji-159	365	11	,	,	PUNCT
aji-159	365	12	2014–2015	2014–2015	NUM
aji-159	365	13	.	.	PUNCT
aji-159	366	1	the	the	DET
aji-159	366	2	new	new	PROPN
aji-159	366	3	england	england	PROPN
aji-159	366	4	journal	journal	PROPN
aji-159	366	5	of	of	ADP
aji-159	366	6	medicine	medicine	NOUN
aji-159	366	7	,	,	PUNCT
aji-159	366	8	375(3	375(3	NUM
aji-159	366	9	)	)	PUNCT
aji-159	366	10	,	,	PUNCT
aji-159	366	11	229–239	229–239	NUM
aji-159	366	12	.	.	PUNCT
aji-159	367	1	platt	platt	PROPN
aji-159	367	2	,	,	PUNCT
aji-159	367	3	l.	l.	PROPN
aji-159	367	4	,	,	PUNCT
aji-159	367	5	bobrova	bobrova	PROPN
aji-159	367	6	,	,	PUNCT
aji-159	367	7	n.	n.	PROPN
aji-159	367	8	,	,	PUNCT
aji-159	367	9	rhodes	rhode	NOUN
aji-159	367	10	,	,	PUNCT
aji-159	367	11	t.	t.	NOUN
aji-159	367	12	,	,	PUNCT
aji-159	367	13	uusküla	uusküla	ADJ
aji-159	367	14	,	,	PUNCT
aji-159	367	15	a.	a.	NOUN
aji-159	367	16	,	,	PUNCT
aji-159	367	17	parry	parry	PROPN
aji-159	367	18	,	,	PUNCT
aji-159	367	19	j.	j.	PROPN
aji-159	367	20	v.	v.	PROPN
aji-159	367	21	,	,	PUNCT
aji-159	367	22	rüütel	rüütel	NOUN
aji-159	367	23	,	,	PUNCT
aji-159	367	24	k.	k.	PROPN
aji-159	367	25	,	,	PUNCT
aji-159	367	26	talu	talu	PROPN
aji-159	367	27	,	,	PUNCT
aji-159	367	28	a.	a.	PROPN
aji-159	367	29	,	,	PUNCT
aji-159	367	30	abel	abel	PROPN
aji-159	367	31	,	,	PUNCT
aji-159	367	32	k.	k.	PROPN
aji-159	367	33	,	,	PUNCT
aji-159	367	34	rajaleid	rajaleid	NOUN
aji-159	367	35	,	,	PUNCT
aji-159	367	36	k.	k.	PROPN
aji-159	367	37	,	,	PUNCT
aji-159	367	38	&	&	CCONJ
aji-159	367	39	judd	judd	PROPN
aji-159	367	40	,	,	PUNCT
aji-159	367	41	a.	a.	PROPN
aji-159	367	42	(	(	PUNCT
aji-159	367	43	2006	2006	NUM
aji-159	367	44	)	)	PUNCT
aji-159	367	45	.	.	PUNCT
aji-159	368	1	high	high	ADJ
aji-159	368	2	hiv	hiv	PROPN
aji-159	368	3	prevalence	prevalence	NOUN
aji-159	368	4	among	among	ADP
aji-159	368	5	injecting	inject	VERB
aji-159	368	6	drug	drug	NOUN
aji-159	368	7	users	user	NOUN
aji-159	368	8	in	in	ADP
aji-159	368	9	estonia	estonia	PROPN
aji-159	368	10	:	:	PUNCT
aji-159	368	11	implications	implication	NOUN
aji-159	368	12	for	for	ADP
aji-159	368	13	understanding	understand	VERB
aji-159	368	14	the	the	DET
aji-159	368	15	khalaf	khalaf	PROPN
aji-159	368	16	;	;	PUNCT
aji-159	368	17	asian	asian	PROPN
aji-159	368	18	j.	j.	PROPN
aji-159	368	19	immunol	immunol	PROPN
aji-159	368	20	.	.	PROPN
aji-159	368	21	,	,	PUNCT
aji-159	368	22	vol	vol	NOUN
aji-159	368	23	.	.	PROPN
aji-159	368	24	8	8	NUM
aji-159	368	25	,	,	PUNCT
aji-159	368	26	no	no	INTJ
aji-159	368	27	.	.	NOUN
aji-159	368	28	1	1	NUM
aji-159	368	29	,	,	PUNCT
aji-159	368	30	pp	pp	ADJ
aji-159	368	31	.	.	PUNCT
aji-159	369	1	50	50	NUM
aji-159	369	2	-	-	SYM
aji-159	369	3	59	59	NUM
aji-159	369	4	,	,	PUNCT
aji-159	369	5	2025	2025	NUM
aji-159	369	6	;	;	PUNCT
aji-159	369	7	article	article	NOUN
aji-159	369	8	no.aji.125999	no.aji.125999	NOUN
aji-159	369	9	58	58	NUM
aji-159	369	10	risk	risk	NOUN
aji-159	369	11	environment	environment	NOUN
aji-159	369	12	.	.	PUNCT
aji-159	370	1	aids	aids	PROPN
aji-159	370	2	,	,	PUNCT
aji-159	370	3	20(16	20(16	NUM
aji-159	370	4	)	)	PUNCT
aji-159	370	5	,	,	PUNCT
aji-159	370	6	2120	2120	NUM
aji-159	370	7	–	–	PUNCT
aji-159	370	8	2123	2123	NUM
aji-159	370	9	.	.	PUNCT
aji-159	371	1	rashti	rashti	NOUN
aji-159	371	2	,	,	PUNCT
aji-159	371	3	r.	r.	PROPN
aji-159	371	4	,	,	PUNCT
aji-159	371	5	sharafi	sharafi	PROPN
aji-159	371	6	,	,	PUNCT
aji-159	371	7	h.	h.	PROPN
aji-159	371	8	,	,	PUNCT
aji-159	371	9	alavian	alavian	PROPN
aji-159	371	10	,	,	PUNCT
aji-159	371	11	s.	s.	PROPN
aji-159	371	12	m.	m.	PROPN
aji-159	371	13	,	,	PUNCT
aji-159	371	14	moradi	moradi	NOUN
aji-159	371	15	,	,	PUNCT
aji-159	371	16	y.	y.	NOUN
aji-159	371	17	,	,	PUNCT
aji-159	371	18	mohamadi	mohamadi	NOUN
aji-159	371	19	bolbanabad	bolbanabad	NOUN
aji-159	371	20	,	,	PUNCT
aji-159	371	21	a.	a.	NOUN
aji-159	371	22	,	,	PUNCT
aji-159	371	23	&	&	CCONJ
aji-159	371	24	moradi	moradi	PROPN
aji-159	371	25	,	,	PUNCT
aji-159	371	26	g.	g.	PROPN
aji-159	371	27	(	(	PUNCT
aji-159	371	28	2020	2020	NUM
aji-159	371	29	)	)	PUNCT
aji-159	371	30	.	.	PUNCT
aji-159	372	1	systematic	systematic	ADJ
aji-159	372	2	review	review	NOUN
aji-159	372	3	and	and	CCONJ
aji-159	372	4	metaanalysis	metaanalysis	NOUN
aji-159	372	5	of	of	ADP
aji-159	372	6	global	global	ADJ
aji-159	372	7	prevalence	prevalence	NOUN
aji-159	372	8	of	of	ADP
aji-159	372	9	hbsag	hbsag	NOUN
aji-159	372	10	and	and	CCONJ
aji-159	372	11	hiv	hiv	PROPN
aji-159	372	12	and	and	CCONJ
aji-159	372	13	hcv	hcv	PROPN
aji-159	372	14	antibodies	antibody	NOUN
aji-159	372	15	among	among	ADP
aji-159	372	16	people	people	NOUN
aji-159	372	17	who	who	PRON
aji-159	372	18	inject	inject	VERB
aji-159	372	19	drugs	drug	NOUN
aji-159	372	20	and	and	CCONJ
aji-159	372	21	female	female	ADJ
aji-159	372	22	sex	sex	NOUN
aji-159	372	23	workers	worker	NOUN
aji-159	372	24	.	.	PUNCT
aji-159	373	1	pathogens	pathogen	NOUN
aji-159	373	2	,	,	PUNCT
aji-159	373	3	9(6	9(6	NUM
aji-159	373	4	)	)	PUNCT
aji-159	373	5	,	,	PUNCT
aji-159	373	6	432	432	X
aji-159	373	7	.	.	PUNCT
aji-159	374	1	royce	royce	PROPN
aji-159	374	2	,	,	PUNCT
aji-159	374	3	r.	r.	PROPN
aji-159	374	4	a.	a.	PROPN
aji-159	374	5	,	,	PUNCT
aji-159	374	6	seña	seña	PROPN
aji-159	374	7	,	,	PUNCT
aji-159	374	8	a.	a.	NOUN
aji-159	374	9	,	,	PUNCT
aji-159	374	10	cates	cat	VERB
aji-159	374	11	,	,	PUNCT
aji-159	374	12	w.	w.	PROPN
aji-159	374	13	,	,	PUNCT
aji-159	374	14	jr	jr	PROPN
aji-159	374	15	.	.	PROPN
aji-159	374	16	,	,	PUNCT
aji-159	374	17	&	&	CCONJ
aji-159	374	18	cohen	cohen	PROPN
aji-159	374	19	,	,	PUNCT
aji-159	374	20	m.	m.	PROPN
aji-159	374	21	s.	s.	PROPN
aji-159	374	22	(	(	PUNCT
aji-159	374	23	1997	1997	NUM
aji-159	374	24	)	)	PUNCT
aji-159	374	25	.	.	PUNCT
aji-159	375	1	sexual	sexual	ADJ
aji-159	375	2	transmission	transmission	NOUN
aji-159	375	3	of	of	ADP
aji-159	375	4	hiv	hiv	PROPN
aji-159	375	5	.	.	PUNCT
aji-159	376	1	the	the	DET
aji-159	376	2	new	new	PROPN
aji-159	376	3	england	england	PROPN
aji-159	376	4	journal	journal	PROPN
aji-159	376	5	of	of	ADP
aji-159	376	6	medicine	medicine	NOUN
aji-159	376	7	,	,	PUNCT
aji-159	376	8	336(15	336(15	NUM
aji-159	376	9	)	)	PUNCT
aji-159	376	10	,	,	PUNCT
aji-159	376	11	1072–1078	1072–1078	NUM
aji-159	376	12	.	.	PUNCT
aji-159	377	1	soliman	soliman	PROPN
aji-159	377	2	,	,	PUNCT
aji-159	377	3	c.	c.	PROPN
aji-159	377	4	,	,	PUNCT
aji-159	377	5	rahman	rahman	PROPN
aji-159	377	6	,	,	PUNCT
aji-159	377	7	i.	i.	PROPN
aji-159	377	8	a.	a.	PROPN
aji-159	377	9	,	,	PUNCT
aji-159	377	10	shawky	shawky	PROPN
aji-159	377	11	,	,	PUNCT
aji-159	377	12	s.	s.	PROPN
aji-159	377	13	,	,	PUNCT
aji-159	377	14	bahaa	bahaa	NOUN
aji-159	377	15	,	,	PUNCT
aji-159	377	16	t.	t.	PROPN
aji-159	377	17	,	,	PUNCT
aji-159	377	18	elkamhawi	elkamhawi	PROPN
aji-159	377	19	,	,	PUNCT
aji-159	377	20	s.	s.	PROPN
aji-159	377	21	,	,	PUNCT
aji-159	377	22	el	el	PROPN
aji-159	377	23	sattar	sattar	PROPN
aji-159	377	24	,	,	PUNCT
aji-159	377	25	a.	a.	NOUN
aji-159	377	26	a.	a.	PROPN
aji-159	377	27	,	,	PUNCT
aji-159	377	28	oraby	oraby	PROPN
aji-159	377	29	,	,	PUNCT
aji-159	377	30	d.	d.	PROPN
aji-159	377	31	,	,	PUNCT
aji-159	377	32	khaled	khaled	PROPN
aji-159	377	33	,	,	PUNCT
aji-159	377	34	d.	d.	PROPN
aji-159	377	35	,	,	PUNCT
aji-159	377	36	feyisetan	feyisetan	PROPN
aji-159	377	37	,	,	PUNCT
aji-159	377	38	b.	b.	PROPN
aji-159	377	39	,	,	PUNCT
aji-159	377	40	salah	salah	PROPN
aji-159	377	41	,	,	PUNCT
aji-159	377	42	e.	e.	PROPN
aji-159	377	43	,	,	PUNCT
aji-159	377	44	el	el	PROPN
aji-159	377	45	taher	taher	PROPN
aji-159	377	46	,	,	PUNCT
aji-159	377	47	z.	z.	PROPN
aji-159	377	48	,	,	PUNCT
aji-159	377	49	&	&	CCONJ
aji-159	377	50	el	el	PROPN
aji-159	377	51	sayed	say	VERB
aji-159	377	52	,	,	PUNCT
aji-159	377	53	n.	n.	PROPN
aji-159	377	54	(	(	PUNCT
aji-159	377	55	2010	2010	NUM
aji-159	377	56	)	)	PUNCT
aji-159	377	57	.	.	PUNCT
aji-159	378	1	hiv	hiv	PROPN
aji-159	378	2	prevalence	prevalence	NOUN
aji-159	378	3	and	and	CCONJ
aji-159	378	4	risk	risk	NOUN
aji-159	378	5	behaviors	behavior	NOUN
aji-159	378	6	of	of	ADP
aji-159	378	7	male	male	ADJ
aji-159	378	8	injection	injection	NOUN
aji-159	378	9	drug	drug	NOUN
aji-159	378	10	users	user	NOUN
aji-159	378	11	in	in	ADP
aji-159	378	12	cairo	cairo	PROPN
aji-159	378	13	,	,	PUNCT
aji-159	378	14	egypt	egypt	PROPN
aji-159	378	15	.	.	PUNCT
aji-159	379	1	aids	aids	PROPN
aji-159	379	2	,	,	PUNCT
aji-159	379	3	24(suppl	24(suppl	NUM
aji-159	379	4	2	2	NUM
aji-159	379	5	)	)	PUNCT
aji-159	379	6	,	,	PUNCT
aji-159	379	7	s33	s33	PROPN
aji-159	379	8	–	–	PUNCT
aji-159	379	9	s38	s38	NOUN
aji-159	379	10	.	.	PUNCT
aji-159	380	1	soto	soto	PROPN
aji-159	380	2	,	,	PUNCT
aji-159	380	3	r.	r.	PROPN
aji-159	380	4	j.	j.	PROPN
aji-159	380	5	,	,	PUNCT
aji-159	380	6	ghee	ghee	PROPN
aji-159	380	7	,	,	PUNCT
aji-159	380	8	a.	a.	PROPN
aji-159	380	9	e.	e.	PROPN
aji-159	380	10	,	,	PUNCT
aji-159	380	11	nunez	nunez	PROPN
aji-159	380	12	,	,	PUNCT
aji-159	380	13	c.	c.	PROPN
aji-159	380	14	a.	a.	PROPN
aji-159	380	15	,	,	PUNCT
aji-159	380	16	mayorga	mayorga	PROPN
aji-159	380	17	,	,	PUNCT
aji-159	380	18	r.	r.	PROPN
aji-159	380	19	,	,	PUNCT
aji-159	380	20	tapia	tapia	PROPN
aji-159	380	21	,	,	PUNCT
aji-159	380	22	k.	k.	PROPN
aji-159	380	23	a.	a.	PROPN
aji-159	380	24	,	,	PUNCT
aji-159	380	25	astete	astete	ADJ
aji-159	380	26	,	,	PUNCT
aji-159	380	27	s.	s.	PROPN
aji-159	380	28	g.	g.	PROPN
aji-159	380	29	,	,	PUNCT
aji-159	380	30	hughes	hughes	PROPN
aji-159	380	31	,	,	PUNCT
aji-159	380	32	j.	j.	PROPN
aji-159	380	33	p.	p.	PROPN
aji-159	380	34	,	,	PUNCT
aji-159	380	35	buffardi	buffardi	PROPN
aji-159	380	36	,	,	PUNCT
aji-159	380	37	a.	a.	PROPN
aji-159	380	38	l.	l.	PROPN
aji-159	380	39	,	,	PUNCT
aji-159	380	40	holte	holte	PROPN
aji-159	380	41	,	,	PUNCT
aji-159	380	42	s.	s.	PROPN
aji-159	380	43	e.	e.	PROPN
aji-159	380	44	,	,	PUNCT
aji-159	380	45	&	&	CCONJ
aji-159	380	46	holmes	holmes	PROPN
aji-159	380	47	,	,	PUNCT
aji-159	380	48	k.	k.	PROPN
aji-159	380	49	k.	k.	PROPN
aji-159	380	50	,	,	PUNCT
aji-159	380	51	estudio	estudio	PROPN
aji-159	380	52	multicentrico	multicentrico	PROPN
aji-159	380	53	study	study	NOUN
aji-159	380	54	team	team	NOUN
aji-159	380	55	.	.	PUNCT
aji-159	381	1	(	(	PUNCT
aji-159	381	2	2007	2007	NUM
aji-159	381	3	)	)	PUNCT
aji-159	381	4	.	.	PUNCT
aji-159	382	1	sentinel	sentinel	PROPN
aji-159	382	2	surveillance	surveillance	NOUN
aji-159	382	3	of	of	ADP
aji-159	382	4	sexually	sexually	ADV
aji-159	382	5	transmitted	transmit	VERB
aji-159	382	6	infections	infection	NOUN
aji-159	382	7	/	/	SYM
aji-159	382	8	hiv	hiv	PROPN
aji-159	382	9	and	and	CCONJ
aji-159	382	10	risk	risk	NOUN
aji-159	382	11	behaviors	behavior	NOUN
aji-159	382	12	in	in	ADP
aji-159	382	13	vulnerable	vulnerable	ADJ
aji-159	382	14	populations	population	NOUN
aji-159	382	15	in	in	ADP
aji-159	382	16	5	5	NUM
aji-159	382	17	central	central	ADJ
aji-159	382	18	american	american	ADJ
aji-159	382	19	countries	country	NOUN
aji-159	382	20	.	.	PUNCT
aji-159	383	1	journal	journal	PROPN
aji-159	383	2	of	of	ADP
aji-159	383	3	acquired	acquire	VERB
aji-159	383	4	immune	immune	ADJ
aji-159	383	5	deficiency	deficiency	NOUN
aji-159	383	6	syndromes	syndrome	NOUN
aji-159	383	7	,	,	PUNCT
aji-159	383	8	46(1	46(1	NOUN
aji-159	383	9	)	)	PUNCT
aji-159	383	10	,	,	PUNCT
aji-159	383	11	101–111	101–111	NUM
aji-159	383	12	.	.	PUNCT
aji-159	384	1	unaids	unaid	NOUN
aji-159	384	2	.	.	PUNCT
aji-159	385	1	(	(	PUNCT
aji-159	385	2	2022	2022	NUM
aji-159	385	3	)	)	PUNCT
aji-159	385	4	.	.	PUNCT
aji-159	386	1	global	global	PROPN
aji-159	386	2	hiv	hiv	PROPN
aji-159	386	3	&	&	CCONJ
aji-159	386	4	aids	aids	PROPN
aji-159	386	5	statistics	statistic	NOUN
aji-159	386	6	.	.	PUNCT
aji-159	387	1	fact	fact	NOUN
aji-159	387	2	sheet	sheet	NOUN
aji-159	387	3	.	.	PUNCT
aji-159	388	1	available	available	ADJ
aji-159	388	2	:	:	PUNCT
aji-159	388	3	http://www.communications@unaids.org/e	http://www.communications@unaids.org/e	PROPN
aji-159	388	4	n	n	CCONJ
aji-159	388	5	/	/	SYM
aji-159	388	6	resources	resource	NOUN
aji-159	388	7	/	/	SYM
aji-159	388	8	campaigns	campaign	NOUN
aji-159	388	9	/	/	SYM
aji-159	388	10	globalreport2021	globalreport2021	PROPN
aji-159	388	11	/	/	SYM
aji-159	388	12	f	f	PROPN
aji-159	388	13	actsheet	actsheet	PROPN
aji-159	388	14	valadez	valadez	PROPN
aji-159	388	15	,	,	PUNCT
aji-159	388	16	j.	j.	PROPN
aji-159	388	17	j.	j.	PROPN
aji-159	388	18	,	,	PUNCT
aji-159	388	19	berendes	berende	NOUN
aji-159	388	20	,	,	PUNCT
aji-159	388	21	s.	s.	PROPN
aji-159	388	22	,	,	PUNCT
aji-159	388	23	jeffery	jeffery	PROPN
aji-159	388	24	,	,	PUNCT
aji-159	388	25	c.	c.	PROPN
aji-159	388	26	,	,	PUNCT
aji-159	388	27	thomson	thomson	PROPN
aji-159	388	28	,	,	PUNCT
aji-159	388	29	j.	j.	PROPN
aji-159	388	30	,	,	PUNCT
aji-159	388	31	ben	ben	PROPN
aji-159	388	32	othman	othman	PROPN
aji-159	388	33	,	,	PUNCT
aji-159	388	34	h.	h.	PROPN
aji-159	388	35	,	,	PUNCT
aji-159	388	36	danon	danon	PROPN
aji-159	388	37	,	,	PUNCT
aji-159	388	38	l.	l.	PROPN
aji-159	388	39	,	,	PUNCT
aji-159	388	40	turki	turki	NOUN
aji-159	388	41	,	,	PUNCT
aji-159	388	42	a.	a.	NOUN
aji-159	388	43	a.	a.	PROPN
aji-159	388	44	,	,	PUNCT
aji-159	388	45	saffialden	saffialden	PROPN
aji-159	388	46	,	,	PUNCT
aji-159	388	47	r.	r.	PROPN
aji-159	388	48	,	,	PUNCT
aji-159	388	49	&	&	CCONJ
aji-159	388	50	mirzoyan	mirzoyan	PROPN
aji-159	388	51	,	,	PUNCT
aji-159	388	52	l.	l.	PROPN
aji-159	388	53	(	(	PUNCT
aji-159	388	54	2013	2013	NUM
aji-159	388	55	)	)	PUNCT
aji-159	388	56	.	.	PUNCT
aji-159	389	1	filling	fill	VERB
aji-159	389	2	the	the	DET
aji-159	389	3	knowledge	knowledge	NOUN
aji-159	389	4	gap	gap	NOUN
aji-159	389	5	:	:	PUNCT
aji-159	389	6	measuring	measure	VERB
aji-159	389	7	hiv	hiv	PROPN
aji-159	389	8	prevalence	prevalence	NOUN
aji-159	389	9	and	and	CCONJ
aji-159	389	10	risk	risk	NOUN
aji-159	389	11	factors	factor	NOUN
aji-159	389	12	among	among	ADP
aji-159	389	13	men	man	NOUN
aji-159	389	14	who	who	PRON
aji-159	389	15	have	have	VERB
aji-159	389	16	sex	sex	NOUN
aji-159	389	17	with	with	ADP
aji-159	389	18	men	man	NOUN
aji-159	389	19	and	and	CCONJ
aji-159	389	20	female	female	ADJ
aji-159	389	21	sex	sex	NOUN
aji-159	389	22	workers	worker	NOUN
aji-159	389	23	in	in	ADP
aji-159	389	24	tripoli	tripoli	PROPN
aji-159	389	25	,	,	PUNCT
aji-159	389	26	libya	libya	PROPN
aji-159	389	27	.	.	PUNCT
aji-159	390	1	plos	plos	PROPN
aji-159	390	2	one	one	NUM
aji-159	390	3	,	,	PUNCT
aji-159	390	4	8(6	8(6	NUM
aji-159	390	5	)	)	PUNCT
aji-159	390	6	,	,	PUNCT
aji-159	390	7	e66701	e66701	PROPN
aji-159	390	8	.	.	PROPN
aji-159	390	9	vandepitte	vandepitte	PROPN
aji-159	390	10	,	,	PUNCT
aji-159	390	11	j.	j.	PROPN
aji-159	390	12	m.	m.	PROPN
aji-159	390	13	,	,	PUNCT
aji-159	390	14	malele	malele	PROPN
aji-159	390	15	,	,	PUNCT
aji-159	390	16	f.	f.	PROPN
aji-159	390	17	,	,	PUNCT
aji-159	390	18	kivuvu	kivuvu	PROPN
aji-159	390	19	,	,	PUNCT
aji-159	390	20	d.	d.	PROPN
aji-159	390	21	m.	m.	PROPN
aji-159	390	22	,	,	PUNCT
aji-159	390	23	edidi	edidi	PROPN
aji-159	390	24	,	,	PUNCT
aji-159	390	25	s.	s.	PROPN
aji-159	390	26	,	,	PUNCT
aji-159	390	27	muwonga	muwonga	PROPN
aji-159	390	28	,	,	PUNCT
aji-159	390	29	j.	j.	PROPN
aji-159	390	30	,	,	PUNCT
aji-159	390	31	lepira	lepira	PROPN
aji-159	390	32	,	,	PUNCT
aji-159	390	33	f.	f.	PROPN
aji-159	390	34	,	,	PUNCT
aji-159	390	35	abdellati	abdellati	PROPN
aji-159	390	36	,	,	PUNCT
aji-159	390	37	s.	s.	PROPN
aji-159	390	38	,	,	PUNCT
aji-159	390	39	kabamba	kabamba	PROPN
aji-159	390	40	,	,	PUNCT
aji-159	390	41	j.	j.	PROPN
aji-159	390	42	,	,	PUNCT
aji-159	390	43	van	van	PROPN
aji-159	390	44	overloop	overloop	PROPN
aji-159	390	45	,	,	PUNCT
aji-159	390	46	c.	c.	PROPN
aji-159	390	47	,	,	PUNCT
aji-159	390	48	&	&	CCONJ
aji-159	390	49	buvé	buvé	PROPN
aji-159	390	50	,	,	PUNCT
aji-159	390	51	a.	a.	NOUN
aji-159	390	52	(	(	PUNCT
aji-159	390	53	2007	2007	NUM
aji-159	390	54	)	)	PUNCT
aji-159	390	55	.	.	PUNCT
aji-159	391	1	hiv	hiv	PROPN
aji-159	391	2	and	and	CCONJ
aji-159	391	3	other	other	ADJ
aji-159	391	4	sexually	sexually	ADV
aji-159	391	5	transmitted	transmit	VERB
aji-159	391	6	infections	infection	NOUN
aji-159	391	7	among	among	ADP
aji-159	391	8	female	female	ADJ
aji-159	391	9	sex	sex	NOUN
aji-159	391	10	workers	worker	NOUN
aji-159	391	11	in	in	ADP
aji-159	391	12	kinshasa	kinshasa	PROPN
aji-159	391	13	,	,	PUNCT
aji-159	391	14	democratic	democratic	PROPN
aji-159	391	15	republic	republic	PROPN
aji-159	391	16	of	of	ADP
aji-159	391	17	congo	congo	PROPN
aji-159	391	18	,	,	PUNCT
aji-159	391	19	in	in	ADP
aji-159	391	20	2002	2002	NUM
aji-159	391	21	.	.	PUNCT
aji-159	392	1	sexually	sexually	ADV
aji-159	392	2	transmitted	transmit	VERB
aji-159	392	3	diseases	disease	NOUN
aji-159	392	4	,	,	PUNCT
aji-159	392	5	34(4	34(4	NUM
aji-159	392	6	)	)	PUNCT
aji-159	392	7	,	,	PUNCT
aji-159	392	8	203–208	203–208	NUM
aji-159	392	9	.	.	PUNCT
aji-159	392	10	wahdan	wahdan	PROPN
aji-159	392	11	,	,	PUNCT
aji-159	392	12	i.	i.	PROPN
aji-159	392	13	,	,	PUNCT
aji-159	392	14	wahdan	wahdan	PROPN
aji-159	392	15	,	,	PUNCT
aji-159	392	16	a.	a.	PROPN
aji-159	392	17	,	,	PUNCT
aji-159	392	18	el	el	PROPN
aji-159	392	19	gueneidy	gueneidy	PROPN
aji-159	392	20	,	,	PUNCT
aji-159	392	21	m.	m.	NOUN
aji-159	392	22	,	,	PUNCT
aji-159	392	23	&	&	CCONJ
aji-159	392	24	abd	abd	PROPN
aji-159	392	25	el	el	PROPN
aji-159	392	26	rahman	rahman	PROPN
aji-159	392	27	,	,	PUNCT
aji-159	392	28	i.	i.	PROPN
aji-159	392	29	(	(	PUNCT
aji-159	392	30	2013	2013	NUM
aji-159	392	31	)	)	PUNCT
aji-159	392	32	.	.	PUNCT
aji-159	393	1	prevalence	prevalence	NOUN
aji-159	393	2	and	and	CCONJ
aji-159	393	3	determinants	determinant	NOUN
aji-159	393	4	of	of	ADP
aji-159	393	5	condom	condom	NOUN
aji-159	393	6	utilization	utilization	NOUN
aji-159	393	7	among	among	ADP
aji-159	393	8	people	people	NOUN
aji-159	393	9	living	live	VERB
aji-159	393	10	with	with	ADP
aji-159	393	11	hiv	hiv	PROPN
aji-159	393	12	/	/	SYM
aji-159	393	13	aids	aids	PROPN
aji-159	393	14	in	in	ADP
aji-159	393	15	egypt	egypt	PROPN
aji-159	393	16	.	.	PUNCT
aji-159	394	1	eastern	eastern	PROPN
aji-159	394	2	mediterranean	mediterranean	PROPN
aji-159	394	3	health	health	PROPN
aji-159	394	4	journal	journal	PROPN
aji-159	394	5	,	,	PUNCT
aji-159	394	6	19(12	19(12	NUM
aji-159	394	7	)	)	PUNCT
aji-159	394	8	,	,	PUNCT
aji-159	394	9	967–974	967–974	NUM
aji-159	394	10	.	.	PUNCT
aji-159	395	1	wang	wang	PROPN
aji-159	395	2	,	,	PUNCT
aji-159	395	3	h.	h.	PROPN
aji-159	395	4	,	,	PUNCT
aji-159	395	5	chen	chen	PROPN
aji-159	395	6	,	,	PUNCT
aji-159	395	7	r.	r.	PROPN
aji-159	395	8	y.	y.	PROPN
aji-159	395	9	,	,	PUNCT
aji-159	395	10	ding	ding	NOUN
aji-159	395	11	,	,	PUNCT
aji-159	395	12	g.	g.	PROPN
aji-159	395	13	,	,	PUNCT
aji-159	395	14	ma	ma	PROPN
aji-159	395	15	,	,	PUNCT
aji-159	395	16	y.	y.	PROPN
aji-159	395	17	,	,	PUNCT
aji-159	395	18	ma	ma	PROPN
aji-159	395	19	,	,	PUNCT
aji-159	395	20	j.	j.	PROPN
aji-159	395	21	,	,	PUNCT
aji-159	395	22	jiao	jiao	PROPN
aji-159	395	23	,	,	PUNCT
aji-159	395	24	j.	j.	PROPN
aji-159	395	25	h.	h.	PROPN
aji-159	395	26	,	,	PUNCT
aji-159	395	27	wu	wu	PROPN
aji-159	395	28	,	,	PUNCT
aji-159	395	29	z.	z.	PROPN
aji-159	395	30	,	,	PUNCT
aji-159	395	31	sharp	sharp	ADJ
aji-159	395	32	,	,	PUNCT
aji-159	395	33	g.	g.	PROPN
aji-159	395	34	b.	b.	PROPN
aji-159	395	35	,	,	PUNCT
aji-159	395	36	&	&	CCONJ
aji-159	395	37	wang	wang	PROPN
aji-159	395	38	,	,	PUNCT
aji-159	395	39	n.	n.	PROPN
aji-159	395	40	(	(	PUNCT
aji-159	395	41	2009	2009	NUM
aji-159	395	42	)	)	PUNCT
aji-159	395	43	.	.	PUNCT
aji-159	396	1	prevalence	prevalence	NOUN
aji-159	396	2	and	and	CCONJ
aji-159	396	3	predictors	predictor	NOUN
aji-159	396	4	of	of	ADP
aji-159	396	5	hiv	hiv	PROPN
aji-159	396	6	infection	infection	NOUN
aji-159	396	7	among	among	ADP
aji-159	396	8	female	female	ADJ
aji-159	396	9	sex	sex	NOUN
aji-159	396	10	workers	worker	NOUN
aji-159	396	11	in	in	ADP
aji-159	396	12	kaiyuan	kaiyuan	PROPN
aji-159	396	13	city	city	PROPN
aji-159	396	14	,	,	PUNCT
aji-159	396	15	yunnan	yunnan	PROPN
aji-159	396	16	province	province	PROPN
aji-159	396	17	,	,	PUNCT
aji-159	396	18	china	china	PROPN
aji-159	396	19	.	.	PUNCT
aji-159	397	1	international	international	ADJ
aji-159	397	2	journal	journal	PROPN
aji-159	397	3	of	of	ADP
aji-159	397	4	infectious	infectious	ADJ
aji-159	397	5	diseases	disease	NOUN
aji-159	397	6	,	,	PUNCT
aji-159	397	7	13(2	13(2	PROPN
aji-159	397	8	)	)	PUNCT
aji-159	397	9	,	,	PUNCT
aji-159	397	10	162–169	162–169	NUM
aji-159	397	11	.	.	PUNCT
aji-159	397	12	watts	watts	PROPN
aji-159	397	13	,	,	PUNCT
aji-159	397	14	d.	d.	PROPN
aji-159	397	15	m.	m.	PROPN
aji-159	397	16	,	,	PUNCT
aji-159	397	17	constantine	constantine	PROPN
aji-159	397	18	,	,	PUNCT
aji-159	397	19	n.	n.	PROPN
aji-159	397	20	t.	t.	PROPN
aji-159	397	21	,	,	PUNCT
aji-159	397	22	sheba	sheba	PROPN
aji-159	397	23	,	,	PUNCT
aji-159	397	24	m.	m.	PROPN
aji-159	397	25	f.	f.	PROPN
aji-159	397	26	,	,	PUNCT
aji-159	397	27	kamal	kamal	PROPN
aji-159	397	28	,	,	PUNCT
aji-159	397	29	m.	m.	NOUN
aji-159	397	30	,	,	PUNCT
aji-159	397	31	callahan	callahan	PROPN
aji-159	397	32	,	,	PUNCT
aji-159	397	33	j.	j.	PROPN
aji-159	397	34	d.	d.	PROPN
aji-159	397	35	,	,	PUNCT
aji-159	397	36	&	&	CCONJ
aji-159	397	37	kilpatrick	kilpatrick	PROPN
aji-159	397	38	,	,	PUNCT
aji-159	397	39	m.	m.	PROPN
aji-159	397	40	e.	e.	PROPN
aji-159	397	41	(	(	PUNCT
aji-159	397	42	1993	1993	NUM
aji-159	397	43	)	)	PUNCT
aji-159	397	44	.	.	PUNCT
aji-159	398	1	prevalence	prevalence	NOUN
aji-159	398	2	of	of	ADP
aji-159	398	3	hiv	hiv	PROPN
aji-159	398	4	infection	infection	NOUN
aji-159	398	5	and	and	CCONJ
aji-159	398	6	aids	aid	NOUN
aji-159	398	7	in	in	ADP
aji-159	398	8	egypt	egypt	PROPN
aji-159	398	9	over	over	ADP
aji-159	398	10	four	four	NUM
aji-159	398	11	years	year	NOUN
aji-159	398	12	of	of	ADP
aji-159	398	13	surveillance	surveillance	NOUN
aji-159	398	14	(	(	PUNCT
aji-159	398	15	1986–1990	1986–1990	NUM
aji-159	398	16	)	)	PUNCT
aji-159	398	17	.	.	PUNCT
aji-159	399	1	journal	journal	NOUN
aji-159	399	2	of	of	ADP
aji-159	399	3	tropical	tropical	ADJ
aji-159	399	4	medicine	medicine	NOUN
aji-159	399	5	and	and	CCONJ
aji-159	399	6	hygiene	hygiene	NOUN
aji-159	399	7	,	,	PUNCT
aji-159	399	8	96(2	96(2	NUM
aji-159	399	9	)	)	PUNCT
aji-159	399	10	,	,	PUNCT
aji-159	399	11	113–117	113–117	NUM
aji-159	399	12	.	.	PUNCT
aji-159	400	1	wayal	wayal	PROPN
aji-159	400	2	,	,	PUNCT
aji-159	400	3	s.	s.	PROPN
aji-159	400	4	,	,	PUNCT
aji-159	400	5	cowan	cowan	PROPN
aji-159	400	6	,	,	PUNCT
aji-159	400	7	f.	f.	PROPN
aji-159	400	8	,	,	PUNCT
aji-159	400	9	warner	warner	PROPN
aji-159	400	10	,	,	PUNCT
aji-159	400	11	p.	p.	NOUN
aji-159	400	12	,	,	PUNCT
aji-159	400	13	copas	copas	PROPN
aji-159	400	14	,	,	PUNCT
aji-159	400	15	a.	a.	PROPN
aji-159	400	16	,	,	PUNCT
aji-159	400	17	mabey	mabey	PROPN
aji-159	400	18	,	,	PUNCT
aji-159	400	19	d.	d.	PROPN
aji-159	400	20	,	,	PUNCT
aji-159	400	21	&	&	CCONJ
aji-159	400	22	shahmanesh	shahmanesh	PROPN
aji-159	400	23	,	,	PUNCT
aji-159	400	24	m.	m.	NOUN
aji-159	400	25	(	(	PUNCT
aji-159	400	26	2011	2011	NUM
aji-159	400	27	)	)	PUNCT
aji-159	400	28	.	.	PUNCT
aji-159	401	1	contraceptive	contraceptive	ADJ
aji-159	401	2	practices	practice	NOUN
aji-159	401	3	,	,	PUNCT
aji-159	401	4	sexual	sexual	ADJ
aji-159	401	5	and	and	CCONJ
aji-159	401	6	reproductive	reproductive	ADJ
aji-159	401	7	health	health	NOUN
aji-159	401	8	needs	need	NOUN
aji-159	401	9	of	of	ADP
aji-159	401	10	hiv	hiv	PROPN
aji-159	401	11	-	-	PUNCT
aji-159	401	12	positive	positive	ADJ
aji-159	401	13	and	and	CCONJ
aji-159	401	14	negative	negative	ADJ
aji-159	401	15	female	female	ADJ
aji-159	401	16	sex	sex	NOUN
aji-159	401	17	workers	worker	NOUN
aji-159	401	18	in	in	ADP
aji-159	401	19	goa	goa	PROPN
aji-159	401	20	,	,	PUNCT
aji-159	401	21	india	india	PROPN
aji-159	401	22	.	.	PROPN
aji-159	401	23	sexually	sexually	ADV
aji-159	401	24	transmitted	transmit	VERB
aji-159	401	25	infections	infection	NOUN
aji-159	401	26	,	,	PUNCT
aji-159	401	27	87(1	87(1	NUM
aji-159	401	28	)	)	PUNCT
aji-159	401	29	,	,	PUNCT
aji-159	401	30	58–64	58–64	PROPN
aji-159	401	31	.	.	PUNCT
aji-159	401	32	wenz	wenz	PROPN
aji-159	401	33	,	,	PUNCT
aji-159	401	34	b.	b.	PROPN
aji-159	401	35	,	,	PUNCT
aji-159	401	36	nielsen	nielsen	PROPN
aji-159	401	37	,	,	PUNCT
aji-159	401	38	s.	s.	PROPN
aji-159	401	39	,	,	PUNCT
aji-159	401	40	gassowski	gassowski	PROPN
aji-159	401	41	,	,	PUNCT
aji-159	401	42	m.	m.	NOUN
aji-159	401	43	,	,	PUNCT
aji-159	401	44	santoshövener	santoshövener	PROPN
aji-159	401	45	,	,	PUNCT
aji-159	401	46	c.	c.	PROPN
aji-159	401	47	,	,	PUNCT
aji-159	401	48	cai	cai	PROPN
aji-159	401	49	,	,	PUNCT
aji-159	401	50	w.	w.	PROPN
aji-159	401	51	,	,	PUNCT
aji-159	401	52	ross	ross	PROPN
aji-159	401	53	,	,	PUNCT
aji-159	401	54	r.	r.	PROPN
aji-159	401	55	s.	s.	PROPN
aji-159	401	56	,	,	PUNCT
aji-159	401	57	bock	bock	NOUN
aji-159	401	58	,	,	PUNCT
aji-159	401	59	c.	c.	PROPN
aji-159	401	60	t.	t.	PROPN
aji-159	401	61	,	,	PUNCT
aji-159	401	62	ratsch	ratsch	PROPN
aji-159	401	63	,	,	PUNCT
aji-159	401	64	b.	b.	PROPN
aji-159	401	65	a.	a.	PROPN
aji-159	401	66	,	,	PUNCT
aji-159	401	67	kücherer	kücherer	NOUN
aji-159	401	68	,	,	PUNCT
aji-159	401	69	c.	c.	NOUN
aji-159	401	70	,	,	PUNCT
aji-159	401	71	bannert	bannert	NOUN
aji-159	401	72	,	,	PUNCT
aji-159	401	73	n.	n.	NOUN
aji-159	401	74	,	,	PUNCT
aji-159	401	75	bremer	bremer	NOUN
aji-159	401	76	,	,	PUNCT
aji-159	401	77	v.	v.	ADV
aji-159	401	78	,	,	PUNCT
aji-159	401	79	hamouda	hamouda	NOUN
aji-159	401	80	,	,	PUNCT
aji-159	401	81	o.	o.	PROPN
aji-159	401	82	,	,	PUNCT
aji-159	401	83	marcus	marcus	PROPN
aji-159	401	84	,	,	PUNCT
aji-159	401	85	u.	u.	PROPN
aji-159	401	86	,	,	PUNCT
aji-159	401	87	zimmermann	zimmermann	PROPN
aji-159	401	88	,	,	PUNCT
aji-159	401	89	r.	r.	PROPN
aji-159	401	90	,	,	PUNCT
aji-159	401	91	&	&	CCONJ
aji-159	401	92	druck	druck	PROPN
aji-159	401	93	study	study	PROPN
aji-159	401	94	group	group	NOUN
aji-159	401	95	.	.	PUNCT
aji-159	402	1	(	(	PUNCT
aji-159	402	2	2016	2016	NUM
aji-159	402	3	)	)	PUNCT
aji-159	402	4	.	.	PUNCT
aji-159	403	1	high	high	ADJ
aji-159	403	2	variability	variability	NOUN
aji-159	403	3	of	of	ADP
aji-159	403	4	hiv	hiv	PROPN
aji-159	403	5	and	and	CCONJ
aji-159	403	6	hcv	hcv	PROPN
aji-159	403	7	seroprevalence	seroprevalence	NOUN
aji-159	403	8	and	and	CCONJ
aji-159	403	9	risk	risk	NOUN
aji-159	403	10	behaviours	behaviour	NOUN
aji-159	403	11	among	among	ADP
aji-159	403	12	people	people	NOUN
aji-159	403	13	who	who	PRON
aji-159	403	14	inject	inject	VERB
aji-159	403	15	drugs	drug	NOUN
aji-159	403	16	:	:	PUNCT
aji-159	403	17	results	result	VERB
aji-159	403	18	from	from	ADP
aji-159	403	19	a	a	DET
aji-159	403	20	cross	cross	ADJ
aji-159	403	21	-	-	ADJ
aji-159	403	22	sectional	sectional	ADJ
aji-159	403	23	study	study	NOUN
aji-159	403	24	using	use	VERB
aji-159	403	25	respondentdriven	respondentdriven	NOUN
aji-159	403	26	sampling	sample	VERB
aji-159	403	27	in	in	ADP
aji-159	403	28	eight	eight	NUM
aji-159	403	29	german	german	ADJ
aji-159	403	30	cities	city	NOUN
aji-159	403	31	(	(	PUNCT
aji-159	403	32	2011–14	2011–14	NUM
aji-159	403	33	)	)	PUNCT
aji-159	403	34	.	.	PUNCT
aji-159	404	1	bmc	bmc	ADJ
aji-159	404	2	public	public	ADJ
aji-159	404	3	health	health	NOUN
aji-159	404	4	,	,	PUNCT
aji-159	404	5	16(1	16(1	NUM
aji-159	404	6	)	)	PUNCT
aji-159	404	7	,	,	PUNCT
aji-159	404	8	927	927	NUM
aji-159	404	9	.	.	PUNCT
aji-159	405	1	world	world	PROPN
aji-159	405	2	health	health	PROPN
aji-159	405	3	organization	organization	NOUN
aji-159	405	4	(	(	PUNCT
aji-159	405	5	who	who	PRON
aji-159	405	6	)	)	PUNCT
aji-159	405	7	.	.	PUNCT
aji-159	406	1	(	(	PUNCT
aji-159	406	2	2012	2012	NUM
aji-159	406	3	)	)	PUNCT
aji-159	406	4	.	.	PUNCT
aji-159	407	1	guidelines	guideline	NOUN
aji-159	407	2	:	:	PUNCT
aji-159	407	3	prevention	prevention	NOUN
aji-159	407	4	and	and	CCONJ
aji-159	407	5	treatment	treatment	NOUN
aji-159	407	6	of	of	ADP
aji-159	407	7	hiv	hiv	PROPN
aji-159	407	8	and	and	CCONJ
aji-159	407	9	other	other	ADJ
aji-159	407	10	sexually	sexually	ADV
aji-159	407	11	transmitted	transmit	VERB
aji-159	407	12	infections	infection	NOUN
aji-159	407	13	for	for	ADP
aji-159	407	14	sex	sex	NOUN
aji-159	407	15	workers	worker	NOUN
aji-159	407	16	in	in	ADP
aji-159	407	17	lowand	lowand	ADJ
aji-159	407	18	middle	middle	ADJ
aji-159	407	19	-	-	PUNCT
aji-159	407	20	income	income	NOUN
aji-159	407	21	countries	country	NOUN
aji-159	407	22	.	.	PUNCT
aji-159	408	1	geneva	geneva	PROPN
aji-159	408	2	:	:	PUNCT
aji-159	408	3	world	world	PROPN
aji-159	408	4	health	health	PROPN
aji-159	408	5	organization	organization	PROPN
aji-159	408	6	.	.	PUNCT
aji-159	409	1	world	world	PROPN
aji-159	409	2	health	health	PROPN
aji-159	409	3	organization	organization	NOUN
aji-159	409	4	(	(	PUNCT
aji-159	409	5	who	who	PRON
aji-159	409	6	)	)	PUNCT
aji-159	409	7	.	.	PUNCT
aji-159	410	1	(	(	PUNCT
aji-159	410	2	2024	2024	NUM
aji-159	410	3	)	)	PUNCT
aji-159	410	4	.	.	PUNCT
aji-159	411	1	global	global	PROPN
aji-159	411	2	hiv	hiv	PROPN
aji-159	411	3	,	,	PUNCT
aji-159	411	4	hepatitis	hepatitis	NOUN
aji-159	411	5	and	and	CCONJ
aji-159	411	6	stis	stis	PROPN
aji-159	411	7	programmes	programme	NOUN
aji-159	411	8	:	:	PUNCT
aji-159	411	9	people	people	NOUN
aji-159	411	10	who	who	PRON
aji-159	411	11	inject	inject	VERB
aji-159	411	12	drugs	drug	NOUN
aji-159	411	13	.	.	PUNCT
aji-159	412	1	available	available	ADJ
aji-159	412	2	:	:	PUNCT
aji-159	413	1	https://www.who.int/teams/global-hivhepatitis-and-stisprogrammes/populations/people-whoinject-drugs	https://www.who.int/teams/global-hivhepatitis-and-stisprogrammes/populations/people-whoinject-drugs	PROPN
aji-159	413	2	world	world	PROPN
aji-159	413	3	health	health	PROPN
aji-159	413	4	organization	organization	NOUN
aji-159	413	5	(	(	PUNCT
aji-159	413	6	who	who	PRON
aji-159	413	7	)	)	PUNCT
aji-159	413	8	.	.	PUNCT
aji-159	414	1	(	(	PUNCT
aji-159	414	2	2024	2024	NUM
aji-159	414	3	)	)	PUNCT
aji-159	414	4	.	.	PUNCT
aji-159	415	1	hiv	hiv	PROPN
aji-159	415	2	and	and	CCONJ
aji-159	415	3	aids	aids	PROPN
aji-159	415	4	.	.	PUNCT
aji-159	416	1	available	available	ADJ
aji-159	416	2	:	:	PUNCT
aji-159	416	3	https://www.who.int/news-room/factsheets/detail/hiv-aids	https://www.who.int/news-room/factsheets/detail/hiv-aids	PROPN
aji-159	416	4	yousaf	yousaf	PROPN
aji-159	416	5	,	,	PUNCT
aji-159	416	6	m.	m.	PROPN
aji-159	416	7	z.	z.	PROPN
aji-159	416	8	,	,	PUNCT
aji-159	416	9	zia	zia	PROPN
aji-159	416	10	,	,	PUNCT
aji-159	416	11	s.	s.	PROPN
aji-159	416	12	,	,	PUNCT
aji-159	416	13	babar	babar	PROPN
aji-159	416	14	,	,	PUNCT
aji-159	416	15	m.	m.	PROPN
aji-159	416	16	e.	e.	PROPN
aji-159	416	17	,	,	PUNCT
aji-159	416	18	&	&	CCONJ
aji-159	416	19	ashfaq	ashfaq	PROPN
aji-159	416	20	,	,	PUNCT
aji-159	416	21	u.	u.	PROPN
aji-159	416	22	a.	a.	PROPN
aji-159	417	1	(	(	PUNCT
aji-159	417	2	2011	2011	NUM
aji-159	417	3	)	)	PUNCT
aji-159	417	4	.	.	PUNCT
aji-159	418	1	the	the	DET
aji-159	418	2	epidemic	epidemic	NOUN
aji-159	418	3	of	of	ADP
aji-159	418	4	hiv	hiv	PROPN
aji-159	418	5	/	/	SYM
aji-159	418	6	aids	aids	PROPN
aji-159	418	7	in	in	ADP
aji-159	418	8	developing	develop	VERB
aji-159	418	9	countries	country	NOUN
aji-159	418	10	;	;	PUNCT
aji-159	418	11	the	the	DET
aji-159	418	12	current	current	ADJ
aji-159	418	13	scenario	scenario	NOUN
aji-159	418	14	in	in	ADP
aji-159	418	15	pakistan	pakistan	PROPN
aji-159	418	16	.	.	PUNCT
aji-159	419	1	virology	virology	NOUN
aji-159	419	2	journal	journal	NOUN
aji-159	419	3	,	,	PUNCT
aji-159	419	4	8	8	NUM
aji-159	419	5	,	,	PUNCT
aji-159	419	6	401	401	NUM
aji-159	419	7	.	.	PUNCT
aji-159	420	1	zhang	zhang	PROPN
aji-159	420	2	,	,	PUNCT
aji-159	420	3	y.	y.	PROPN
aji-159	420	4	,	,	PUNCT
aji-159	420	5	shan	shan	PROPN
aji-159	420	6	,	,	PUNCT
aji-159	420	7	h.	h.	PROPN
aji-159	420	8	,	,	PUNCT
aji-159	420	9	trizzino	trizzino	PROPN
aji-159	420	10	,	,	PUNCT
aji-159	420	11	j.	j.	PROPN
aji-159	420	12	,	,	PUNCT
aji-159	420	13	ruan	ruan	PROPN
aji-159	420	14	,	,	PUNCT
aji-159	420	15	y.	y.	PROPN
aji-159	420	16	,	,	PUNCT
aji-159	420	17	beauchamp	beauchamp	PROPN
aji-159	420	18	,	,	PUNCT
aji-159	420	19	g.	g.	PROPN
aji-159	420	20	,	,	PUNCT
aji-159	420	21	mâsse	mâsse	PROPN
aji-159	420	22	,	,	PUNCT
aji-159	420	23	b.	b.	PROPN
aji-159	420	24	,	,	PUNCT
aji-159	420	25	ma	ma	PROPN
aji-159	420	26	,	,	PUNCT
aji-159	420	27	j.	j.	PROPN
aji-159	420	28	,	,	PUNCT
aji-159	420	29	gu	gu	PROPN
aji-159	420	30	,	,	PUNCT
aji-159	420	31	y.	y.	PROPN
aji-159	420	32	,	,	PUNCT
aji-159	420	33	he	he	PRON
aji-159	420	34	,	,	PUNCT
aji-159	420	35	y.	y.	PROPN
aji-159	420	36	,	,	PUNCT
aji-159	420	37	rui	rui	PROPN
aji-159	420	38	,	,	PUNCT
aji-159	420	39	b.	b.	PROPN
aji-159	420	40	,	,	PUNCT
aji-159	420	41	wang	wang	PROPN
aji-159	420	42	,	,	PUNCT
aji-159	420	43	j.	j.	PROPN
aji-159	420	44	,	,	PUNCT
aji-159	420	45	poundstone	poundstone	PROPN
aji-159	420	46	,	,	PUNCT
aji-159	420	47	k.	k.	PROPN
aji-159	420	48	,	,	PUNCT
aji-159	420	49	khalaf	khalaf	PROPN
aji-159	420	50	;	;	PUNCT
aji-159	420	51	asian	asian	PROPN
aji-159	420	52	j.	j.	PROPN
aji-159	420	53	immunol	immunol	PROPN
aji-159	420	54	.	.	PROPN
aji-159	420	55	,	,	PUNCT
aji-159	420	56	vol	vol	NOUN
aji-159	420	57	.	.	PROPN
aji-159	420	58	8	8	NUM
aji-159	420	59	,	,	PUNCT
aji-159	420	60	no	no	INTJ
aji-159	420	61	.	.	NOUN
aji-159	420	62	1	1	NUM
aji-159	420	63	,	,	PUNCT
aji-159	420	64	pp	pp	ADJ
aji-159	420	65	.	.	PUNCT
aji-159	421	1	50	50	NUM
aji-159	421	2	-	-	SYM
aji-159	421	3	59	59	NUM
aji-159	421	4	,	,	PUNCT
aji-159	421	5	2025	2025	NUM
aji-159	421	6	;	;	PUNCT
aji-159	421	7	article	article	NOUN
aji-159	421	8	no.aji.125999	no.aji.125999	NOUN
aji-159	421	9	59	59	NUM
aji-159	421	10	jiang	jiang	PROPN
aji-159	421	11	,	,	PUNCT
aji-159	421	12	y.	y.	PROPN
aji-159	421	13	,	,	PUNCT
aji-159	421	14	brooks	brooks	PROPN
aji-159	421	15	jackson	jackson	PROPN
aji-159	421	16	,	,	PUNCT
aji-159	421	17	j.	j.	PROPN
aji-159	421	18	,	,	PUNCT
aji-159	421	19	&	&	CCONJ
aji-159	421	20	shao	shao	PROPN
aji-159	421	21	,	,	PUNCT
aji-159	421	22	y.	y.	PROPN
aji-159	421	23	(	(	PUNCT
aji-159	421	24	2007	2007	NUM
aji-159	421	25	)	)	PUNCT
aji-159	421	26	.	.	PUNCT
aji-159	422	1	demographic	demographic	ADJ
aji-159	422	2	characteristics	characteristic	NOUN
aji-159	422	3	and	and	CCONJ
aji-159	422	4	risk	risk	NOUN
aji-159	422	5	behaviors	behavior	NOUN
aji-159	422	6	associated	associate	VERB
aji-159	422	7	with	with	ADP
aji-159	422	8	hiv	hiv	PROPN
aji-159	422	9	positive	positive	ADJ
aji-159	422	10	injecting	inject	VERB
aji-159	422	11	drug	drug	NOUN
aji-159	422	12	users	user	NOUN
aji-159	422	13	in	in	ADP
aji-159	422	14	xinjiang	xinjiang	PROPN
aji-159	422	15	,	,	PUNCT
aji-159	422	16	china	china	PROPN
aji-159	422	17	.	.	PUNCT
aji-159	422	18	journal	journal	PROPN
aji-159	422	19	of	of	ADP
aji-159	422	20	infection	infection	NOUN
aji-159	422	21	,	,	PUNCT
aji-159	422	22	54(3	54(3	NUM
aji-159	422	23	)	)	PUNCT
aji-159	422	24	,	,	PUNCT
aji-159	422	25	285–290	285–290	NUM
aji-159	422	26	.	.	PUNCT
aji-159	423	1	znazen	znazen	PROPN
aji-159	423	2	,	,	PUNCT
aji-159	423	3	a.	a.	NOUN
aji-159	423	4	,	,	PUNCT
aji-159	423	5	frikha	frikha	ADJ
aji-159	423	6	-	-	PUNCT
aji-159	423	7	gargouri	gargouri	NOUN
aji-159	423	8	,	,	PUNCT
aji-159	423	9	o.	o.	PROPN
aji-159	423	10	,	,	PUNCT
aji-159	423	11	berrajah	berrajah	PROPN
aji-159	423	12	,	,	PUNCT
aji-159	423	13	l.	l.	PROPN
aji-159	423	14	,	,	PUNCT
aji-159	423	15	bellalouna	bellalouna	PROPN
aji-159	423	16	,	,	PUNCT
aji-159	423	17	s.	s.	PROPN
aji-159	423	18	,	,	PUNCT
aji-159	423	19	hakim	hakim	PROPN
aji-159	423	20	,	,	PUNCT
aji-159	423	21	h.	h.	PROPN
aji-159	423	22	,	,	PUNCT
aji-159	423	23	gueddana	gueddana	PROPN
aji-159	423	24	,	,	PUNCT
aji-159	423	25	n.	n.	NOUN
aji-159	423	26	,	,	PUNCT
aji-159	423	27	&	&	CCONJ
aji-159	423	28	hammami	hammami	NOUN
aji-159	423	29	,	,	PUNCT
aji-159	423	30	a.	a.	NOUN
aji-159	423	31	(	(	PUNCT
aji-159	423	32	2010	2010	NUM
aji-159	423	33	)	)	PUNCT
aji-159	423	34	.	.	PUNCT
aji-159	424	1	sexually	sexually	ADV
aji-159	424	2	transmitted	transmit	VERB
aji-159	424	3	infections	infection	NOUN
aji-159	424	4	among	among	ADP
aji-159	424	5	female	female	ADJ
aji-159	424	6	sex	sex	NOUN
aji-159	424	7	workers	worker	NOUN
aji-159	424	8	in	in	ADP
aji-159	424	9	tunisia	tunisia	NOUN
aji-159	424	10	:	:	PUNCT
aji-159	424	11	high	high	ADJ
aji-159	424	12	prevalence	prevalence	NOUN
aji-159	424	13	of	of	ADP
aji-159	424	14	chlamydia	chlamydia	NOUN
aji-159	424	15	trachomatis	trachomatis	ADJ
aji-159	424	16	.	.	PUNCT
aji-159	425	1	sexually	sexually	ADV
aji-159	425	2	transmitted	transmit	VERB
aji-159	425	3	infections	infection	NOUN
aji-159	425	4	,	,	PUNCT
aji-159	425	5	86(7	86(7	NOUN
aji-159	425	6	)	)	PUNCT
aji-159	425	7	,	,	PUNCT
aji-159	425	8	500–505	500–505	NUM
aji-159	425	9	.	.	PUNCT
aji-159	426	1	disclaimer	disclaimer	ADJ
aji-159	426	2	/	/	SYM
aji-159	426	3	publisher	publisher	NOUN
aji-159	426	4	’s	’s	PART
aji-159	426	5	note	note	NOUN
aji-159	426	6	:	:	PUNCT
aji-159	426	7	the	the	DET
aji-159	426	8	statements	statement	NOUN
aji-159	426	9	,	,	PUNCT
aji-159	426	10	opinions	opinion	NOUN
aji-159	426	11	and	and	CCONJ
aji-159	426	12	data	datum	NOUN
aji-159	426	13	contained	contain	VERB
aji-159	426	14	in	in	ADP
aji-159	426	15	all	all	DET
aji-159	426	16	publications	publication	NOUN
aji-159	426	17	are	be	AUX
aji-159	426	18	solely	solely	ADV
aji-159	426	19	those	those	PRON
aji-159	426	20	of	of	ADP
aji-159	426	21	the	the	DET
aji-159	426	22	individual	individual	ADJ
aji-159	426	23	author(s	author(s	PROPN
aji-159	426	24	)	)	PUNCT
aji-159	426	25	and	and	CCONJ
aji-159	426	26	contributor(s	contributor(s	NOUN
aji-159	426	27	)	)	PUNCT
aji-159	426	28	and	and	CCONJ
aji-159	426	29	not	not	PART
aji-159	426	30	of	of	ADP
aji-159	426	31	the	the	DET
aji-159	426	32	publisher	publisher	NOUN
aji-159	426	33	and/or	and/or	CCONJ
aji-159	426	34	the	the	DET
aji-159	426	35	editor(s	editor(s	NOUN
aji-159	426	36	)	)	PUNCT
aji-159	426	37	.	.	PUNCT
aji-159	427	1	this	this	DET
aji-159	427	2	publisher	publisher	NOUN
aji-159	427	3	and/or	and/or	CCONJ
aji-159	427	4	the	the	DET
aji-159	427	5	editor(s	editor(s	NOUN
aji-159	427	6	)	)	PUNCT
aji-159	427	7	disclaim	disclaim	VERB
aji-159	427	8	responsibility	responsibility	NOUN
aji-159	427	9	for	for	ADP
aji-159	427	10	any	any	DET
aji-159	427	11	injury	injury	NOUN
aji-159	427	12	to	to	ADP
aji-159	427	13	people	people	NOUN
aji-159	427	14	or	or	CCONJ
aji-159	427	15	property	property	NOUN
aji-159	427	16	resulting	result	VERB
aji-159	427	17	from	from	ADP
aji-159	427	18	any	any	DET
aji-159	427	19	ideas	idea	NOUN
aji-159	427	20	,	,	PUNCT
aji-159	427	21	methods	method	NOUN
aji-159	427	22	,	,	PUNCT
aji-159	427	23	instructions	instruction	NOUN
aji-159	427	24	or	or	CCONJ
aji-159	427	25	products	product	NOUN
aji-159	427	26	referred	refer	VERB
aji-159	427	27	to	to	ADP
aji-159	427	28	in	in	ADP
aji-159	427	29	the	the	DET
aji-159	427	30	content	content	NOUN
aji-159	427	31	.	.	PUNCT
aji-159	428	1	_	_	PUNCT
aji-159	429	1	_	_	PUNCT
aji-159	430	1	_	_	PUNCT
aji-159	431	1	_	_	PUNCT
aji-159	432	1	_	_	PUNCT
aji-159	433	1	_	_	PUNCT
aji-159	434	1	_	_	PUNCT
aji-159	435	1	_	_	PUNCT
aji-159	436	1	_	_	PUNCT
aji-159	437	1	_	_	PUNCT
aji-159	438	1	_	_	PUNCT
aji-159	439	1	_	_	PUNCT
aji-159	440	1	_	_	PUNCT
aji-159	441	1	_	_	PUNCT
aji-159	442	1	_	_	PUNCT
aji-159	443	1	_	_	PUNCT
aji-159	444	1	_	_	PUNCT
aji-159	445	1	_	_	PUNCT
aji-159	446	1	_	_	PUNCT
aji-159	447	1	_	_	PUNCT
aji-159	448	1	_	_	PUNCT
aji-159	449	1	_	_	PUNCT
aji-159	450	1	_	_	PUNCT
aji-159	451	1	_	_	PUNCT
aji-159	452	1	_	_	PUNCT
aji-159	453	1	_	_	PUNCT
aji-159	454	1	_	_	PUNCT
aji-159	455	1	_	_	PUNCT
aji-159	456	1	_	_	PUNCT
aji-159	457	1	_	_	PUNCT
aji-159	458	1	_	_	PUNCT
aji-159	459	1	_	_	PUNCT
aji-159	460	1	_	_	PUNCT
aji-159	461	1	_	_	PUNCT
aji-159	462	1	_	_	PUNCT
aji-159	463	1	_	_	PUNCT
aji-159	464	1	_	_	PUNCT
aji-159	465	1	_	_	PUNCT
aji-159	466	1	_	_	PUNCT
aji-159	467	1	_	_	PUNCT
aji-159	468	1	_	_	PUNCT
aji-159	469	1	_	_	PUNCT
aji-159	470	1	_	_	PUNCT
aji-159	471	1	_	_	PUNCT
aji-159	472	1	_	_	PUNCT
aji-159	473	1	_	_	PUNCT
aji-159	474	1	_	_	PUNCT
aji-159	475	1	_	_	PUNCT
aji-159	476	1	_	_	PUNCT
aji-159	477	1	_	_	PUNCT
aji-159	478	1	_	_	PUNCT
aji-159	479	1	_	_	PUNCT
aji-159	480	1	_	_	PUNCT
aji-159	481	1	_	_	PUNCT
aji-159	482	1	_	_	PUNCT
aji-159	483	1	_	_	PUNCT
aji-159	484	1	_	_	PUNCT
aji-159	485	1	_	_	PUNCT
aji-159	486	1	_	_	PUNCT
aji-159	487	1	_	_	PUNCT
aji-159	488	1	_	_	PUNCT
aji-159	489	1	_	_	PUNCT
aji-159	490	1	_	_	PUNCT
aji-159	491	1	_	_	PUNCT
aji-159	492	1	_	_	PUNCT
aji-159	493	1	_	_	PUNCT
aji-159	494	1	_	_	PUNCT
aji-159	495	1	_	_	PUNCT
aji-159	496	1	_	_	PUNCT
aji-159	497	1	_	_	PUNCT
aji-159	498	1	_	_	PUNCT
aji-159	499	1	_	_	PUNCT
aji-159	500	1	_	_	PUNCT
aji-159	501	1	_	_	PUNCT
aji-159	502	1	_	_	PUNCT
aji-159	503	1	_	_	PUNCT
aji-159	504	1	_	_	PUNCT
aji-159	505	1	_	_	PUNCT
aji-159	506	1	_	_	PUNCT
aji-159	507	1	_	_	PUNCT
aji-159	508	1	_	_	PUNCT
aji-159	509	1	©	©	PRON
aji-159	509	2	copyright	copyright	NOUN
aji-159	509	3	(	(	PUNCT
aji-159	509	4	2025	2025	NUM
aji-159	509	5	):	):	PUNCT
aji-159	509	6	author(s	author(s	NOUN
aji-159	509	7	)	)	PUNCT
aji-159	509	8	.	.	PUNCT
aji-159	510	1	the	the	DET
aji-159	510	2	licensee	licensee	NOUN
aji-159	510	3	is	be	AUX
aji-159	510	4	the	the	DET
aji-159	510	5	journal	journal	PROPN
aji-159	510	6	publisher	publisher	NOUN
aji-159	510	7	.	.	PUNCT
aji-159	511	1	this	this	PRON
aji-159	511	2	is	be	AUX
aji-159	511	3	an	an	DET
aji-159	511	4	open	open	ADJ
aji-159	511	5	access	access	NOUN
aji-159	511	6	article	article	NOUN
aji-159	511	7	distributed	distribute	VERB
aji-159	511	8	under	under	ADP
aji-159	511	9	the	the	DET
aji-159	511	10	terms	term	NOUN
aji-159	511	11	of	of	ADP
aji-159	511	12	the	the	DET
aji-159	511	13	creative	creative	ADJ
aji-159	511	14	commons	common	NOUN
aji-159	511	15	attribution	attribution	NOUN
aji-159	511	16	license	license	NOUN
aji-159	511	17	(	(	PUNCT
aji-159	511	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-159	511	19	)	)	PUNCT
aji-159	511	20	,	,	PUNCT
aji-159	511	21	which	which	PRON
aji-159	511	22	permits	permit	VERB
aji-159	511	23	unrestricted	unrestricted	ADJ
aji-159	511	24	use	use	NOUN
aji-159	511	25	,	,	PUNCT
aji-159	511	26	distribution	distribution	NOUN
aji-159	511	27	,	,	PUNCT
aji-159	511	28	and	and	CCONJ
aji-159	511	29	reproduction	reproduction	NOUN
aji-159	511	30	in	in	ADP
aji-159	511	31	any	any	DET
aji-159	511	32	medium	medium	NOUN
aji-159	511	33	,	,	PUNCT
aji-159	511	34	provided	provide	VERB
aji-159	511	35	the	the	DET
aji-159	511	36	original	original	ADJ
aji-159	511	37	work	work	NOUN
aji-159	511	38	is	be	AUX
aji-159	511	39	properly	properly	ADV
aji-159	511	40	cited	cite	VERB
aji-159	511	41	.	.	PUNCT
aji-159	512	1	peer	peer	NOUN
aji-159	512	2	-	-	PUNCT
aji-159	512	3	review	review	NOUN
aji-159	512	4	history	history	NOUN
aji-159	512	5	:	:	PUNCT
aji-159	512	6	the	the	DET
aji-159	512	7	peer	peer	NOUN
aji-159	512	8	review	review	NOUN
aji-159	512	9	history	history	NOUN
aji-159	512	10	for	for	ADP
aji-159	512	11	this	this	DET
aji-159	512	12	paper	paper	NOUN
aji-159	512	13	can	can	AUX
aji-159	512	14	be	be	AUX
aji-159	512	15	accessed	access	VERB
aji-159	512	16	here	here	ADV
aji-159	512	17	:	:	PUNCT
aji-159	512	18	https://pr.sdiarticle5.com/review-history/125999	https://pr.sdiarticle5.com/review-history/125999	X
aji-159	512	19	https://pr.sdiarticle5.com/review-history/125999	https://pr.sdiarticle5.com/review-history/125999	PRON